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ABSTRACT
The main aim of this dissertation was to design and synthesize molecular probes with ease
to be used in medical and environmental applications. The first chapter focuses on a novel pseudorotaxane probe that can be used in

129

Xe imaging, which was synthesized using commercially

available cyclodextrin moieties with a one-step reaction. This is probe can be synthesized in high
yields and results in an acceptable level of hyperCEST depletion percentage. The second chapter
showcases pillararenes as a potential candidate for 129Xe imaging. In addition, this chapter discusses
the aid of a computational programs to design the supramolecular scaffold before the synthesis.
The third chapter is an extension of the first chapter, which focuses on designing rotaxanes probes,
which are interlocked molecular structures. Furthermore, these novel cyclodextrin based rotaxanes
were able to capture a positively charged guest which gives an access point to use these as a
potential drug delivery agent. Chapter 4 describes on a novel supramolecular scaffold that is
synthesized using a co-pillararene. This fluorescent co-pillararene is capable of switching from a
self-inclusion form to an open form via temperature, solvent and external guests, which makes this
pillararene an excellent molecular switch. Chapters 5 and 6 elaborate the use of water-soluble
pillararene structures in toxicant removal via host-guest inclusion phenomena and self-aggregation
with the use of commercially existing double-stranded DNA. Chapter 7 deviates from the
supramolecular regime and discusses the development of novel antibiotic drug molecules and their
novel functionalization to increase their potency.
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Fernando, John Christy, Brianna Peloquin, Paul Cesana, Samantha Donahue and Brenton DeBoef.
The fourth manuscript (Chapter 4) will be submitted to Chemical Communications in 2019 with
authors Ashvin Fernando, Paul Cesana, Adriana Mendieta, Cassandra, Al Bach, and Brenton
DeBoef. The fifth manuscript (Chapter 5) will be submitted to Supramolecular chemistry in 2019
with authors Ashvin Fernando, Teresa Mako, Adelaide Levenson, Paul Cesana, Adriana Mendieta,
Mindy Levine, and Brenton DeBoef. The sixth manuscript (Chapter 6) will be submitted to ACS
Biomacromolecules in 2019 with authors Ashvin Fernando, Paul Cesana, Adriana Mendieta, Jason
R Dwyer, and Brenton DeBoef. The seventh manuscript (Chapter 7) will be submitted a journal of
antibiotics 2019 with authors Samantha A. Donahue, Ashvin Fernando, Gerwald Jogl, Paul Cesana,
Breton DeBoef, and Steven T. Gregory.
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ABSTRACT
Hyperpolarized (HP) xenon-129 (Xe) mag- netic resonance (MR) imaging has the potential to
detect biological analytes with high sensitivity and high resolution when coupled with xenonencapsulating molecular probes. Despite the development of numerous HP Xe probes, one of the
challenges that has hampered the translation of these agents from in vitro demonstration to in vivo
testing is the difficulty in synthesizing the Xe-encapsulating cage molecule. In this study, we
demonstrate that a pseudorotaxane, based on a γ-cyclodextrin macrocycle, is easily synthesized in
one step and is detectable using HyperCEST-enhanced 129Xe MR spectroscopy.
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Introduction
Hyperpolarized (HP) xenon-129 magnetic resonance imaging (MRI) has the potential to become a
molecular imaging platform for safely producing highly resolved three-dimensional images of
biochemical phenomena through the use of xenon- capturing molecular probes. Currently, the most
prevalent molecular imaging techniques, positron emission tomography and single-photon
emission computed tomography, involve the administration of radiolabeled chemical probes. Other
methods for enhancing MR sensitivity, such as parahydrogen-induced polarization, signal
amplification by reversible exchange, and dissolution dynamic nuclear polarization, and dynamic
1H imaging techniques, such as paramagnetic chemical exchange saturation transfer, involve the
difficult synthesis of molecular probes using parahydrogen, specific isotopes, or toxic metal ions
before the imaging experiment is performed1-3. Contrastingly, molecular probes based on the
pseudorotaxanes described herein are simple to synthesize and the inclusion of the nonradioactive,
nontoxic 129Xe isotope occurs spontaneously in situ. Xe gas can be inhaled, and its biodistribution
can be imaged using an MRI instrument with a broadband coil.4−6 HP Xe atoms cannot, by
themselves, be tuned to target particular regions in the body, but targeted HP Xe biosensors that
are capable of binding both biochemical receptors and xenon atoms in vivo have been postulated
as a new molecular imaging platform.7−9
Employing hyperpolarized nuclei and a saturation transfer pulse sequence, known as HyperCEST,
provides up to a billion times sensitivity enhancement compared to that of thermally polarized
nuclei, allowing for picomolar concentrations of the Xe-encapsulating probe to be detected.10-11 We
recently disclosed the first in vivo images of an HP Xe probe in a live animal using the millimolar
quantities of the nontargeted Xe cage, cucurbit[6]uril (CB6).12 This work demonstrated that
molecular probes can be imaged in vivo via HyperCEST, but despite this work and numerous other
prototypes,8,13−25 targeted HP Xe MRI biosensors have yet to be used for in vivo imaging in a whole
animal. The development of these potential biosensors has not been slowed by a lack of interest in
3

the techniques or by barriers in MRI technology. In our opinion, the problem is more fundamental:
the supramolecular hosts that encapsulate xenon are difficult to synthesize and functionalize, so
sufficient quantities of the targeted probes for in vivo imaging are simply not available. Herein, we
describe the development of a new class of water- soluble HP Xe biosensors that use a
pseudorotaxane to encapsulate HP Xe and can be imaged using a HyperCEST pulse sequence. The
modular nature of the probes and their facile synthesis should allow for the rapid development of
targeted molecular probes for HP Xe MRI (Figure 1)

Figure 1.1:Proposed binding of Xe via formation of a ternary complex and detection via
HyperCEST
Until recently, the hollow, ball-shaped molecular cages, known as cryptophanes, appeared to be
privileged structures in the field of HP Xe imaging.26−28 Cucurbit[6]uril (CB6) and cucurbit[7]uril
4

(CB7) have also been reported as HP Xe probes,11,29-30 but the larger cucurbit[8]uril (CB8) does not
show any affinity for Xe. α, β, and γ-cyclodextrins (CDs), which are truncated cone-shaped
macrocycles composed of six, seven, or eight D-glycopyranoside units, are some of the most
commonly used hosts in supramolecular chemistry,31 and they would be ideal components of 129Xe
probes because they are nontoxic and water soluble (Figure 2).
Unfortunately, either α, β, and γ-CD fail to bind Xe in aqueous media or the reversible binding has
too fast of an exchange rate to form a distinct peak that is observable by129Xe NMR at room
temperature.32,33 We hypothesized that macrocycles that were too large to bind Xe on their own,
such as CB8, β-CD, and γ-CD, could be threaded with long alkyl chains to create pseudorotaxane
complexes that were capable of forming a ternary complex with Xe (Figure 1). 34 Rotaxanes are
well-known supramolecular species composed of a molecular axle that is threaded through a tubeshaped host, creating a noncovalently bound structure. To serve as a Xe cage, the inner diameter of
the rotaxane macrocycle must be large enough to fit both the molecular axle and a Xe atom in its
hydrophobic core. However, a macrocycle that is too large would not be detectable using
HyperCEST because the Xe would exchange in and out of the host at a rate that is too high to
support HyperCEST detection. Prior to this work, the only precedent for the formation of this kind
of ternary complex with Xe was reported by Cohen, who showed that a pillararene could
simultaneously bind hexane and Xe.35 To test the above mentioned hypothesis, we designed a series
of new pseudorotaxanes based on cucurbiturils and cyclodextrins to determine their potential as
xenon hosts.
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Figure 1.2: Structures of hosts and guests used in this study
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RESULTS AND DISCUSSION
Three cucurbiturils (CB6, CB7, and CB8) and three cyclo- dextrins (α, β, and γ-CD) were chosen
as the host molecules. These six macrocycles were threaded with 8- and 10-carbon molecular
threads that contained terminal ethylimidazolium groups, which served to enhance the water
solubility of the hydrophobic alkanes and enabled facile detection by mass spectrometry (1 and
2).36 In all of the cases studied, the rapid formation of threaded complexes was observed by mass
spectrometry and 1H NMR, though most cases showed rapid host−guest exchange on the NMR
time scale. Analysis by 129Xe NMR identified the promising scaffolds
that combined the desired attributes of facile synthesis with MR detectability via HyperCEST. For
the HP Xe studies, we used a custom-built fritted phantom inside a custom dual-tuned 1H/129Xe
radiofrequency (RF) coil to acquire all free induction decay (FID) spectra. The aqueous solutions
of the pseudor- otaxanes were placed inside the fritted phantom, and HP Xe was introduced below
the fritted phantom, creating micro- bubbles that percolated vertically through the sample. A series
of saturation prepulses at a variety of chemical shift offsets were loaded into user interface software
of the GE Achieva 3T MR scanner. Spectra with different saturation prepulses were acquired
approximately every 6 s.
As expected, irradiation at +128 ppm (relative to the peak corresponding to xenon gas) produced a
67% depletion for a sample of unthreaded CB6, thus confirming that our experimental method was
reliable (Table 1, entry 1). However, it should be noted that contrary to previous reports, we did
not observe a HyperCEST signal for CB7 (entry 4).37 None of the studies with cucurbituril-derived
pseudorotaxanes produced any HyperCEST attenuation (entries 2−3, 5−6, and 8−9), likely
indicating that there is not sufficient space to bind xenon in the cavity of the supramolecular
complex. Gratifyingly, we found that cycodextrin-based pseudorotax- anes reversibly encapsulated
Xe and could be detected by 129Xe magnetic resonance spectroscopy. HyperCEST depletions of
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43 and 52% were observed for the γ-CD containing C8 and C10 diethylimidazolium bars (2 ⊂ γCD and 1 ⊂ γ-CD, respectively, entries 17 and 18).

a

Entry

Pseudo-rotaxane

Cavity
Volume (Å3)a

HyperCEST
(%)c

δ (ppm)b

1

CB6

164

67%

+128

2

+2

52

0%

-

3

+1

41

0%

-

4

CB7

279

0%

-

5

+2

82

0%

-

6

+1

79

0%

-

7

CB8

479

0%

-

8

+2

138

0%

-

9

+1

125

0%

-

10

α-CD

174

0%

-

11

+2

52.1

0%

-

12

+1

48.1

0%

-

13

β-CD

262

0%

-

14

+2

85.1

0%

-

15

+1

74.2

0%

-

16

γ-CD

427

0%

-

17

+2

170.1

43%

+128

18

+1

176.2

52%

+128

Volume of xenon binding pocket based on computed host and pseudorotaxane structures. See the

Supporting Information for details.
b

Depletion of the peak corresponding to unbound Xe. Samples were dissolved in water (2 mL, 10

mM), and one-dimensional 129Xe spectra were recorded. HyperCEST spectra were subsequently
acquired using a series of off-resonance pulses varying by 5 ppm
Table 1-1: Characterization and HyperCEST Data for Pseudorotaxanes
Like CB6, the maximum HyperCEST depletion for the γ-CD pseudorotaxanes occurred when the
samples were irradiated at a frequency of +128 ppm, relative to the Xe gas-phase signal.
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HyperCEST depletion spectra for 1 ⊂ γ-CD are shown in Figure 3. Importantly, the magnitude of
the HyperCEST depletion for 1 ⊂ γ-CD was comparable to that of CB6, a xenon cage that we have
recently shown to be amenable.
to in vivo HP Xe MRI.12 1H NMR also confirms the formation of the ternary
pseudorotaxane−xenon complex [(Xe·1) ⊂ γ-CD, Figure 4]. Formation of the pseudorotaxane with
γ-CD and 1 can be monitored by an upfield shift in the triplet corresponding to the proton attached
to the C3 position in the cyclodextrin. This proton is positioned on the interior of the macrocycle,
so it is shielded when the pseudorotaxane forms. Subsequent binding of xenon further shifts the
C3−H peak upfield, indicating that the xenon also binds to the interior of the macrocyclic host. No
shifts of the protons corresponding to the ethylimidazolium groups of the host pseudorotaxane are
observed. Whereas these spectra might not, by themselves, be definitive evidence for the formation
of the proposed ternary complex, when considered in the context of the HyperCEST data shown in
Figure 3, the data are consistent with the formation of a ternary complex. Importantly, the control
experiments in entries 10, 13, and 16 of Table 1 show that xenon does not form a binary complex
with cyclodextrins that can be detected by HyperCEST.
The formation of the pseudorotaxanes was observed by mass spectrometry. Additionally, NMR
and isothermal calorimetry (ITC) binding studies were used to characterize the most promising
pseudorotaxanes.38 The association constant, Ka, for 1 ⊂ γ-CD was determined by NMR in pure
water to be 2.94 × 103 M−1 at 300 K, and the Ka for 2 ⊂ γ-CD was determined to be 4.10 × 103 M−1
at 300 K. ITC was also used to corroborate the Ka for 1 ⊂ γ-CD in pure water, 1.00 × 104 M−1 at
300 K. Importantly, ITC in fetal bovine serum also showed formation of the pseudorotaxane
complex, though the binding affinity was two orders of magnitude lower, 1.01 × 102 M−1 at 300 K.
This indicates that the pseudorotaxanes form in complex, biological media, so they could find
application as hyperpolarized xenon biosensors.
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Figure 1.3: Free Induction Decay (FID) spectra of 10 mM aqueous solution of 1⸦γ-CD following
off-resonance (+255 ppm, left) and on-resonance (+128 ppm, center) HyperCEST pulses.
HyperCEST depletion z-spectrum of a 10 mM aqueous solution of 1⸦γ-CD (right). Each data point
indicates the HyperCEST depletion when the molecule is irradiated with a pulse at a given chemical
shift off-set.
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The data shown herein indicate that two parameters can be used to predict the ability of a
pseudorotaxane to form a ternary complex with xenon. First, the pseudorotaxane must form a 1:1
host−guest complex. Our data does not probe a wide range of host−guest association constants, but
it appears that an affinity on the order of 103 is sufficient.
Second, the pseudorotaxane must contain an internal hydrophobic cavity with a volume of
approximately 164−176 Å3 (Table 1, entries 1, 17, and 18). These parameters explain why all the
pseudorotaxanes with hosts besides γ-CD failed to bind Xe; they simply did not have a large enough
internal cavity. α-Cyclodextrin also has a cavity that is of sufficient size to bind Xe (174 Å3, entry
10), and this binding has been previously reported;32 however, the chemical shift of the bound
complex is 3 ppm away from the peak corresponding to dissolved xenon, too close to be observed,
as our HyperCEST pulse is ∼10 ppm wide.

Figure 1.4: 1H NMR spectra indicating the formation of the ter-nary complex (25 oC, [γ-CD] = [1]
= 100 mM.) A/ 1H NMR spectrum of γ-cyclodextrin. B/ 1H NMR spectrum after addition of 1
equiv of 1. C/ 1H NMR spectrum after addition of 1.5 atm xenon
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It should be noted that the pseudorotaxanes that we are describing herein are markedly distinct from
the rotaxane-based HP Xe probes that have been recently described by Dmochowski, Pines, and
Francis.19,39 In those cases, a threaded CB6 structure was synthesized that could not bind Xe, but
when the thread was severed, either by action of an enzyme or by a change in pH, the CB6 was
released, and a signal was observed. These probes represent a creative approach for synthesizing
“turn on” HP Xe sensors; contrastingly, the rotaxanes that we describe herein are a new scaffold
that is capable of producing an HP Xe signal via formation of a ternary binding motif The data
shown in Table 1 and Figure 3 were obtained using a Phillips Achieva 3T clinical whole-body MR
scanner, which provides significant advantages over conventional NMR spectrometers, namely, the
ability of performing whole-body imaging experiments. These advantages come with some tradeoffs, specifically the ability of acquiring HyperCEST depletion spectra with a Lorenzian fit line,
such as in the data processed for cryptophane and cucurbituril agents, as demonstrated by others
using high-field, high-resolution NMR spectrome- ters.11,39−42 However, the use of a clinical
scanner bodes well for eventual clinical translation of our techniques to in vivo experiments, which
we recently demonstrated using a non- targeted 129Xe contrast agent.12
In conclusion, we have discovered a novel method for synthesizing potential HP Xe probes using
pseudorotaxane structures of γ-CD. These supramolecular complexes form a novel ternary structure
in the presence of HP Xe, which can be detected via 129Xe MR spectroscopy. Current efforts in
our laboratories are dedicated to synthesizing rotaxane-based probes that will not dissociate and in
the application of these new probes for targeted molecular imaging.
NMR HyperCEST Detection. Natural abundant 129Xe gas
was polarized to 26−30% using a Xemed polarizer (Xemed, Durham, NH). Next, 1.0 mL of sample
was drawn into a glass frit cell using a syringe. The cell was then inserted into a custom RF coil
tuned to the Larmor frequency of 129Xe (35.33 MHz) at 3T, where HP 129Xe gas was introduced
to the vessel from the Tedlar bag in the pressure chamber, which was pressurized at 35 kPa above
12

atmosphere. The solution was mixed with HP 129Xe gas as it passed through the fine fritted disc
and produced several microbubbles, which continuously dissolved into solution and exited the
vessel through the outflow tube. The concentration of 129Xe at any point during the experiment
was between 1 and 10 mM. A Philips Achieva 3T clinical scanner was used to collect all NMR
spectra. The RF pulse length was determined with the use of ref B1, a parameter of Philips MR
scanners. The pulse length and flip angle were used to calculate the amplitude of the RF pulse and
field strength. In this study, the B1 field strength was determined by the scanner to be 15.9 μT. In
the acquisition of NMR spectra, a pulsed saturation pre-pulse train consisting of 96−20 ms 3-lobe
sinc pulses with 0 ms pulse intervals was applied at various chemical shift offsets.
Free induction decay (FID) spectra were acquired at various chemical shift frequency offsets,
approximately 5 ppm apart. Each FID spectra was acquired approximately 6 s apart. Off- resonance
FID spectra were obtained quarterly in this series and acquired with a saturation pre-pulse at +271
ppm off- resonance from the gas-phase peak. A HyperCEST depletion spectrum was collected for
each sample (see the Supporting Information) by measuring HyperCEST depletion at various
frequency offsets from the Xe gas-phase peak. A minimum of three spectra were obtained at each
of the various chemical shifts, and a plot of the mean signal depletion as a function of the frequency
of the chemical shift offset (z-spectrum) was produced. The mean signal-to-noise ratio (SNR)
obtained from all control spectra for individual samples was used in the measurement of signal
depletion. The SNR for each spectrum was calculated using MATLAB (MathWorks, Natick, MA).
To measure signal depletion, the mean HyperCEST saturation spectrum SNR was subtracted from
the mean control spectrum SNR. This difference was then divided by the mean control spectrum
SNR to produce the signal depletion by the HyperCEST effect.
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1.2

SUPPORTING INFORMATION
Cyclodextrin-based Pseudorotaxanes: Easily Conjugatable Scaffolds for Synthesizing
Hyperpolarized Xenon-129 Magnetic Resonance Imaging Agents

Experimental Section
Reagents
Substrates, including 1-ethylimidazole, 1,8-dibromooctane, 1,10-dibromodecane, 1,5dibromopentane,

cucurbit[6]uril,

cucurbit[7]uril,

cucurbit[8]uril,

-cyclodextrin,

-

cyclodextrin and -cyclodextrin were purchased from Sigma-Aldrich, Fisher Scientific, and
TCI chemicals. All reagents were stored under an inert atmosphere before use. Unless
otherwise noted, all reactions were performed under N2.

Instrumentation
NMR spectra were obtained using a Bruker Avance 300 MHz and 400 MHz spectrometers.
Low resolution mass spectrometry was performed using a Shimadzu LRMS-2020. High
resolution mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap XL™
instrument. Isothermal calorimetry was performed using TA Instruments TAM III™
instrument.
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Synthesis of guest molecules
Synthesis of C10 diethylimidazolium guest, 1

1-Ethylimidazole (1.942 mL, 20 mmol) and 1,10-dibromodecane (1.792 mL, 8 mmol) were
dissolved in toluene (15 mL) and refluxed for 12 hours. Once complete, the toluene was
decanted, and the crude product was washed with diethyl ether (3 x 20 mL) and dried under
vacuum until a white solid product formed (2.20 g, 56% yield). Spectral data matched the
reported values.1
H NMR (400 MHz, DMSO-d6) δ 9.34 (s, J = 1.7 Hz, 2H), 7.85 (dd, J = 5.8, 1.9 Hz, 4H), 4.20

1

(dq, J = 14.3, 7.3 Hz, 8H), 1.79 (p, J = 7.3 Hz, 4H), 1.43 (t, J = 7.3 Hz, 6H), 1.25 (s, 12H).
13

C NMR (101 MHz, DMSO-d6) δ 136.1, 122.8, 122.6, 49.2, 44.6, 29.8, 29.2, 28.8, 25.9, 15.5.

HRMS ESI (m/z): [M+] calculated for C20H36N42+ 166.1467, observed 166.1455.
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Figure 1.5: 1H NMR of Guest 1
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Figure 1.6: 13C NMR of Guest 1
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Synthesis of C8 diethylimidazolium guest, 2

1-Ethylimidazole (1.06 mL, 11 mmol) and 1,8-dibromooctane (808.7 µL, 4.4 mmol) were
dissolved in toluene (15 mL) and refluxed for 12 hrs. Once complete, the toluene was decanted,
and the crude product was washed with diethyl ether (3 x 20 mL) and dried under vacuum until
a white solid product formed (0.51 g, 38% yield). Spectral data matched the reported values.1
H NMR (400 MHz, DMSO-d6) δ 9.40 (s, 2H), 7.86 (d, J = 1.7 Hz, 4H), 4.11 (m, 8H), 1.79 (p,

1

J = 7.2 Hz, 4H), 1.42 (t, J = 7.3 Hz, 6H), 1.12 (m, 8H).
13

C NMR (101 MHz, DMSO-d6) δ 136.2, 122.8, 122.6, 49.2, 49.6, 29.7, 28.6, 25.8, 15.6.

HRMS ESI (m/z): [M+] calculated for C18H32N42+ 152.1308, observed 152.1298.
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Figure 1.7: 1H NMR of Guest 2
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Figure 1.8: 13C NMR of Guest 2
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Synthesis of pseudorotaxanes using cucurbit[n]urils and bars
10 mM stock solutions of cucurbit[n]uril (n= 6, 7, 8) and the guests were prepared using D2O
as the solvent. Using the above stock solutions, 0.25 mL of the host and 0.25 mL of the guest
were mixed inside a GC vial. The threading of the guest into the host was achieved by heating
the solution inside the GC vial to 85 oC for 3 min. This solution was then cooled to room
temperature and transferred to an NMR tube. While the initial CB solutions were cloudy, the
final pseudorotaxane solutions were clear and homogeneous. 1H NMR spectra were then
acquired at 300 K. 1H NMR was performed to see the movement of the alkyl protons in the
guest and the movement of the guests after the inclusion complexes were formed.
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2

2CB6
Figure 1.9: 1H NMR of 2⸦CB6
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2

2CB6

Figure 1.10: 1H NMR (magnified) of 2⸦CB6 in the region of the guest protons
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1CB6
Figure 1.11: 1H NMR of 1⸦CB6
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1CB6
Figure 1.12: 1H NMR (magnified) of 1⸦CB6 in the region of guest protons
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2

2CB7
Figure 1.13: 1H NMR of 2⸦CB7
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2

2CB7

Figure 1.14: 1H NMR (magnified) of 2⸦CB7 in the region of guest protons
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1CB7
Figure 1.15: 1H NMR of 1⸦CB7
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1CB7
Figure 1.16: 1H NMR (magnified) of 1⸦CB7 in the region of guest protons
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Figure 1.17: 1H NMR of 2⸦CB8

34

2
C8 diethylimidazolium bar (3)

2CB8

C8 diethylimidazolium bar (2)

2CB8

Figure 1.18: 1H NMR (magnified) of 2⸦CB8 in the region of guest protons
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Figure 1.19: 1H NMR of 1⸦CB8
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C10 diethylimidazolium bar (1)

1CB8

C10 diethylimidazolium bar (1)

1CB8

Figure 1.20: 1H NMR (magnified) of 1CB8 in the region of guest protons
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Synthesis of Pseudorotaxanes using α, β, and γ-CDs
10 mM stock solutions of cyclodextrins (α, β, γ) and the guests were prepared using D2O as the
solvent. Using the above stock solutions, 0.25 mL of the host and 0.25 mL of the guest were
mixed inside a GC vial. The threading of the guest in to the host was achieved by heating the
solution inside the GC vial to 40 oC for 3 min. This solution was then cooled to room
temperature and transferred to a NMR tube. The final solutions containing the pseudorotaxanes
were clear and homogeneous. All 1H NMR spectra were acquired at 300 K. 1H NMR was
performed to see the movement of the alkyl protons in the guest and the movement of the
cyclodextrins’ H-3 proton and H-5 protons, which are present inside the cavity of the CDs.
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α-CD

2

2α-CD
Figure 1.21: 1H NMR of 2⸦α-CD
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2

2α-CD

Figure 1.22: 1H NMR (magnified) of 2⸦α-CD in the region of guest protons
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α-CD

1α-CD
Figure 1.23: 1H NMR of 1⸦α-CD
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β-CD

2

2β-CD
Figure 1.24: 1H NMR of 2⸦β-CD
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β-CD

1β-CD
Figure 1.25: 1H NMR of 1⸦β-CD
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1β-CD
Figure 1.26: 1H NMR (magnified) of 1 β-CD in the region of guest protons
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γ-CD

2

2γ-CD
Figure 1.27: 1H NMR of 2⸦γ-CD
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2

2γ-CD

Figure 1.28: 1H NMR (magnified) of 2⸦γ-CD in the region of guest protons
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2

2γ-CD

Figure 1.29: 1H NMR (magnified) of 2⸦γ-CD in the region of H-3 proton of γ-CD
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γ-CD

1γ-CD
Figure 1.30: 1H NMR of 1⸦γ-CD
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1γ-CD
Figure 1.31: 1H NMR (magnified) of 1⸦γ-CD in the region of guest protons
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1γ-CD
Figure 1.32: 1H NMR (magnified) of 1⸦γ-CD in the region of H-3 proton of γ-CD
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Determination of association constants for host cyclodextrins and guests
The NMR titration experiments were conducted per the following procedures.2 The host CD
concentrations were kept constant while the guest concentration was increased periodically.
Stock solutions of 2 mM host (cyclodextrin) and 200 mM guest were prepared. A series of
NMR samples were prepared in 5 mm NMR tubes. The series ranged from 0.111 mM to
200 mM. All samples were then heated for 3 min at 40 oC to facilitate the threading of the
guest in to the host. All samples were cooled to room temperature before the 1H NMR
experiments. All 1H NMR were performed at 300 K. The H-3 proton of the host CD was
monitored. Data was processed using an Excel spreadsheet using the equation shown below.
The plots are shown below. The data were also evaluated using the “OpenDataFit” website,
which is an online free fitting program found at supramolecular.org.2 The two different
analysis methods provided similar results.
The following equation was used to calculate the association constant:
1
∆𝛿𝑚𝑎𝑥
1
1
∆𝛿 = (
) + {[𝐻0 ] + [𝐺0 ] + − (([𝐻0 ] + [𝐺0 ] + )2 − 4[𝐻0 ] [𝐺0 ])2 }
2[𝐻0 ]
𝐾
𝐾

where ∆δ = change in chemical shift after the addition of the guest, [H0] = initial host
concentration, [G0] = initial concentration, and K = association constant. ∆δ was plotted as
a function of the guest concentration.
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Figure 1.33: 1H-NMR stacked plot of γ-cyclodextrin and varying guest (1)
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Δδ (Chemical shift)

Guest Concentration (mM)

Δδ (Chemical shift)

Figure 1.34: 1:1 Binding curve for the association of 1 with γ-CD.

Figure 1.35: 1:1 Binding curve for the association of 1 with γ-CD.

Guest Concentration (mM)
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Δδ (Chemical shift)

Guest Concentration (mM)

Δδ (Chemical shift)

Figure 1.36: 1:1 Binding curve for the association of 2 with γ-CD.

Guest Concentration (mM)

Figure 1.37: 1:1 Binding curve for the association of 2 with γ-CD.

Mass spectroscopic studies
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All compounds were prepared in the deionized water at a concentration of 200 µM for
both guest and host molecules separately and as a mixture. Then they were diluted to 20
µM (each) in a solution of methanol/water (50/50) to produce the standards for mass
spectrometric analysis. The final solutions were infused into a Thermo Scientific LTQ
Orbitrap XL™ (Waltham, MA, USA) mass spectrometer at a rate of 10 µL/min using
electrospray ionization source in a positive mode. The rest of the ionization and ion optics
parameters were as follows: sheath gas 15, auxiliary gas 3, spray voltage 5 kV, capillary
temperature 275 °C, capillary voltage 47 V, tube lens 225 V, multipole 00 offset -5.5 V,
lens 0 -6.0 V, multipole 0 offset -5.75 V, lens 1 -10.0 V, gate lens -46.0 V, multiple 1 offset
-19.5 V, multipole RF amplitude 400.0 V, front lens -6.75 V. The mass spectra were
collected using full scan mode with resolution of 30000 in the range between 100 and
2000 amu. The spectra were averaged over at least 50 micro scans with 10.0 ms
maximum injection time and 2.0x105 ions for AGC target settings.
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Figure 1.38: Mass spectrum of α-CD
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.

Figure 1.39: Mass spectrum of β-CD
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Figure 1.40: Mass spectrum of γ-CD
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Figure 1.41: 1⸦γ-CD (ESI+, 5 uL/min, FS, 20 uM/20 uM) – m/z 1707.6307

59

Relative Abundance

0

20

40

60

80

0
100

20

40

60

80

100

1703

1704

1705

Isotope Simulation

1706

1707

1708

1709
m/z

1710

1711

1713.7207 1714.8379

1712

1713

1714

1715

1712.6424 1713.6433
1714.6466

1711.6390

1710.6357

1711.6286

1710.6334

1709.6323

1708.6377

1707.2381
1707.6344

1708.6333

1707.6307

1709.6313

c 68 h 116 brn 4 o 40:
C 68 H 116 Br 1 N 4 O 40
pa Chrg 1

NL:
2.15E5

NL:
3.65E4
ESI+
_GCD-10C_11_26july2017_2#4-92
RT: 0.05-1.45 AV: 89 T:
FTMS + p ESI Full ms
[100.00-2000.00]

Figure 1.42: 3⸦γ-CD (ESI+, 5 uL/min, FS, 20 uM/20 uM) – m/z 1679.5996
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Figure 1.43: 1⸦α-CD (ESI+, 5 uL/min, FS, 20 uM/20 uM) – m/z 1707.6307
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Figure 1.44: 3⸦α-CD (ESI+, 5 uL/min, FS, 20 uM/20 uM) – m/z 638.2887
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Figure 1.45: 1⸦β-CD (ESI+, 5 uL/min, FS, 20 uM/20 uM) – m/z 733.3298
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Determination of association constants for guest probes and γ-CD using Isothermal
Titration Calorimetry (ITC)
A 1000 mM solution of 1 and 100 mM solutions of γ-CD were made in water and plasma. Once
the solutions were made, the guest solution was loaded in to the micro-syringe and the γ-CD
solution was placed in the sample ampoule (2 ml). Lower concentrations of the host and guest
did not provide sufficient heat flow for reliable ITC analysis. For the titration, a 1 µl/S rate and
21 injections were chosen. Except for the first injection, which was 3 µl, all the other injections
were 10 µl injections. Each titration was performed for 20 minutes with a 5-minute base line.
For data analysis, blank titrations were performed with addition of guest 1 to DI water and
plasma without the γ-CD. The data from the blank titration were used to subtract the heat of
dilutions. Once the Raw heat data was obtained, the data was processed using the online
software, AFFINImeter (https://www.affinimeter.com/).

64

Figure 1.46: ITC of 1 with γ-CD in water
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Figure 1.47: ITC of 1 with γ-CD in bovine plasma
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Association Constant of 1γ-CD = 1.00 ± 0.0327 x 104 M-1

Figure 1.48: Analysis of ITC binding data for 1 with γ-CD in water
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Association Constant of 1γ-CD (plasma) = 1.0114 ± 0.0592 x 102 M-1

Figure 1.49: Analysis of ITC binding data for 1 with γ-CD in bovine plasma
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A series of computational studies were performed to measure the cavity size of the
pseudorotaxanes using the Spartan 16 computational chemistry package. A first minimization
was performed using molecular mechanics with the MMFF force field in the gas phase. Once
the minima were obtained, the same force field was used to run the simulation in water as the
solvation source. After that, the semi-empirical PM3 force field was used to minimize the
structure in the gas phase. This was followed using an energy minimization (PM3) using
external water molecules (One water molecule of water was used per oxygen atom in the host.)
to mimic the hydrophobic and hydrophilic interactions of the guest to the hydrophobic cavity
of the host.
Guest

Guest-1
ΔE (kcal/mol)

Guest-2
ΔE (kcal/mol)

α-CD

-132.23

-108.96

β-CD

-448.94

-433.7

γ-CD

-778.93

-722.71

CB[6]

-198.98

-174.29

CB[7]

-234.64

-210.69

CB[8]

-370.23

-338.92

Host

Table 1-2: Calculated binding energies for pseudorotaxanes
Molecular modeling calculations were performed using Spartan 16 for all complexes as guests
encapsulated in the hosts to estimate the stabilization energy obtained by complexation (which
provides an indication of the relative binding constants). Above ΔE values are given in kcal/mol.
The following equation was used to obtain the final values:3
ΔE = E (complex) – E(host) – E(Guest)
External water molecules (one water molecule per oxygen in the host molecule) were used to mimic
the solvent environment for both the hosts and the host-guest complexes.
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Table 1-3: Computed distances between guest and host for 2⸦CB6
Atom labels

C-C distance (Ao)

C32, C47

8.725

C31, C47

7.318

C20, C47

7.369

C34, C47

6.039

C18, C47

6.557

C17, C47

5.805

C19, C47

6.511

C15, C47

5.832

bold distances represent the atoms that are inside the host cavity
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Table 1-4: Computed distances between guest and host for 1⸦CB6
Atom labels

C-C distance (Ao)

C32, C47

7.802

C31, C47

6.976

C20, C47

5.740

C34, C47

5.322

C18, C47

4.389

C17, C47

4.884

C16, C47

4.766

C15, C47

6.154

C57, C47

6.473

C13, C47

8.001

bold distances represent the atoms that are inside the host cavity
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Table 1-5: Computed distances between guest and host for 2⸦CB7
Atom labels

C-C distance (Ao)

C14, C58

7.802

C13, C58

6.976

C11, C58

5.740

C9, C58

5.322

C4, C58

4.389

C5, C58

4.884

C3, C58

4.766

C1, C58

6.154

bold distances represent the atoms that are inside the host cavity
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Table 1-6: Computed distances between guest and host for 1⸦CB7
Atom labels

C-C distance (Ao)

C1, C47

7.726

C3, C47

6.481

C5, C47

6.161

C7, C47

5.075

C9, C47

5.333

C11, C47

5.256

C13, C47

6.071

C14, C47

6.712

C25, C47

8.012

C26, C47

8.876

bold distances represent the atoms that are inside the host cavity
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Table 1-7: Computed distances between guest and host for 2⸦CB8
Atom labels

C-C distance (Ao)

C25, C71

7.809

C24, C71

6.389

C19, C71

6.084

C14, C71

5.255

C4, C71

5.808

C3, C71

5.340

C2, C71

6.566

C1, C71

6.593

bold distances represent the atoms that are inside the host cavity
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Table 1-8: Computed distances between guest and host for 1⸦CB8
Atom labels

C-C distance (Ao)

C40, C20

8.521

C39, C20

7.202

C25, C20

7.066

C24, C20

5.895

C19, C20

6.276

C14, C20

5.438

C4, C20

6.455

C3, C20

6.089

C2, C20

7.453

C1, C20

7.586

bold distances represent the atoms that are inside the host cavity
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Table 1-9: Computed distances between guest and host for 2⸦α-CD
Atom labels

C-C distance (Ao)

C6, C10

6.903

C5, C10

5.739

C4, C10

6.250

C3, C10

5.493

C2, C10

6.404

C7, C10

6.458

C18, C10

7.366

C19, C10

7.791

bold distances represent the atoms that are inside the host cavity
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Table 1-10: Computed distances between guest and host for 1⸦α-CD
Atom labels

C-C distance (Ao)

C32, C13

8.006

C21, C13

7.552

C2, C13

6.093

C3, C13

5.953

C4, C13

4.690

C5, C13

5.155

C6, C13

4.398

C7, C13

5.408

C18, C13

5.257

C19, C13

6.569

bold distances represent the atoms that are inside the host cavity
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Table 1-11: Computed distances between guest and host for 1⸦α-CD
Atom labels

C-C distance (Ao)

C13, C30

6.811

C12, C30

6.102

C11, C30

5.812

C5, C30

5.383

C4, C30

5.423

C3, C30

5.094

C2, C30

5.709

C1, C30

5.740

bold distances represent the atoms that are inside the host cavity
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Table 1-12: Computed distances between guest and host for 1⸦β-CD
Atom labels

C-C distance (Ao)

C35, C59

7.385

C34, C59

6.2783

C13, C59

6.664

C12, C59

5.892

C11, C59

6.763

C5, C59

6.527

C4, C59

7.629

C3, C59

7.812

C2, C59

8.992

C1, C59

9.554

bold distances represent the atoms that are inside the host cavity
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Table 1-13: Computed distances between guest and host for 2⸦γ-CD
Atom labels

C-C distance (Ao)

C2, C19

7.907

C3, C19

7.947

C4, C19

9.127

C7, C19

9.408

C9, C19

10.558

C23, C19

10.887

C25, C19

12.338

C33, C19

12.767

bold distances represent the atoms that are inside the host cavity
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Table 1-14: Computed distances between guest and host for 1⸦γ-CD
Atom labels

C-C distance (Ao)

C2, C19

9.347

C3, C19

8.737

C4, C19

9.309

C7, C19

9.223

C9, C19

10.032

C23, C19

10.344

C25, C19

11.233

C33, C19

11.926

C45, C19

12.772

C46, C19

13.599

bold distances represent the atoms that are inside the host cavity
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Xenon NMR studies
Naturally abundant 129Xe gas was placed into a 1.0 L Tedlar bag and polarized to 60-80% via
the spin exchange optical pumping (SEOP) technique using a Xemed polarizer (Xemed,
Durham, NH, USA). It was then placed into a Tedlar bag which was immediately moved into
a pressurized chamber within the bore of a Philips Achieva 3.0 T clinical MRI scanner to
preserve its polarization. The pressure inside of the chamber was maintained between 20-45
kPa above atmospheric pressure using a pressure-sensitive ventilation device connected to a
nitrogen (N2) source, to facilitate the flow of HP 129Xe gas from the Tedlar bag into the glassfritted cell containing rotaxane solution.
Following polarization of 129Xe gas, 2.5 mL of solution (50 mM) was transferred into a custommade glass-fritted cell using a syringe. The cell containing the solution was then placed inside
of a custom-made quadrature radio-frequency (RF) coil tuned to the Larmor frequency of 129Xe
(35.33 MHz) at 3.0 T. The Tedlar bag, already in the bore of the MRI, was then connected to
the cell’s inflow tube. Once connected, the pressure-stopper on the Tedlar bag was released to
allow for the continuous flow of HP 129Xe gas into the glass-fritted cell, which produced several
microbubbles as it passed through the fine fritted disc, thereby dissolving into the solution. As
HP 129Xe gas continually flowed through the glass-fritted cell,

129

Xe nuclear magnetic

resonance (NMR) spectral data was simultaneously obtained. The concentration of

129

Xe at

any point during the spectral acquisition was between 1-5 mM24.
All

129

Xe NMR spectra were acquired using a Philips Achieva 3.0 T clinical MRI scanner.

Scanner software was modified for the automatic measurement of hyperpolarized chemical exchange saturation transfer (HyperCEST) depletion spectra. To saturate HP 129Xe encapsulated
within the rotaxane molecules, two different pre-pulse trains were used: the first consisted of
16- 30 ms 3-lobe sinc pulses, while the second consisted of 16- 30 ms sinusoidal pulses, both
with 0 ms pulse intervals. To acquire each depletion spectrum, 37 free induction decay (FID)
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spectra were collected at various chemical shift frequency offsets with TR = 4s. Each FID
spectrum was acquired using a selective 90-degree “spredrex” excitation pulse with a 9.95 ms
duration and bandwidth of 1424 Hz (40.3 ppm at 3.0 T).
The data sampling number was 2048, which corresponds to the spectral resolution of 0.44 ppm.
Saturation pre-pulse frequency was automatically adjusted to range from -150 ppm to 30 ppm,
where 0 ppm represents dissolved-phase

129

Xe, with a predetermined step before each of the

subsequent excitation pulses. Offset frequency steps were 176.7 Hz, which correspond to 5
ppm at 3.0 T.

Figure 1.50: HyperCEST pulse sequence
The pulse diagrams shown above were used to prepare HyperCEST depletion spectra using
different saturation pre-pulse trains including 3-lobe sinc pulses (A) and sinusoidal pulses (B).
Here, fj represents the frequency of saturation pulses during FID acquisition number j. All
spoiler gradients along x, y, z axis is also illustrated.
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Figure 1.51: Apparatus for obtain HP Xe spectra

Figure 1.52: Custom-made coil and sample chamber
The image above illustrates the continuous flow of HP
vessel. As depicted, once the flow of HP

129

Xe gas throughout the glass-fritted

129

Xe reaches the fine glass-fritted disc, numerous

microbubbles are produced, thereby causing dissolution of HP

129

Xe into solution. The RF

pulse is applied at the chemical shift frequency offset which corresponds to the ternary complex
formed by the interaction of HP 129Xe with the pseudorotaxane complex.
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Cavity volume calculations
Commercially available MOE4 software was used to calculate the free space in the host after
the guest was threaded inside the CD or CB cavity, using the Assisted Model Building with
Energy Refinement (AMBER) force field for energy minimizations and molecular dynamics.
A custom-made active site volume script provided from MOE was used in the process. The
script computationally filled the void space in the pseudorotaxane with spheres having a
volume of 2.75 A3. The volume of the cavity was calculated as the sum of the volumes of the
spheres. This method is analogous to Rebek’s technique for calculating the volume of a
cavitand.4
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Abstract
A decacationic water-soluble pillar[5]arene (P5A) possessing a non-solvated hydrophobic core has
been designed and synthesized. This supramolecular host is capable of binding xenon, as evidenced
by a hyperCEST depletion experiment. Fluorescence-based studies have also demonstrated that
xenon binds into the cavity of the pillararene with an association constant of 4.6 x 103 M-1. These
data indicate that the water soluble pillararene is a potential scaffold for building targeted
biosensors that can be detected by xenon-129 magnetic resonance imaging.
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Introduction
There is a clear and pressing need for the development of safe magnetic resonance imaging
(MRI) contrast agents. One possible alternative to the current Gd-based contrast agents, which
have recently been shown to have toxicity issues, is the use of hyperpolarized xenon-129. Inhaled
129

Xe is non-toxic, readily distributes throughout the body, and can be easily detected using a

conventional MRI instrument with a broadband coil. We have recently shown that the 129Xe image
of a living rat can be overlaid onto a conventional 1H image to provide selective contrast.

1

The

key for this work was the use of the macrocyclic contrast agent, cucurbit[6]uril (CB6), which was
injected into the animal prior to the imaging experiment. The biodistribution of CB6 was imaged
because the molecular host bound the inhaled 129Xe in vivo, producing a unique localized signal in
the

129

Xe magnetic resonance spectrum. Whereas Gd(III) ions produce image contrast in a

conventional T1-weighted MR image by reversibly binding water molecules, the macrocyclic host
reversibly bound xenon atoms and this reversible binding was selectively imaged via a saturation
transfer pulse sequence, hyperCEST, thus providing localized contrast. 2-5
This seminal in vivo imaging experiment serves as an important proof-of-concept;
however, the use of CB6 was not optimal, as it is known to bind sodium and potassium ions that
are present in vivo, and it biodistribution cannot be changed as it is difficult to chemically modify.
6-12

Cryptophanes have also been extensively studied for their ability to bind xenon; however, they

are notoriously difficult to synthesize, are not by themselves water soluble, and water-soluble
derivatives such as TPCA have been recently shown to form complex aggregates in aqueous
solution. 13-16
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Figure 2.1: Comparison of Xe-binding hosts
We have recently focused our research efforts on the development of new supramolecular
structures for binding xenon, including the development of pseudorotaxanes that form unique
ternary complexes with 129Xe. 17 The ideal molecular host for use in

129

Xe MRI would be easy to

synthesize in large quantities, highly water-soluble, and would reversibly bind 129Xe, as evidenced
by a hyperCEST experiment.

Herein, we describe the design and synthesis of a cationic

pillar[5]arene macrocycle that meets all of these criteria.
Pillar[5]arenes (P5As), are pentameric macrocycles, synthesized by the templated FriedelCrafts cyclization of hydroquinone derivatives. Since they were initially synthesized by Ogoshi a
decade ago, 18 P5As have been used for a wide range of host-guest chemistry. 19,20 P5As contain a
central cavity of approximately 5.8 Å3, which is comparable to other macrocycles that have been
shown to have an affinity for xenon, such as CB6 and cryptophane-A, and recently both Cohen and
Schroeder have shown that P5A derivatives can interact with xenon, as evidenced by conventional
129

Xe NMR and by magnetization transfer experiments.

21,22

Herein, we report the design and

synthesis of a P5A structure that has been optimzed for its ability to bind xenon, we then quantify
its affinity for the nobel gas, and we demonstrate the first example of hyperCEST depletion for a
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pillararene macrocycle, thus validating its potential as a contrast agent for

129

Xe MRI, and laying

the necessary groundwork for subsequent in vivo imaging studies.
Results and discussion
We began our studies by computationally modelling a variety of P5A structures. Gas phase
energy minimized structures of pillararenes were obtained using semi-empirical computations and
a PM3 force field. A xenon atom was then placed outside the hydrophobic core of the P5A structure,
and the energy of the system was minimized again to model the dynamics of the two species.
Interestingly, the simplest P5A, which was decorated with 10 methyl groups (4), failed to bind
xenon in this computational experiment. Additionally, P5A structures that were decorated with
longer alkyl chains also failed to bind xenon (e.g. 2). In both of these cases, the molecular dynamics
experiments showed that the alkyl arms of the P5A structures preferred to fold onto themselves via
hydrophobic collapse. Contrastingly, the P5A structure containing 10 cationic imidazolium groups,
opened like the petals of a flower, revealing the hydrophobic core. The aforementioned gas phase
molecular dynamics experiment predicted that this decacationic P5A should be an excellent
candidate for binding xenon. Moreover, we predicted that this highly charged compound should
be readily water soluble, making it an excellent candidate for a hyperCEST contrast agent (Scheme
1).

91

Br
(CH2O)n
BF3-Et2O

O

ClCH2CH2Cl
70 oC, 1 h
92%

O
Br

1

Br

O

N
N N
N

N

Br

Br

Br

Br
O

O

N
Me
N

O

O

Br

O
O

O

O
Br
Br

Br

Toluene
reflux
87%

O

O

N
N

2

O

O
O

O

Br

N

O

O

N
O

N

N
N

N

N

Me
Me O
O

Me
O

O
Me

O
O Me
Me

O
Me

Me
O

O

O
N
N

Me
O

N
N

N

O
Me

N
4
3

Xe

Xe

No Xe binding

predicted Xe binding

Xe

No Xe binding

Scheme 2-1: Synthesis and computed structures of neutral and decacationic pillararenes
We further used molecular dynamics simulations in an aqueous environment to predict the
binding and hydrophobicity of the host structure. These simulations were performed using 1000
iterations with 0.001 ps time step size for discretizing the equations of motion for unconstrained
bond lengths, which allows free motion. The simulations were conducted in the presence of 1,830
water molecules within a P1 type cell with x, y, z distances of 90 Å, 90 Å, 90 Å (Figure 2). As
before, the xenon atom was computationally placed outside the hydrophobic cavity of the P5A and
was observed to rapidly associate with the hydrophobic core during the moleculear dynamics
simulation, thus indicating that the cationic P5A was capable of binding a single xenon atom in
aqueous solution. As shown in Figure 3, these computations prediceted that the hydrophobic core
of the P5A was not a good host for water molecules, thus it was capable of binding a xenon atom
with no desolvation cost.
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Figure 2.2: L to R: molecular dynamics simulations of Xe and 3 using 1830 water molecules;
computed hydrophobic surface of 3 is shown in red; Xe binds ot the hydrophobic surface of 3
As previously shown in the Scheme 1, the synthesis of the water-soluble P5A commenced
with the Friedel-Crafts cyclization of 1,4-bis(2-bromoethoxy)benzene in dichlorethane.26 As
previously reported by Huang, this solvent is crucial for the synthesis of pillara[5]arenes because
it serves as a template, allowing for high yields of the cyclic oligomer and preventing polymeric
products. Subsequently, the 10 imidazolium ions were added in a single step, and the decacationic
pillararene was isolated by recrystallization from methanol and diethyl ether.
1

H NMR spectroscopy of the pillararenes confirmed the computationally predicted

structures that were previously shown (Figure 3). The decabromo-P5A (2) was characterized by
sharp peaks in the 1H NMR spectrum, indicating that its structure was rigid and compact, whereas
the 1H NMR spectrum of the decacationic-P5A (3) contained broad peaks, indicating that the charge
repulsion created an open, flexible, open conformation.
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Figure 2.3: Stacked 1H-NMR of 2 in CDCl3 (top) and 3 in DMSO-d6 (bottom). Product peaks are
highlighted
Fluorescence quenching by xenon provided a sensitive method for measuring Xe binding,
even at substoichiometric Xe concentrations. P5As are weakly fluorescent, and titration of aqueous
xenon into the a solution of 3 induced quenching. 23 (See supporting information for experimental
details.) The data from the fluorescence quenching experiments was plotted using a non-linear
curve fitting method for single-site binding (1:1) as described by Thordarson. 24
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Figure 2.4: Left image; Fluorescence quenching phenomena when Xe (aq) added into a solution
of WSP5A (aq) in phosphate buffer.(Gaussian curve smoothing using Origin lab software), right
image; occupancy curve with respect to the concentration of Xe (aq) used
Dmochowski has performed similar fluorescence quenching studies for measuring the affinity of
xenon for the water-soluble cryptophane shown in Figure 1,

14

reporting an association constant

(Ka) of 1.7 x 104 M-1. The association constant that we obtained for 3 was one order of magnitude
lower 4.6 x 103 M-1, but it should be noted that 129Xe contrast agents do not necessarily have to bind
xenon with high affinity; the hyperCEST experiment capitalizes on reversible binding of xenon in
a supramolecular host. The quenching data show a maximum occupancy of 1, which is a clear
illustration of single-site binding.
Finally, the potential application of 3 as a

129

Xe contrast agent was assessed. The z-

spectrum of an aqueous solution of 3 is shown in Figure 5. The characteristic peak at -80 ppm
corresponds to the key 129Xe@3 complex. The hyperCEST depletion in this experiment is 30%,
which should be sufficient for imaging studies. 25 It is also likely that this result could be improved
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by modifying the pre-pulse train parameters, which should allow for better depolarization of the
encapsulated Xe. Importantly, these data were acquired in a Phillips Achieva 3T MRI scanner,
indicating that this technology can likely be translated for preclinical and clinical imaging studies.
Determination of HyperCEST depletion of water-soluble P5A
Naturally abundant 129Xe gas was polarized to 45-50% using a Xemed polarizer (Xemed, Durham,
NH). 50 mg water-soluble pillar-5-arene dissolved in 4 ml of DI H2O. 0.1 ml of DMSO was added
into the sample to prevent foaming inside the glass frit cell. Then, 2.0ml of the sample was drawn
into a glass frit using a syringe. The glass frit cell placed in the quadrature custom-built RF coil
tuned to the Larmor frequency of

129

Xe at 3T (35.33 MHz). The 0.5 lL Tedlar bag filled with

hyperpolarized 129Xe was connected to the frit shoulder and placed in the pressure chamber, which
pressurized at 24 kPa above the atmosphere. As HP

129

Xe flowed through the frit membrane, it

produced microbubbles, which facilitated dissolution of Xe.
A Philips Achieva 3T clinical MRI scanner was used to measure all NMR spectra. The saturation
pre-pulse train of 16 3-lobe sic pulses with a duration of 30 ms and with 0 ms pulse intervals was
applied at various chemical shift offsets concerning the dissolved phase peak. The bandwidth of
one 3-lobe sinc pulse of 30 ms duration is equal to 3 ppm. Therefore, each following pre-pulse train
was applied 3 ppm apart from the frequency of the previous train. Following each saturation train,
the FID spectrum was acquired. The spectral region from -150 ppm to 150 ppm was studied. The
spectral bandwidth was equal to 32 kHz. The data sampling number was similar to 2048 yielding
a spectral resolution of 0.44 ppm. A HyperCEST depletion spectrum was recalculated from the
measured spectra at various frequency offsets from the Xe dissolved phase peak. The 129Xe NMR
spectra were analyzed using MATLAB (MathWorks, Natick, MA).
The obtained HyperCest depletion spectrum was denoised using a Fast Fourier Transform Low
Pass parabolic filter. The Pass Frequency was equal to 0.04 ppm-1, and the Stop Frequency was
equal to 0.11 ppm-1. Following denoising, the obtained HyperCEST spectrum fitted by two peaks
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of Lorentzian shapes. The processing of the HyperCEST spectrum was done in the OriginPro 2016
software (OriginLab Corp., Northampton, MA).

Figure 2.5: Left, HyperCEST depletion spectra for Xe binding in water-soluble pillar[5]arene.
Right, energy minimized molecular model of Xe-bound P[5]A with the use of molecular dynamics.
The obtained depletion spectrum had a pillar-5-arene peak at -80 ppm. This is approximately 10
ppm upfield compared to the cucurbit[6]uril (CB6) peak position. After denoising, the peak
amplitude decreased by 4%. Although the depletion was just 30 %, that is approximately 2.7 times
smaller than CB6, and this supramolecular cage is a promising Xe biosensor. This result could be
improved by modifying the pre-pulse train parameters which allow better depolarization of Xe
inside the cage. The obtained hyperCEST depletion spectra undoubtedly show that the WSP5A
host structure is reversibly encapsulating a hyper-polarized Xe atom.
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Conclusions
We have successfully designed and synthesized a water-soluble pillar[5]arene that is capable of
binding xenon, and we have characterized the xenon affinity by both fluorescence quenching
titrations and hyperCEST. Subsequent efforts in our laboratories will be dedicated to the synthesis
of functionalized P5A structures, in order to create targeted contrast agents, and the use of these
new agents for in vivo imaging.
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2.2

SUPPORTING INFORMATION

Deca methyl imidazolium pillar[5]arene as a viable contrast agent for hyperCEST 129Xe MRI
Experimental Section
Reagents
Substrates, including CBr4, dry acetonitrile, dry 1,2-dichloroethane, boron trifluoride ethane,
tri phenyl phosphine, methyl imidazole were purchased from Sigma-Aldrich, Fisher Scientific,
and TCI chemicals. All reagents were stored under an inert atmosphere before use. Unless
otherwise noted, all reactions were performed under N2.

Instrumentation
NMR spectra were obtained using a Bruker Avance 300 MHz and 400 MHz spectrometer. Low
resolution mass spectrometry was performed using a Shimadzu LRMS-2020. High resolution
mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap XL™ instrument.
Fluorescence spectra was obtained using Shimatzu Fluorimeter and UV-Vis data was obtained
via Shimatzu UV-Vis spectrometer.
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Synthetic route for the synthesis of Water soluble pillar[5]arene

The above molecule was synthesized according to the literature procedures1, with further
optimizations and better yields.
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Synthesis of brominated monomer, 1

A solution of 1,4-bis(2-hydroxyethoxy)benzene (10.0 g, 50.4 mmol) and triphenylphosphine
(31.5 g, 120mmol) in dry acetonitrile (250 mL) was cooled in an ice bath. Under vigorous
stirring, carbon tetrabromide (39.8 g, 120 mmol) was slowly added in four portions. In every
addition the solution immediately turns bright yellow and with stirring returns back to its
colorless form. On the final addition the solution stays cloudy. The mixture was stirred at room
temperature for 4 hours and 20 minutes. Then cold water (200 mL) was added to the reaction
mixture to give white precipitation. The precipitate was collected, washed with another 200 ml
of cold water followed with methanol/water (3:2, 3 × 100 mL). The collected white solids were
dried under vacuum for 24 hours and used without further purification. (14.5 g, 97%). 1H NMR
and 13C NMR was performed using CDCl3. 1H NMR (400 MHz, Chloroform-d) δ 6.89 (s, 4H),
4.27 (t, J = 6.3 Hz, 4H), 3.64 (t, J = 6.3 Hz, 4H). 13C NMR (101 MHz, Chloroform-d) δ 153.5,
117.2, 68.6, 29.6.
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Figure 3.1: 1H NMR of 1
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Figure 3.2: 13C NMR of 1
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Synthesis of deca-brominated pillar[5]arene, 2

A solution of 2 (3.37 g, 11.5 mmol) and paraformaldehyde (0.349 g, 11.5 mmol) in 1,2dichloroethane (50 mL) was cooled with ice bath. Boron trifluoride etherate (3.26 g, 23.0
mmol) was added to the solution and the mixture was stirred at room temperature for 1 hour.
Between the 1 hour the reaction undergoes various color changes. All color changes are shown.
The reaction mixture was then washed with water (2 × 50 mL), the further washes were done
using saturated sodium bicarbonate (2 x 50 ml) and brine solution (2 x 50ml). The organic layer
was dried with Na2SO4. The solvent was evaporated to provide a crude product. The crude
product was pure; hence no further purification was needed. ( yield 85%). 1H NMR and 13C
NMR was performed using CDCl3. 1H NMR (400 MHz, Chloroform-d) δ 6.91 (s, 10H), 4.23
(t, J = 6.3, 5.1 Hz, 20H), 3.84 (s, 10H), 3.63 (t, J = 5.6 Hz, 20H).
Chloroform-d) δ 149.7, 129.1, 116.1, 68.9, 30.7, 29.4.
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13

C NMR (101 MHz,

Figure 3.3: 1H NMR of 2
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Figure 3.4: 13C NMR of 2
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Synthesis of deca methyl imidazolium pillar[5]arene, 3

A mixture of 3 (1.68 g, 1.00 mmol) and N-methylimidazole (1.64 g, 20.0 mmol) in toluene (25 mL)
was stirred in a 40 mL pressure tube at 120 ºC for 24 hours. The reaction was performed multiple
times using a round bottom flask, but the reaction never worked. After cooling, the solvent was
removed by evaporation and the residue was recrystallized from ethanol/diethyl ether (1:2) to give
a white solid (2.1 g, 87%). 1H NMR and 13C NMR was performed using DMSO-d6. 1H NMR (300
MHz, DMSO-d6) δ 9.17 (br, 10H), 8.11 (s, 10H), 7.44 (br, 11H), 6.72 (br, 10H), 4.72 (br, 21H),
4.45 (br, 20H), 3.74 (br, 31H), 3.51 (br, 10H).
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Figure 3.5: 1H-NMR of 3
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Figure 3.6: 13C-NMR of 3
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Mass spectrometry of the water soluble P5A

Figure 3.7: Mass spectrum of 3 for [M − 3Br]3+ Calculated C95H121O10N20Br7 754.1270

Figure 3.8: Mass spectrum of 3 for [M − 5Br]5+ Calculated C95H121O10N20Br5 420.1090
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Figure 3.9: Mass spectrum of 3 for [M − 6Br]6+ Calculated C95H121O10N20Br4 336.9378

Figure 3.10: Mass spectrum of 3 for [M − 7Br]7+ Calculated C95H121O10N20Br3 277.2442
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Saturated Aqueous Xenon Solutions for Fluorescence Quenching Experiments.
Deionized water (25 ml) was added to an acid washed 50 mL round bottom flask. The flask was
capped with a septum, bubbled with nitrogen for 20 minutes, and then high vacuumed through a
22-gauge needle for 5 minutes. After degassing, the needle was pushed to the bottom of the flask,
and xenon was bubbled through the solution for 5 minutes. A 26-gauge needle was used to relieve
excess pressure. Both needles were removed, and the solution was set aside. Next, a Chemware
TedlarTM gas sampling bag with a septum valve (6” x 6”, Fisher Scientific) was connected by ¼”
tubing and a three-way stopcock to both a xenon tank and a needle. The entire system was
vacuumed through the needle using a separate round bottom flask, its septa, and the house vacuum
line. The Tedlar bag was filled with xenon, its nozzle closed, and the three-way stopcock was
removed. The needle was placed directly onto the tubing connecting the Tedlar bag, and then
pierced through the septum into the headspace of the xenon solution round bottom flask. The
system was placed into a 37̊C incubator for a few hours to equilibrate2.

Figure 3.11: The above figures represent the experimental setup for obtaining the saturated Xe
solution in DI water
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WSP5A Fluorescence quenching of WSP5A with Xenon
A 5.1 x 10-4M stock solution of P5A in deionized water was made using a 100 mL volumetric flask
and added into a 100 mL round bottom flask with septum. The round bottom flask was bubbled
with nitrogen for 5 minutes, and then high vacuumed for 5 minutes in order to degas the solution.
The same dilution and degassing process was used to prepare a 1 x 10-3M phosphate buffer solution.
In a reduced volume cuvette with a septum seal (1.5mL, 1cm path length, Starna Cells), stock
solution of P5A and phosphate buffer was added in order to dilute the P5A concentration to 15 μM
at 1.5 mL. The cuvette solution was bubbled with nitrogen for 5 minutes and vacuumed for 5
minutes in order to ensure degassing. Saturated aqueous xenon was added so that the Xe
concentration varied from 0 to 9.8 x 10-4M through the titration at 1.5 mL total volume. The cuvette
solution was allowed to equilibrate for 15 minutes in the fluorimeter before emission spectra were
obtained.
Saturated xenon measurement was made by directly bubbling xenon into a degassed P5A solution
in the cuvette for 5 minutes. The solution was allowed to equilibrate for 15 minutes in the
fluorimeter before spectra were obtained2
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Figure 3.12: Fluorescence quenching phenomena when Xe was added in to a solution of P5A in
phosphate buffer (before curve smoothening was applied)
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Figure 3.13: Fluorescence quenching phenomena when Xe was added in to a solution of P5A in
phosphate buffer (Gaussian curve smoothing using Origin lab software)
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Single site binding model (non-linear curve fit)

http://app.supramolecular.org/bindfit/view/ef59fc0f-0786-4811-8258-0ad6bd25392c

120

Xenon Occupancy Curve for WSP5A
The fluorescence quenching of P5A is caused by the creation of a host guest complex
between P5A and xenon in solution according to reaction (1):
(1) 𝑃5𝐴(𝑠𝑜𝑙 ′ 𝑛) + 𝑋𝑒(𝑠𝑜𝑙 ′ 𝑛) ⇋ 𝑋𝑒@𝑃5𝐴
The association constant, Ka, for this reaction is defined as,
[𝑋𝑒@𝑃5𝐴]
[𝑋𝑒][𝑃5𝐴]
and the occupancy of the P5A cage is defined as,
𝐾𝑎 =

[𝑋𝑒@𝑃5𝐴]
[𝑃5𝐴]
because the concentration of occupied P5A is equivalent to the concentration of xenon within the
𝑂𝑐𝑐𝑢𝑝𝑎𝑛𝑐𝑦 =

P5A. In order to determine the concentration of occupied P5A, an ICE table for reaction (1) must
be developed (shown below), where Y represents the initial concentration of free xenon in solution.

Initial
Change
Equilibrium

P5A
15x10-6M
-X
15x10-6M - X

Xe
Y
-X
Y-X

Xe@P5A
0
X
X

Substituting the equilibrium concentrations shown above in the ICE table equivalent to the known
Ka, 4.7x103M-1, the concentration of bound xenon, represented as X in the ICE table, can be
determined.
[𝑋]
= 4.7𝑥103 𝑀−1
[𝑌 − 𝑋][15𝑥10−6 𝑀]
The X values were determined for each xenon solution concentration titrated and shown in the table
𝐾𝑎 =

below. Then, they were graphed as a function of xenon solution concentration, and the occupancy
curve was developed.
[Xe] soln (M)
1.05x10-4
2.80x10-4
3.50x10-4
2.00x10-4
9.80x10-4
3.32x10-3

Occupancy
0.318
0.558
0.613
0.473
0.818
0.939
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Figure 3.14: Occupancy curve for WSPA

122

Xenon NMR studies
Naturally abundant 129Xe gas was placed into a 1.0 L Tedlar bag and polarized to 60-80% via
the spin exchange optical pumping (SEOP) technique using a Xemed polarizer (Xemed,
Durham, NH, USA). It was then placed into a Tedlar bag which was immediately moved into
a pressurized chamber within the bore of a Philips Achieva 3.0 T clinical MRI scanner to
preserve its polarization. The pressure inside of the chamber was maintained between 20-45
kPa above atmospheric pressure using a pressure-sensitive ventilation device connected to a
nitrogen (N2) source, to facilitate the flow of HP 129Xe gas from the Tedlar bag into the glassfritted cell containing rotaxane solution.
Following polarization of 129Xe gas, 2.5 mL of solution (50 mM) was transferred into a custommade glass-fritted cell using a syringe. The cell containing the solution was then placed inside
of a custom-made quadrature radio-frequency (RF) coil tuned to the Larmor frequency of 129Xe
(35.33 MHz) at 3.0 T. The Tedlar bag, already in the bore of the MRI, was then connected to
the cell’s inflow tube. Once connected, the pressure-stopper on the Tedlar bag was released to
allow for the continuous flow of HP 129Xe gas into the glass-fritted cell, which produced several
microbubbles as it passed through the fine fritted disc, thereby dissolving into the solution. As
HP 129Xe gas continually flowed through the glass-fritted cell,

129

Xe nuclear magnetic

resonance (NMR) spectral data was simultaneously obtained. The concentration of

129

Xe at

any point during the spectral acquisition was between 1-5 mM24.
All

129

Xe NMR spectra were acquired using a Philips Achieva 3.0 T clinical MRI scanner.

Scanner software was modified for the automatic measurement of hyperpolarized chemical exchange saturation transfer (HyperCEST) depletion spectra. To saturate HP 129Xe encapsulated
within the rotaxane molecules, two different pre-pulse trains were used: the first consisted of
16- 30 ms 3-lobe sinc pulses, while the second consisted of 16- 30 ms sinusoidal pulses, both
with 0 ms pulse intervals. To acquire each depletion spectrum, 37 free induction decay (FID)
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spectra were collected at various chemical shift frequency offsets with TR = 4s. Each FID
spectrum was acquired using a selective 90-degree “spredrex” excitation pulse with a 9.95 ms
duration and bandwidth of 1424 Hz (40.3 ppm at 3.0 T).
The data sampling number was 2048, which corresponds to the spectral resolution of 0.44 ppm.
Saturation pre-pulse frequency was automatically adjusted to range from -150 ppm to 30 ppm,
where 0 ppm represents dissolved-phase

129

Xe, with a predetermined step before each of the

subsequent excitation pulses. Offset frequency steps were 176.7 Hz, which correspond to 5
ppm at 3.0 T.

The pulse diagrams shown above were used to prepare HyperCEST depletion spectra using
different saturation pre-pulse trains including 3-lobe sinc pulses (A) and sinusoidal pulses (B).
Here, fj represents the frequency of saturation pulses during FID acquisition number j. All
spoiler gradients along x, y, z axis are also illustrated.
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Above setup was used to obtain the Xe-spectra and to obtain the final depletion spectra.

The image above illustrates the continuous flow of HP
vessel. As depicted, once the flow of HP

129

Xe gas throughout the glass-fritted

129

Xe reaches the fine glass-fritted disc, numerous

microbubbles are produced, thereby causing dissolution of HP

129

Xe into solution. The RF

pulse is applied at the chemical shift frequency offset which corresponds to the ternary complex
formed by the interaction of HP 129Xe with the WSP5A solution.
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ABSTRACT
A versatile, three component, one-pot synthesis of β and γ cyclodextrin-based rotaxanes has been
developed, and the novel supramolecular products have been characterized. The key, end-capping
Diels-Alder reaction can be used to synthesize 1:1, 1:2 and 2:1 rotaxane structures. The syntheses
can be performed on gram-scale, resulting in high yields of pure rotaxane products.
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Mechanically interlocked supramolecular complexes, such as catenanes and rotaxanes, are
currently used in a wide variety of applications, including catalysis, drug delivery, hydrogel
formations, and molecular devices/machines1.
Our interest in the field of mechanically interlocked compounds originated from our recent
synthesis of pseudo-rotaxanes that contain hydrophobic cavities2. We found that pseudorotaxanes
made of a linear alkane guest and γ-cyclodextrin as a host could form ternary complexes with
xenon, and these complexes could be detected using a CEST pulse sequence in a clinical MRI. We
envision this as a possible platform for the development of xenon-129 MRI biosensors, but
rotaxanes that contain hydrophobic cavities could also be used for a variety of other applications
involving the capture of environmental analytes or drug delivery3. However, to improve the
stability and biocompatibility of the supramolecular framework, we commenced a synthetic
campaign towards the synthesis of end-capped rotaxane structures that contained a hydrophobic
cavity.
One of the classic methods for synthesis of rotaxanes involves the threading of a linear molecular
guest through a cyclic macromolecular host4. This association is then followed by a rapid and
quantitative reaction at the two termini of the molecular thread, creating large stoppers on the ends
of the guest and thus preventing dissociation5. Common end-capping schemes for rotaxane
synthesis use coupling or click-type reactions that attach bulky end groups because these reactions
are generally fast, high-yielding and can be performed in a variety of solvents6. Herein, we present
an efficient and general process for the synthesis of cyclodextrin-based rotaxanes using a 4+2
cycloaddition as the end-capping step. The method can be used to synthesize rotaxanes having a
host: guest ratio of 1:1, 2:1, or 1:2 in high yields and high purities. The 1:1 and 2:1 (host: guest)
rotaxanes contain a sizeable hydrophobic cavity that can be used for the formation of ternary
complexes with hydrophobic molecular payloads.

129

As shown in Scheme 1, a linear host compound containing terminal anthracene 1 rapidly formed
pseudo-rotaxane complexes with β- and γ-cyclodextrins in toluene. The pseudo-rotaxanes then
underwent efficient end-capping cycloadditions with the furan protected maleimide, 2.
Three classes of rotaxanes were synthesized, one with a single CD host and a guest (1:1), one
rotaxane with two CD’s and one guest (1:2) and one rotaxane with a single CD with two guests
(2:1). The formation of these various rotaxanes was easily verified by integrating the 1H NMR.

Scheme 3-1: Reaction scheme for the complete synthesis of γ-CD rotaxane 1:1 and γ-CD rotaxane
1:2
The rotaxanes mentioned above were obtained through the reaction of 1 with γ-CD or β-CD in the
proper stoichiometric amounts. To achieve the final rotaxane, first 1 was mixed with γ-CD and
toluene was added. The complete solution was sonicated for 15 minutes and was stirred at 80-90
°C for 1 hour to accommodate the threading of the 1 into the hydrophobic γ-CD cavity. Increased
temperature usage allows more hydrophobic interactions with the γ-CD cavity7.
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Additionally, the oxygens on 1 tend to form hydrogen bonding interactions with the hydroxy groups
in the cavity of the γ-CD. The formation of this inclusion complex can be observed by the
appearance of turbidity in the reaction mixture. Similar observations have been reported with the
formation of poly-pseudo rotaxanes8 and have been attributed to their aggregation via
intermolecular hydrogen bonds.
The association constant for 1 and γ-CD was found out to be 2.5 (±0.15) x 103 M-1 using NMR
titrations. Complexation between 1 and γ-CD was monitored through 1H-NMR as shown in figure
S58. The main observation in 1H-NMR was shifting of the alkane hydrogens caused by the
shielding that occurred when the complex formed. Once the complexation was completed (which
takes approximately 1 hour) dienophile 8 was added to the reaction. The mixture was then stirred
in the dark at reflux for 18 hours.

Figure 3.1: 1H-NMR of 3 (400 MHz, DMSO-d6)
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The completion of the reaction was physically observed by the change in colors of the reaction, due
to the loss of conjugation in the anthracene. The final rotaxanes (3, 4 and 5) were obtained by
vacuum evaporation of the excess toluene and placed under high vacuum overnight. As shown in
scheme 2 the same method can be employed to form rotaxane structures containing small molecule
affinity tags (e.g. 7). The synthesis of dienophile-affinity tag conjugate is a straight forward SN2
reaction, allowing for a wide variety chemical probes to be attached to the rotaxane core for
potential application as drug delivery or molecular imaging agents. In addition, the reaction was
performed on gram scale and the reaction yields remain the same, proving that reaction can be
scaled up with ease.
Interestingly, the structure of the molecular thread proved to be critical for the formation of the
rotaxanes. When the same reaction that is shown in Figure 1 was performed on a diene like 1, but
containing a 12-carbon central chain, no rotaxane products were observed. This indicates that
hydrogen bonding between the interior hydroxyl groups of the CD and the oxygens in the ethylene
glycol chain may play a crucial role in the formation of rotaxanes 3-7. These types of associations
are found in cucurbit[n]urils based click chemistry.9 As shown in Scheme 1, in the presence of γCD the double Diels Alder reaction produced an overall yield of 90% for the rotaxane 3, whereas
the same reaction in the absence of γ-CD, produced only a 45% of the double Diels-Alder
product(not shown). We hypothesize that the excellent yields for 3-7 are an example of cooperative
capture synthesis, where the cyclodextrin acts as a cofactor that preorganizes the reagents for the
Diels-Alder reaction, leading to increased reaction efficiency.11
The Rotaxanes 3-5were characterized using 1H-NMR and 2-D NMR, as well as high-resolution
mass spectroscopy. The use of DMSO as an NMR solvent has been shown to prevent the formation
of any inclusion compounds with CDs. Thus indicating that the interlocked structure produced are
stable rotaxanes, as opposed to labile inclusion complexes10.
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The dienophile guest 1 contains a distinguishable singlet in the aromatic region arising from the
proton in the middle of the anthracene core. This singlet moves from the aromatic region of the
spectrum after the Diels-Alder reaction. In addition, two small singlets coupled to each other arise
from the newly formed C-C bond (labeled as U-V in Figure 1). The doublet near 4.7 ppm
corresponds to the Z-hydrogen which is directly coupled to the new U-V bond. This provides
significant proof that the Diels-Alder reaction took place, in the presence of γ-CD. Similar NMR
evidence is equally seen in β-CD based rotaxane systems.
As shown in Figure 1, the ethylene protons in the guest were shifted downfield, indicating that they
are located inside the host’s cavity. Additionally, the peaks of both the cyclodextrins or the guest
protons are not subjected to peak broadening which designates that the molecule formed here is a
one single inter-locked rotaxane molecule, not an inclusion complex. The most conclusive evidence
demonstrating the formation of the rotaxane is shown in the 2D ROESY spectra of 3. The cross
peaks are shown in Figure 2 corresponds to the ethylene protons of the guest molecule that are
correlated with H-3 and H-5 protons of the γ-CD which are found inside the hydrophobic cavity.
Similar ROE cross peaks were observed for β-CD based rotaxanes.
The control reaction, in which a guest that contained Diels-Alder adducts was mixed with γ-CD,
did not produce these cross peaks. This demonstrates that the synthesis is shown previously in
Scheme 2 and 3 forms stable rotaxanes. While the anthracene moieties are still small enough to
pass through the center of the CD, the Diels-Alder adducts are too bulky for the guest to de-thread,
once it is interlocked.
Additionally, an NOE correlation was observed, corresponding to the N-H present in the guest and
the OH2 proton of the γ-CD that lies on the outer rim of the γ-CD (See supporting info). This
indicates that the cyclodextrin is situated between the boundaries of the two amines present in the
guest.
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Figure 3.2: ROESY NMR of 3 (400 MHz, DMSO-d6). The arrows point towards the regions of H3
and H5 protons NOE correlation with C-D protons of the guest molecule. Mixing time = 500 ms
Comparable correlations were seen for the Rotaxane with ThT groups, 10. 7 was successfully
synthesized with a yield of 85%. Furthermore, we have synthesized similar 1:1, 1:2 and 2:1
rotaxanes using β-cyclodextrin as a host-structure, similar characterizations were acquired along
with mass spectroscopy to confirm their structures.
Analysis of large rotaxanes which exceed 2000 Da were analyzed using a Waters Synapt G2 HDMS
mass spectrometer with resolution of 1000, in the mass range of 100 to 5000 m/z. Mass specta for
compounds 3, 4 and 5 were obtained via lower capillary voltages, while higher capillary voltages
were used for 10 which is a much larger and heavier compound. The usage of more power was due
to fragmentation requires more power.
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Scheme 3-2: Reaction scheme for the complete synthesis of ThT-rotaxane 1:1 and ThT-rotaxane
1:2
We can observe signals with isotopic pattern and mass accuracy for the expected 3 with two charges
[M+2H]2+ monoisotopic m/z 1010.3765 (2.67 ppm) for the for the formula C92H122O46N4. The
spectrum also has signals related to [M+H] + monoisotopic m/z 2019.7424 (1.04 ppm). In the same
m/z region signals are observed for a non-covalent dimer [2M+2H] +.
For 4 The mass spectrum shows a base peak with 1959.0930 Zooming into this region we could
observe signals with isotopic pattern and mass accuracy for the expected compound with two
charges [M+2H]2+ monoisotopic m/z 1658.5902 (3.07 ppm) for the for the formula C140H202O86N4.
The spectrum for 7 shows signals with mass accuracy and isotopic pattern for [M+2H] 2+. The
monoisotopic m/z 1980.6952 has -1,87 ppm mass accuracy for the theoretical m/z of 7. Reason for
this behavior is that higher voltages must be used for fragmentation, which results in losing the
molecular ion peak, but the monoisotopic m/z confirms that the rotaxane is present. The above135

mentioned mass spectroscopy data proves that the rotaxanes were stable and formed as mentioned
in scheme 1 and 2. Furthermore, β-CD based rotaxanes shows mass adducts that matches the
theoretical mass adducts, hence we can conclude that both rotaxanes types were successfully
synthesized.
Computational studies were performed using commercially available MOE software. The same
software was used to design the supramolecular compounds in 3-D space, energy minimizations,
dynamics, and docking. Energy minimizations were conducted using the MMFX94 force field22,
with an R-field of 1.80. A unit cell was created around the molecule with a cell size of 43.321 Å in
x, y, z directions. Rigid water molecules were chosen, with a gradient of 0.001 RMS kcal/mol/Å.
Complex name

ΔE Complex (stabilization energy) /
[kcal/mol]

ΔG binding (final docking
score) / [kcal/mol]

1 and γ-CD (1:1)

-8.0068

-6.9883

1 and γ-CD (2:1)

-8.5634

-8.2360

3

-15.6887

-9.7994

4

-17.6590

-8.1153

10

-33.2087

-8.8183

Table 3-1: Stabilization energies and docking scores of complexes
As given in table 1, the molecular dynamics data confirms that 7 has the lowest negative ΔE
Complex which means that 7 has the highest stability. Docking results further explained the reason
behind this. After docking the ThT rotaxane into the γ-CD cavity. The complex arranged in a very
orderly manner wrapping around the CD cavity as given in figure 3 which explains the low
ΔEComplex due to high ordered packing.
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Figure 3.3: Images of 3 (to the left) and 10 (to the right) after docking using MOE software, the
surfaces represent the hydrophobic surface of the cyclodextrin and the ligand placement inside the
hydrophobic centroid
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Figure 3.4: from top to bottom, energy minimized molecular models of γ-CD rotaxane 1:1, γ-CD
rotaxane 2:1 and γ-CD rotaxane 1:2
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Figure 3.5: Stacked image of methylimidazolium guest, 1:1 γ-CD rotaxane and complexation of
the host and the guest in 1:1 ratio
A 16-Carbon aliphatic bar with an imidazole polar head-group was chosen as a molecular mimic
to “Perifosine” to examine the binding properties of the Rotaxane complex. Similar compounds in
the literature exhibit the ability to stabilize charged species in DMSO due to stabilization by etheric
oxygens at the center of the bar threaded inside the cyclodextrin. Given in figure 5 are the NMR
spectra supporting this conclusion, showing shielding of the charged Imidazole head-group and
nearby protons indicating inclusion of the head-group into the rotaxane complex in DMSO. We
further hypothesize that in aqueous solution, hydrophobic interactions will predominate, and drive
the aliphatic chain to enter the complex instead of the head-group. Imidazole functionalization of
other molecules may provide a facile method of functionalizing guest molecules that do not interact
with the rotaxane host complex in their native state.
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Figure 3.6: The expanded in images of the imidazole 1H NMR peaks displaying the shielding effect
of these peaks in the presence of the 1:1 rotaxane system showing that the cavity itself is exhibiting
the hydrophilic effects
In addition, we used this same guest to perform an NMR titration to investigate the association of
the guest inside the host cavity. With the increased addition of the guest, the imidazole peaks shifted
further towards de-shielding side showing that the polar headgroup is indeed inside the cavity of
the γ-CD rotaxane. We did not observe the same change in the aliphatic non-polar tail end. The
NMR titrations for 16-C ethyl imidazolium chain and the γ-CD rotaxane 1:1 showed an association
constant of 4.98 ± 0.013x 103 M-1.
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The cavity space inside the γ-CD rotaxane is not enough to achieve 1:2 binding. This is further
confirmed from the computational modeling seen on figure 4.
Conclusion
We have discovered a new efficient method of synthesizing rotaxane with ease and high yields.
These rotaxanes can also be easily functionalized using SN2 chemistry. Furthermore, we have
shown that these rotaxanes can be potentially used in drug delivery systems to carry small molecule
payloads that consist of charged species. In addition, structures 3-7 can be used as a useful tool to
add other different drugs and targets depending on the disease which it is targeted.
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3.2

SUPPORTING INFORMATION

Efficient Synthesis of β-cyclodextrin and γ-cyclodextrin based rotaxanes via Diels-Alder EndCapping
Experimental Section
Reagents
Substrates mentioned in the supplementary information were purchased from Sigma-Aldrich,
Fisher Scientific, and TCI chemicals. All reagents were stored under an inert atmosphere before
use. Unless otherwise noted, all reactions were performed under N2.

Instrumentation
NMR spectra were obtained using a Bruker Avance 300 MHz and 400 MHz spectrometers.
Low resolution mass spectrometry was performed using a Shimadzu LRMS-2020. High
resolution mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap XL™
instrument
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Synthesis of Thioflavin analog

p-Amino Benzoic Acid (2.74 g, 20.0 mmol) and 2-Aminothiophenol (2.14 ml, 20.0 mmol) were
dissolved in (21.03 g, 250.00 mmol) polyphosphoric acid. The mixture was Heated at 200 oC and
stirred for 4.5 hours. After cooling, 10% Na2CO3 was slowly poured into solution. This resulted in
a greenish mixture. This solution was stirred until gas evolution was completed. Next, the solution
was filtered using vacuum filtration. The solid was washed with water (3x50mL) and recrystallized
with MeOH and H2O to give the final product. The yield was 70%. 1H-NMR was performed using
DMSO-d6. The literature-based procedure was followed1. LRMS ESI (m/z): [M+H] calculated for
C13H10N2S 227.06, observed 227.05. 1H NMR (400 MHz, DMSO-d6) δ 8.02 (d, J = 8.0, 1.1 Hz,
1H), 7.90 (d, J = 8.0 Hz, 1H), 7.76 (t, J = 8.7 Hz, 2H), 7.45 (d, J = 7.7 Hz, 1H), 7.34 (d, J = 7.7 Hz,
1H), 6.67 (d, J = 8.6 Hz, 2H), 5.88 (br, 2H).
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Figure 3.7: 1H NMR of Thioflavin analog
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Figure 3.8: Mass spectrum of Thioflavin analog
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Synthesis of Thioflavin analog based linker

ThT-NH2 (452.6 mg, 2.00 mmol) was dissolved in 20 ml of anhydrous CH2Cl2. To this mixture 6Bromohexonoyl chloride (305.0 µl, 2.00 mmol) was added drop wisely. The reaction was
performed inside a glove box under Nitrogen atmosphere. The reaction mixture was stirred
overnight at room temperature. The reaction was monitored by TLC. After overnight stirring, the
mixture was poured into several centrifuge tubes and centrifuged at 6000 rpm for 15 minutes. Once
centrifugation was completed, the supernatant was discarded. CH2Cl2 was added into the remaining
precipitate and centrifuged again. Once again, the supernatant was discarded, and this was done for
two more times with a total of three washes with CH2Cl2. Finally, the remaining precipitate was
dissolved in deuterated CDCl3 and centrifuged, and the precipitate was collected with the removal
of CDCl3. (CDCl3 was used to remove the CH2Cl2 peak from the spectra.) This was subjected to
overnight vacuum. The product was further purified using automated flash chromatography. The
reaction yielded 59%. 1H-NMR and 13C-NMR were performed using DMSO-d6. LRMS ESI (m/z):
[M+H] calculated for C19H19BrN2OS 403.05, observed 403.05. 1H NMR (400 MHz, DMSO-d6) δ
10.25 (s, 1H), 8.12 (dd, J = 8.0, 1.2 Hz, 1H), 8.03 (td, J = 8.7, 7.8, 2.5 Hz, 3H), 7.80 (dd, J = 8.8,
2.6 Hz, 2H), 7.53 (ddd, J = 8.3, 7.2, 1.3 Hz, 1H), 7.43 (ddd, J = 8.3, 7.2, 1.2 Hz, 1H), 3.64 (q, J =
6.6 Hz, 1H), 3.55 (t, J = 6.7 Hz, 1H), 2.38 (t, J = 7.4 Hz, 2H), 1.80 (dm, J = 34.0, 7.5, 7.0, 6.8 Hz,
2H), 1.68 – 1.58 (m, J = 7.5 Hz, 2H), 1.44 (t, J = 8.2, 7.1 Hz, 2H). 13C NMR (101 MHz, DMSOd6) δ 172.0, 167.5, 154.1, 142.6, 134.7, 128.5, 127.8, 127.0, 125.7, 123.0, 122.7, 119.6, 45.8, 36.8,
35.5, 32.5, 27.7, 26.4, 24.7.
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Figure 3.9: 1H NMR of Thioflavin analog based linker
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Figure 3.10: 13C NMR of Thioflavin analog based linker
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Figure 3.11: Mass spectrum of Thioflavin analog based linker
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Synthesis of 9

Furan protected maleimide (330.3 mg, 2.00 mmol) and ThT-6-Br (403.3 mg, 1.00 mmol) was
dissolved in 10 mL of dry DMF. Next K2CO3 (290.2 mg, 2.10 mmol) was added and into the
mixture. This mixture was heated to 50 ºC for overnight. The literature method only suggested
heating for three hours, but this tends to give a mixture of starting materials and product, but letting
it react for overnight helps to get the product exclusively. The mixture was then dissolved in 50 mL
diethyl ether and washed with 5% HCl, followed by water to remove excess DMF. The organic
layer was then dried with magnesium sulfate and subjected to rotatory evaporator until dryness.
The product was further purified using automated flash chromatography. The method is given
below. LRMS ESI (m/z): [M+H] calculated for C27H25N3O4S 488.16, observed 488.15. 1H NMR
(300 MHz, DMSO-d6) δ 10.20 (s, 1H), 8.15 – 8.09 (m, 1H), 8.06 – 7.99 (m, 3H), 7.79 (td, J = 8.8,
8.8, 5.4 Hz, 2H), 7.53 (ddd, J = 8.3, 7.2, 1.4 Hz, 1H), 7.43 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 6.54 (s,
2H), 5.12 (s, 2H), 3.36 (t, J = 7.1 Hz, 2H), 2.91 (s, 2H), 2.33 (t, J = 7.4 Hz, 2H), 1.60 (p, J = 7.5
Hz, 2H), 1.48 (p, J = 7.2 Hz, 2H), 1.25 (p, J = 9.7, 8.9 Hz, 2H). 13C NMR (101 MHz, DMSO-d6) δ
178.3, 176.9, 172.1, 172.1, 167.5, 162.8, 154.1, 142.6, 136.9, 134.7, 128.4, 127.7, 127.0, 125.7,
123.0, 122.6, 119.6, 48.9, 47.5, 45.7, 38.2, 36.7, 36.2, 34.7, 32.3, 31.2, 27.4, 26.4, 26.1, 24.9, 24.7.
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Figure 3.12: 1H NMR of 9

153

Figure 3.13: 13C NMR of 9
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Figure 3.14: Mass spectrum of 9
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Synthesis of 2

Maleimide (1.33g, 13.73 mmol) and furan (1.50 ml, 20.66 mmol) were dissolved in 10 mL diethyl
ether in a sealed tube and heated to 90-100 °C for 12 hours. The 3, 6-Endoxo-Δ4tetrahydrophthalhide (furan-masked maleimide) precipitated as a white solid after cooling the
mixture to room temperature. The product was then filtered, washed with 3x10mL cold diethyl
ether to remove the unreacted maleimide, giving rise to a yield of 6.04g (89%). The NMR spectra
indicate that the product is exclusively the exo isomer. 1H-NMR and 13C-NMR were performed
using DMSO-d6. LRMS ESI (m/z): [M+H] calculated for C8H7NO3 165.04, observed 165.04. 1H
NMR (300 MHz, DMSO-d6) δ 11.15 (br, 1H), 6.52 (d, J = 0.9 Hz, 2H), 5.11 (t, J = 0.9 Hz, 2H),
2.85 (s, 2H). 13C NMR (101 MHz, DMSO-d6) δ 178.3, 136.9, 80.8, 48.9.
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Figure 3.15 : 1H NMR of 2
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Figure 3.16: 13C NMR of 2
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Figure 3.17: Mass spectrum of 2
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Synthesis of imine 1

To a stirred solution of 2,2′-(Ethylenedioxy)bis(ethylamine) (730.0 µl, 5.00 mmol) in 25%
MeOH/CH2Cl2 (10 mL), was added a solution of 9-anthraldehyde (2.16 g, 10.5 mmol) in 25%
MeOH/CH2Cl2 (10 mL) under N2. The mixture was stirred at room-temperature overnight until the
imine formation was complete (monitored by TLC). The solvent was evaporated under vacuum to
give the crude imine product as a yellow solid, which was used for reduction without further
purification. Reaction yield was 96%. 1H-NMR was performed using DMSO-d6. HRMS ESI (m/z):
[M+H] calculated for C36H33N2O2 525.2542, observed 525.2485. 1H NMR (300 MHz, DMSO-d6)
δ 9.31 (d, J = 1.4 Hz, 2H), 8.62 (s, 2H), 8.55 – 8.45 (m, 4H), 8.14 – 8.04 (m, 4H), 7.57 – 7.47 (m,
8H), 3.97 (t, J = 5.8 Hz, 4H), 3.87 (t, J = 5.4 Hz, 4H), 3.35 (s, 2H), 3.18 (s, 3H).
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Figure 3.18: 1H NMR of imine 1
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Figure 3.19: Mass spectrum of imine 1
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Synthesis of 1

NaBH4 (3 equiv.) was added in small portions to the solution of crude imine (1 equiv.) in 1:1
CH3OH: CH2Cl2 (20 mL) at 0°C. The mixture was stirred at room temperature overnight, then
concentrated under vacuum. The residue was dissolved in CH2Cl2 (50 mL) and washed three times
with 50mLof aqueous Na2CO3 (pH=10). The organic layer was separated, dried over anhydrous
Na2SO4, filtered, and concentrated under vacuum to provide the secondary amines. Reaction yield
was 90%. 1H-NMR and

13

C-NMR were performed using DMSO-d6. HRMS ESI (m/z): [M+H]

calculated for C36H36N2O2 529.2855, observed 529.2794. 1H NMR (300 MHz, DMSO-d6) δ 8.50
(s, 2H), 8.40 – 8.31 (m, 4H), 8.05 (dd, J = 7.7, 2.0 Hz, 4H), 7.55 – 7.44 (m, 8H), 4.58 (s, 4H), 3.49
(t, J = 5.6 Hz, 8H), 2.82 (t, J = 5.6 Hz, 4H), 2.03 (br, 2H). 13C NMR (101 MHz, DMSO-d6) δ 135.0,
132.7, 131.5, 130.3, 129.2, 127.0, 126.3, 125.5, 125.1, 70.5, 70.1, 49.3, 45.2.
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Figure 3.20: 1H NMR of 1
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Figure 3.21: 13C NMR of 1
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Figure 3.22: Mass spectrum of 1
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Diels alder reaction with 1 and 2 [without γ-CD]

8 (2.2 equiv.) and 4 (1 equiv.) was mixed in 20 ml of Toluene. This reaction mixture was refluxed
at 110oC for overnight. Physical observation of the formation of Diels-alder adduct was observed
by the change of colors from yellow solution to white with precipitate. Next, the reaction mixture
was subjected for rotary evaporation until dryness and dried overnight under high vacuum.
Reaction yield was 45%. 1H-NMR and

13

C-NMR were performed using DMSO-d6. HRMS ESI

(m/z): [M+H] calculated for C44H46N4O6 723.3081, observed 723.3083. 1H NMR (400 MHz,
DMSO-d6) δ 10.68 (br, 2H), 7.50 (dd, J = 7.3, 1.5 Hz, 2H), 7.42 (dd, J = 6.9, 1.7 Hz, 2H), 7.25
(ddd, J = 7.0, 4.0, 1.9 Hz, 5H), 7.13 (dddt, J = 12.6, 8.7, 5.1, 1.5 Hz, 9H), 4.65 (d, J = 3.3 Hz, 2H),
3.95 (d, J = 12.3 Hz, 2H), 3.76 (d, J = 12.3 Hz, 2H), 3.66 (d, J = 6.3 Hz, 7H), 3.28 (dd, J = 8.7, 3.1
Hz, 2H), 3.24 – 3.20 (m, 2H), 3.09 – 2.95 (m, 4H), 2.30 (s, 2H), 1.95 (br, 2H). 13C NMR (101 MHz,
DMSO-d6) δ 178.4, 177.9, 143.5, 141.2, 140.4, 129.4, 128.7, 126.8, 126.6, 126.3, 125.2, 124.3,
124.1, 122.8, 70.3, 50.0, 49.1, 48.5, 47.2, 45.0.
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Figure 3.23: 1H NMR of reaction with 1 and 2 [without γ-CD]
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Figure 3.24: 13C NMR of reaction with 1 and 2 [without γ-CD]
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Figure 3.25: Mass spectrum of reaction with 1 and 2 [without γ-CD]
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Synthesis of 3, 4 and 5

γ-CD (1 equiv.) and 4 (1 equiv.) was mixed in 20 ml of Toluene. This reaction mixture was
ultrasonicated for 15 minutes. Then it was heated at 80oC for another 15 minutes. To this solution
8 (2.4 equiv.) was added and the complete reaction mixture was refluxed at 110oC for overnight.
Physical observation of the formation of Diels-alder adduct was observed by the change of colors
from yellow solution to white with precipitate. Next, the reaction mixture was subjected for rotary
evaporation until dryness and dried overnight under high vacuum. By changing the addition
equivalents to 1 or 2 of the γ-CD, it was possible to obtain 1 or 2 CDs on the thread. Reaction yield
was 90%, 89% and 83% in the order of 1:1, 1:2 and 2:1. 1H-NMR, 13C-NMR and ROESY NMR
was performed using DMSO-d6.
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Figure 3.26: 1H NMR of 3
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Figure 3.27: 1H NMR of 4
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Figure 3.28: 13C NMR of 3
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Figure 3.29: ROESY NMR of 3, with a mixing time 500 ms
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Figure 3.30: Complete mass spectrum of 3
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Figure 3.31: mass spectrum of 3 at the range of 1006 – 1016 m/z
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Figure 3.32: mass spectrum of 3 at the range of 2017 – 2028 m/z
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Figure 3.33: Complete mass spectrum of 4
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Figure 3.34: mass spectrum 4 at the range of 1655-1668 m/z

Figure 3.35: Complete mass spectrum of 5
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Figure 3.36: mass spectrum of 5 at the range of 2620 - 2880 m/z
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Figure 3.37: mass spectrum of 5 at the range of 2680 - 2780 m/z
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Synthesis of 6,7 and 8

β-CD (1 equiv.) and 4 (1 equiv.) was mixed in 20 ml of Toluene. This reaction mixture was
ultrasonicated for 15 minutes. Then it was heated at 80oC for another 15 minutes. To this solution
8 (2.4 equiv.) was added, and the complete reaction mixture was refluxed at 110oC for overnight.
Physical observation of the formation of Diels-alder adduct was observed by the change of colors
from yellow solution to white with precipitate. Next, the reaction mixture was subjected for rotary
evaporation until dryness and dried overnight under high vacuum. By changing the addition
equivalents to 1 or 2 of the β-CD, it was possible to obtain 1 or 2 CDs on the thread, resulting 1:2
and 2:1 rotaxanes. Reaction yield was 91%, 92%, 94% in the order of 1:1, 1:2 and 2:1. 1H-NMR,
13

C-NMR and ROESY NMR was performed using DMSO-d6.
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Figure 3.38: 1H NMR for 6

184

Figure 3.39: 13C NMR for 6
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Figure 3.40: COSY spectrum for 6
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Figure 3.41: ROESY spectrum for 6, with a mixing time of 500 ms
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Figure 3.42: 1H NMR of 8
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Figure 3.43: 13C NMR of 8
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Figure 3.44: The COSY spectrum of 8
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Figure 3.45: ROESY spectrum of 8, with a mixing time of 500 ms
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Figure 3.46: 1H NMR of 7
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Figure 3.47: 13C NMR of 7
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Figure 3.48: COSY of 7
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Figure 3.49: ROESY of 7, with a mixing time of 500 ms
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Figure 3.50: Complete mass spectrum of 6

Figure 3.51: mass spectrum of 6 at the range of 800 – 1800 m/z
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Figure 3.52: mass spectrum of 6 at the range of 925 – 939 m/z

Figure 3.53: mass spectrum of 6 at the range of 1846 - 1874 m/z
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Figure 3.54: Complete mass spectrum of 7

Figure 3.55: mass spectrum of 7 at the range of 1500 - 3000 m/z
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Figure 3.56: mass spectrum of 7 at the range of 1475 - 1540 m/z

Figure 3.57: mass spectrum of 7 at the range of 2950 - 3030 m/z
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Figure 3.58: Complete mass spectrum of 8

Figure 3.59: mass spectrum of 8 at the range of 2150 - 2850 m/z
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Figure 3.60: mass spectrum of 8 at the range of 2535 - 2615 m/z
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Synthesis of 10 and 11

γ-CD (1 equiv.) and 4 (1.1 equiv.) was mixed in 20 ml of Toluene. This reaction mixture was
ultrasonicated for 15 minutes. Then it was heated at 80oC for another 15 minutes. To this solution
8 (2.4 equiv.) was added the complete reaction mixture was refluxed at 110oC for overnight.
Physical observation of the formation of Diels-alder adduct was observed by the change of colors
from yellow solution to white with precipitate. Next, the reaction mixture was subjected for rotary
evaporation until dryness and dried overnight under high vacuum. By changing the addition
equivalents to 1 or 2 of the γ-CD, it was possible to obtain 1 or 2 CDs on the thread. Reaction yield
was 85%. 1H-NMR, 13C-NMR and ROESY NMR was performed using DMSO-d6.
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Figure 3.61: 1H NMR of 10
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Figure 3.62: 13C NMR of 10
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Figure 3.63: ROESY spectrum of 10
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Figure 3.64: mass spectrum of 10

Figure 3.65: mass spectrum of 10
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NMR titration of 1 and γ-CD
The NMR titration experiments were conducted per the following procedures.2 The host CD
concentrations were kept constant while the guest concentration was increased periodically. Stock
solutions of 20 mM host (cyclodextrin) and 60 mM guest were prepared. A series of NMR samples
were made in 5 mm NMR tubes. The series ranged from 10 mM to 80 mM. All samples were
prepared and heated for 3 minutes at 80 oC and cooled to room temperature. The NMR was
performed at 300K (Room temperature). The guest protons were monitored. Data was processed
using an Excel spreadsheet using the equation shown below and fitting the data. The plots are
shown below. The data was evaluated using the “OpenDataFit” website which is an online free
fitting program found at supramolecular.org.2 The two different analysis methods provided similar
results.
The following equation was used to calculate the association constant:
1
∆𝛿𝑚𝑎𝑥
1
1
∆𝛿 = (
) + {[𝐻0 ] + [𝐺0 ] + − (([𝐻0 ] + [𝐺0 ] + )2 − 4[𝐻0 ] [𝐺0 ])2 }
2[𝐻0 ]
𝐾
𝐾

where ∆δ = change in chemical shift, [H0] = Initial Host concentration, [G0] = Initial concentration,
and K = association constant. ∆δ was plotted as a function of the guest concentration.

207

Figure 3.66: NMR titration with 1 and γ-CD
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Figure 3.67: Binding curve for 1 and γ-CD
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Computational studies were performed using commercially available Spartan 16 and Molecular
operating environment (MOE) software. Spartan was used to design the supramolecular
compounds in 3D space. Energy minimizations, dynamics and docking were performed using
MOE. Energy minimizations were conducted using the MMFX94 force field,20 with an R-field of
1.80. A unit cell was created around the molecule with a cell size of 43.321 Å in x, y, z directions.
The periodic system was used to perform the calculations. Rigid water molecules were chosen,
with a gradient of 0.001 RMS kcal/mol/Å.02
The energy minimized structure was prepared for docking by using the built-in prep tool named as
“quick-prep.” This tool fixes errors present in the molecule such as adding missing hydrogens and
charges. This molecule was further subjected to molecular simulations via NPA (Nose-PoincareAnderson equation) method21, which is the most correct and most sensitive method used by the
MOE software. All simulations were performed inside the unit cell, with water surrounding water
molecules at a temperature of 300K.
The guest was manually selected to dock the guest inside the CD cavity. This made the CD as the
host receptor. The site finder tool was used to place dummy atoms inside the hydrophobic cavity
of the CD. This was done to optimize the docking procedure. The unit cell mentioned above was
maintained with its initial parameters at the docking stage to mimic the solvent effect. Triangle
matcher was used as the docking placement methodology while London dG was selected as the
initial scoring methodology. A number of 50 poses were passed to the refinement step. Rigid
receptor post-placement refinement was used with GBVI/WSA as the final scoring method. The
lowest negative number for final docking score was chosen as the final values.
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Figure 3.68: Computational modeling for 4 and one γ-CD molecule
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Figure 3.69: Computational modeling for 3
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Figure 3.70: Computational modeling for 10
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Figure 3.71: Computational modeling for 1 and 2 γ-CD molecules
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Figure 3.72: Computational modeling for 4
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Figure 3.73: Computational modeling for 11 (ThT based γ-CD rotaxane 2:1)
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Abstract
The synthesized novel Thioflavin-appended pillararene structure can switch from a folded,
intercalated form to an open form via a change of temperature or in response to a chemical analyte.
This unique behavior was studied using 1D and 2D NMR spectroscopy, fluorescence spectroscopy,
and computational modeling. In synthesizing the novel structure, new reaction conditions with
higher yields for the synthesis and functionalization of copillararenes were developed. The dualfunctionalized pillararene is a unique molecular switch that can be used to bind analyts in it
hydrophobic cavity, producing a signal that can be easily detected by NMR for fluoroescence
spectroscopy.
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Introduction
Despite the relatively short time since their discovery, pillararenes have been widely used
in applications ranging from molecular machines1 to drug delivery.2

These barrel-shaped

macrocyclic structures were first reported by Ogoshi and coworkers.3 When compared with other
supramolecular structures, pillararenes are far more versatile and robust due to their ease of
functionalization and synthesis.4 Our group became interested in the chemistry of pillararenes as
part of our efforts to design and discover molecular structures that are capable of binding xenon,5
which can be used as molecular contrast agents for 129Xe MRI.6 During the course of these studies
we have optimized the conditions by which co-pillararenes (Co-P5A) can be synthesized and
functionalized. Herein, we report these synthetic advances and their application to the development
of a novel molecular switch that can be used as a fluorescent sensor.
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Results and discussion
The synthesis of the Co-P5A commenced using monomers containing bromoethyl and
propargyl groups (1 and 2). These two monomers were mixed in a series stoichiometries and Lewis
acids. Numerous co-P5A syntheses have been published using an excess of the brominated
monomer, usually 10:1,10 but in our hands, the yield for the Co-P5A increased 10-fold when the
ratio was lowered to 5:1. The only side product that we obtained was the per-brominated P5A (See
Supporting Information for details).
Subsequent functionalization of 3 via copper-catalyzed azide-alkyne cycloaddition also
proved to be unfruitful by a variety of common reaction conditions. Molecular modeling indicated
that the barrel-shaped structure of 3 was closed on the top and bottom, as the flexible bromyethyl
and propargyl appendages bent towards the hydrophobic cores. We hypothesized that the insertion
of a guest molecule into the macrocycle could force the propargyl group into a solvent-exposed
position.

This hypothesis was supported by computational modelling and was verified

experimentally.

Simply switching the solvent from tert-butanol or dichloromethane to 1,2-

dichloroethane, a solvent that is known to fit into the inner core of pillararene structures, increased
the yield of the cycloaddition from 0% to 80% (Scheme 4-1).

Figure 4.1: Optimized synthesis of functionalized co-pillararenes. (Molecular modeling images
with propargyl group highlighted.)
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We chose to append two thioflavin T (ThT) molecules to the P5A core using a flexible sixcarbon linker. ThT is a fluorescent dye that is widely used for its ability to bind the -amyloid
plaques that are associated with Alzheimer’s disease. However, the properties that were the most
essential for the design of our molecular switch were ThT’s linear structure and its fluorescent
properties. Following the synthesis of the difunctionalized pillararene, 5, we observed that formed
a unique self-inclusion structure, where one of the pendant ThT-terminated “arms” was threaded
through the core of the P5A (Figure 4-1)

Figure 4.2: Cartoon representation of the self-inclusion behavior with the change of conditions
The inclusion behavior of ThT-pillararene was first studied via 1H NMR spectroscopy in different
solvents (Figures 4.4). In the 1H NMR spectra, the unique upfield chemical shifts between -0.5 and
-2.5 ppm correponds to the protons in the linker arm group connecting the ThT linker to the
pillararene (Light blue region). This indicates the inclusion of the linker connected to the ThT group
into the cavity of the P5A, which resulted in the formation of the inclusion structure ThT-CoP5A.
Similar upfield shift phenomena were also observed from the spectrum using acetone-d6 as the
solvent. However, the signals of the protons of ThT-pillararene in 1H NMR spectra was in the
positive chemical shift range in strong polar solvents, such as DMSO-d6, which meant that the
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inclusion behavior of ThT-CoP5A was destroyed in DMSO-d6. This type of behavior has been
previously shown by Wu and his co-workers9.
This was further investigated using the molecular dynamics studies using MOE
computational software. Firstly a flexible assignment scan was conducted to find out if molecular
dynamics could result in a structure with a self-inclusion. The scan gave us a flexible assignment
showing the self-inclusion assignment. Next, a unit cell was created to accommodate the selfinclusion complex in the inclusion stage and DMSO-d6 was used as a solvent, and multiple
molecular dynamic iterations were carried out. From the results, it was evident that DMSO-d6
pushes the ThT and the linker arm due to binding of DMSO inside the P5A cavity. The same control
study was performed using the CDCl3 as the solvent, the inclusion remains inside with no release
of the linker arm with ThT.
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Figure 4.3: L to R, ThT Co-P5A in a simulated environment surrounded with CHCl3 molecules
(Self-inclusion form), ThT Co-P5A in a simulated environment surrounded with DMSO molecules
(Free-form)
To investigate whether the inclusion behavior was intramolecular or intermolecular, hostguest interaction between just the ThT azido linker and Co-P5A was firstly studied by themselves.
This experiment was used as a control study to show the unique self-inclusion behavior present in
the product itself. As shown in Figure S4.48 and S4.49 in the supplementary information, the 1H
NMR spectra of Co-P5A with the addition of different equivalents of ThT azido linker showed that
the chemical shifts of the linker arm gradually shifted upfield with the increase of the ThT azido
linker, exhibiting a fast exchange process within the NMR timescale. The most visible observation
from this titration is that with the addition the chemical shifts corresponding to the linear arms
became broader, which suggests that binding does take place. This broadening is not seen in the
aromatic range of the linker, indicating that the linker arm protons do indeed bind in the cavity of
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the Co-P5A. The linker arm protons have five distinguishable peak areas which range from ppm of
3.27, 2.38, 1.75, 1.62 and 1.44. These chemical shifts were then moved up field with the addition
of ThT linker to ppm ranges of 3.11, 2.32, 1.66, 1.522 and 1.39. This means that there is only a
slightly upfield shift around 0.16 ppm of these linker arm protons.

Figure 4.4: Top, ThT based CoP5A in CDCl3 and bottom, ThT based CoP5A in DMSO-d6
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Figure 4.5: Temperature study of 1H-NMR of ThT-CoP5A in CDCl3
As the concentration increased, the proton resonances did not exhibit apparent changes
even at high concentration levels of 500 mM, which almost reaches the saturation level of the ThT
linker. As a result, the interaction between ThT azido linker and Co-P5A was weak. This confirms
that the ThT-CoP5A molecule is indeed occurred due to intramolecular forces, this further
confirmed that with the increase in ThT azido linker no negative chemical shift peaks were
observed (seen when the self-inclusion takes place).
Moreover, variable concentration 1H NMR spectroscopy of ThT-CoP5A in CDCl3 was
carried out to monitor the stability of the self-inclusion complex. It was found that the aggregates
formed by ThT-CoP5A were stable even in very dilute CDCl3 solution (1 mM) and still showed
the negative chemical shifts. This points out that these interactions that are formed are strong and
stable.
In addition, we conducted a variable temperature 1H NMR spectroscopy. This was
conducted to show that with heat the self-inclusion complex unwraps to form the free form. As
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seen in figure 6, where the up-field peaks which were showing three doublets start to disappear
slowly and the peaks of the spectra become sharper showing the release of the ThT-linker arm.
However, we can still see that the up-field peaks do not disappear even after heating to 60 °C
showing that a specific population of the Self-inclusion complexes still exists. Also, we reversed
the temperature letting the sample gradually cool down, to show that the final product does not
undergo decomposition at an elevated temperature (60 °C). This shows the stability under varying
temperatures. The stability at 30 – 40 °C is important, allowing us to use the ability of self-inclusion
of this molecule in a biological system.
1

H NMR COSY, ROESY, and TOCSY experiments were performed to investigate the

binding of the linker arm further and show that one of the linker arms exists in the free form and
the other stays at the self-inclusion form. The ROESY data shows that these movements are taking
place in equilibrium in liquid form. The diagonal peaks (light green box) at the negative chemical
shifts corresponds to the linker arm protons that are inside the cavity of the P5A, while the peaks
below (light blue box) those represents the other linker arm protons that are outside the cavity.
Presence of these two different sets of signals for the same linker arms implies that these protons
are in chemical exchange.
Furthermore, these outside protons have direct ROE correlations with 1.85, 1.55 and 1.19
chemical shift peaks which confirms that these are the linker arm protons that is situated outside
the cavity of P5A. Also, the negative peaks at -1.37 and -0.66 show ROE correlations to the
aromatics of the P5A. Similar ROE peaks are seen from the negative chemical shifts to the
methylene groups of P5A structure. Also, through TOCSY studies we were able to pinpoint the
directionality of the linker arm bound to the cavity with respect to its chemical shifts -1.18, -2.38,
-3.62, -3.25, -1.64 and -0.87 ppm. This pattern points out that the highest upfield chemical shifts
are from the protons that are fully encapsulated within the cavity, while the others are exposed
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outside. Therefore, we conclude that a stable pseudorotaxane system was formed in chloroform
solvent.

Figure 4.6: ROESY spectrum of ThT Co-P5A in CDCl3
Subsequently, we attempted to investigate the dynamic behavior of this self-assembled ThT CoP5A. As mentioned earlier, the effect of solvent polarity on this disassembly process was
investigated. It was found that, with the increase of the solvent polarity by gradually adding DMSOd6 or 1,2-dichloroethane into the CDCl3 solution of ThT-CoP5A, the negative chemical shifts for
the linker arm present in th self-inclusion structure disappeared gradually. This observation
suggested that the self-inclusion structure was gradually destroyed, presenting a slow exchange
process within the NMR timescale. When the ratio of the mixture DMSO-d6/CDCl3 was raised to
1: 1 (v/v), most of the self-inclusion structure was switched into the free form. This was shown to
be true to both solvents DMSO and 1,2-DCE (See supporting info for spectra).
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Next, we studied competitive binding using fluorescence as shown in figure 6. ThT moieties are
known to be fluorescent. Hence the overall molecule has a moderate fluorescence activity. This can
be used to show the unwinding of the linker. Furthermore, we performed another titration
experiment that refers to the addition of DMSO into the self-assembled structure in CDCl3 to
observe any changes in the fluorescence emission, due to the thioflavin moieties on the CoP5A
results in fluorescence emission. This led to us to observe an increase in fluorescence emission with
an addition of DMSO. As seen on the figure with the addition of the DMSO, a new band at 385 nm
appeared which was not observed when no DMSO was present. We hypothesize that this new
fluorescence signal corresponds to the open non-included complex.

Figure 4.7: Fluorescence emission spectra of ThT self-assembled CoP5A, with the addition of
DMSO. The excitation wavelength used was 304 nm
Furthermore, it is known that P5A has the tendency to bind small organic compounds such
as adiponitrile inside its hydrophobic cavity. We gradually titrated this linear guest into a solution
of ThT-CoP5A in CDCl3 (the self-included complex). As soon as the guest was added, a new broad
upfield peak started to form , corresponding to included adiponitrile, and the self-inclusion peaks
started to disappear (Figure 4.9).
229

Figure 4.8: Stacked 1H NMR of the non-water soluble and water-soluble ThT CoP5A
Once the self-inclusion phenomena were fully investigated, we focused on synthesizing a
water-soluble version of the ThT-CoP5A (Figure 4.8). This was achieved by adding Me3N and
heating at 100 °C for 48 hours. Surprisingly, once the bromide groups are converted to ammonium
ions, no inclusion phenomena were observed. This could be attributed to steric hindrance to the
upper and lowers rims of the pillararene, but it could also simple be the consequence of the aqueous
solvent, as we have previously shown that the polarity and size of the solvent can switch the ThTCo-P5A from its included to open forms.
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Figure 4.9: Titration of Adiponitrile in to ThT-CoP5A in CDCl3 at 298K, the boxes show zoomed
images of the area, except red box indicates the binding of adiponitrile in the cavity of the ThT CoP5ATitration of Adiponitrile in to ThT-CoP5A in CDCl3 at 298K, the boxes show zoomed images
of the area, except red box indicates the binding of adiponitrile in the cavity of the ThT Co-P5A
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Conclusions
We have successfully synthesized a novel switchable pillar[5]arene structure that can be switched
from closed to open with temperature and polar solvents. This switchable pillar[5]arene can be used
as a molecular switch in applications.
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4.2

SUPPORTING INFORMATION

A switchable pillar[5]arene based dual-arm self-assembly

Experimental section
Reagents
Substrates, hydroquinone, boron trifluoride etherate, 1,2 dichloroethane, dichloromethane,
DMF, sodium azide, CuSO4. 5H2O, sodium ascorbate, tri methyl amine, CBr4, methanol,
acetonitrile,
were purchased from Sigma-Aldrich, Fisher Scientific, and TCI chemicals. All reagents
were stored under an inert atmosphere before use. Unless otherwise noted, all reactions
were performed under N2.
Instrumentation
NMR spectra were obtained using a Bruker Avance 300 MHz and 400 MHz spectrometers.
Low-resolution mass spectrometry was performed using a Shimadzu LRMS-2020. Highresolution mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap
XL™ instrument. Isothermal calorimetry was performed using TA Instruments TAM III™
instrument, Fluorescence spectrometer and UV-Vis spectrometer
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Scheme 4-1: The complete synthetic scheme of synthesis of dual-ThT appended Co-P5A
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Synthesis of Brominated monomer

A solution of 1,4-bis(2-hydroxyethyl)benzene (10.0 g, 50.4 mmol) and triphenylphosphine
(31.5 g, 120mmol) in dry acetonitrile (250 mL) was cooled in an ice bath. While vigorous
stirring, carbon tetrabromide (39.8 g, 120 mmol) was slowly added in four portions. In
every addition, the solution immediately turns in to bright yellow and with futher stirring
returns to its colorless form. On the final addition, the solution stays cloudy. The mixture
was stirred at room temperature for 4 hours and 20 minutes. Then cold water (200 mL) was
added to the reaction mixture to give white precipitation. This collected precipitate was
washed with another 200 ml of cold water and methanol/water wash. (3:2, 3 × 100 mL).
The collected white solids were dried under vacuum for 24 hours and used without further
purification. (14.5 g, 97%). 1H NMR and 13C NMR were performed using CDCl3. 1H NMR
(400 MHz, Chloroform-d) δ 6.89 (s, 4H), 4.27 (t, J = 6.3 Hz, 4H), 3.64 (t, J = 6.3 Hz, 4H).
13

C NMR (101 MHz, DMSO-d6) δ 154.2, 118.3, 69.7, 29.8
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Figure 4.10: 1H NMR of Brominated monomer
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Figure 4.11: 13C-NMR of Brominated monomer
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Synthesis of proapargylated monomer

Hydroquinone, anhydrous potassium carbonate was added into solution of acetonitrile.
Then the reaction mixture containing RBF was placed on an ice bath. Next, the propargyl
bromide was added in drop wisely. Then, the reaction solution was stirred 20 hours at 60
°C. Once the reaction was completed, the solvent was removed via rotary evaporation.
Dichloromethane (100 ml) was added into the RBF, and this was transferred into a
separatory funnel for further washes. Washing steps were conducted using 2.5 M NaOH (3
x 100 ml) followed with DI water (3 x 100 ml) and finally with brine (2 x 100 ml). Then
the DCM layer was collected and dried over anhydrous sodium sulfate. The final mixture
was subjected to dry loaded automated flash chromatography. 1H NMR and 13C NMR were
performed using CDCl3. 1H NMR (400 MHz, DMSO-d6) δ 6.95 (s, 4H), 4.74 (d, J = 2.5
Hz, 4H), 3.53 (t, J = 2.4 Hz, 2H). 13C NMR (101 MHz, DMSO-d6) δ 147.6, 111.3, 74.1,
70.6, 51.7.
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Figure 4.12: 1H-NMR of proapargylated monomer
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Synthesis of Co-pillar[5]arene

Brominated monomer, proapargylated monomer, and paraformaldehyde were added into
an RBF charged with 1,2-dichloroethane. Next, the boron trifluoride etherate was added in
dropwise at room temperature. The reaction mixture was left to stir at room temperature
for 30 minutes. Subsequently, 20 ml of methanol was added after the 30 minutes to quench
the reaction. The resulting solution was evaporated using the rotary evaporator. To the
dried mixture, 20 ml of DCM was added, which was then transferred into a separatory
funnel for further washing. Washing steps were conducted using 10% (m/v) sodium
bicarbonate (2 x 10 ml) which was followed with 10 ml DI water wash. The collected DCM
layer was evaporated and the directly subjected into dry loaded automated flash
chromatography. 1H NMR and

13

C NMR were performed using CDCl3. 1H NMR (400

MHz, Chloroform-d) δ 6.84 (s, 2H), 6.81 – 6.77 (m, 6H), 6.69 (s, 2H), 4.51 (d, J = 2.4 Hz,
4H), 4.18 – 4.05 (m, 17H), 3.80 – 3.73 (m, 10H), 3.53 (dtd, J = 21.0, 5.7, 2.3 Hz, 17H),
2.13 (t, J = 2.4 Hz, 2H). 13C NMR (101 MHz, Chloroform-d) δ 149.73, 149.70, 149.6,
149.3, 129.4, 129.1, 129.0, 128.9, 116.2, 116.1, 115.9, 115.8, 115.6, 79.2, 74.9, 69.1, 69.1,
68.9, 68.9, 68.7, 30.6, 30.5, 30.4, 29.8, 29.7, 29.4.
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Table 4-1: The data represents the yields that were obtained with the change of the brominated
monomer equivalents and the type of Lewis acid
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Ratio was changed from 1:10 to
1:5 w.r.t propargyl monomer to
brominated monomer

Figure 4.13: Top: the flash chromatogram of the 1:10 equivalents in hexane/dichloromethane
solvent system. Peaks correspond to products that were recovered. Bottom: flash chromatogram of
the 1:5 equivalents in hexane/dichloromethane solvent system
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Figure 4.14: 1H-NMR of Co-pillar[5]arene
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Figure 4.15: 13C-NMR of Co-pillar[5]arene
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Figure 4.16: Mass spectrum of Co-pillar[5]arene
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Synthesis of Thioflavin

p-Amino Benzoic Acid (2.74 g, 20.0 mmol) and 2-Aminothiophenol (2.14 ml, 20.0 mmol) was
dissolved in (21.03 g, 250.00 mmol) polyphosphoric acid. The mixture was heated at 200oC and
stirred for 4.5 hours. After cooling, 10% Na2CO3 was slowly poured into solution. This resulted in
a greenish mixture. This solution was stirred until gas evolution was completed. Next, the solution
was filtered using vacuum filtration. The solid was washed with water (3x50mL) and recrystallized
with MeOH and H2O to give the final product. The yield was 70%. 1H-NMR was performed using
DMSO-d6. Literature-based procedure was followed1. LRMS ESI (m/z): [M+H] calculated for
C13H10N2S 227.06, observed 227.05. 1H NMR and 13C NMR were performed using DMSO-d6. 1H
NMR (400 MHz, DMSO-d6) δ 8.02 (d, J = 8.0, 1.1 Hz, 1H), 7.90 (d, J = 8.0 Hz, 1H), 7.76 (t, J =
8.7 Hz, 2H), 7.45 (d, J = 7.7 Hz, 1H), 7.34 (d, J = 7.7 Hz, 1H), 6.67 (d, J = 8.6 Hz, 2H), 5.88 (br,
2H).
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Figure 4.17: 1H NMR of Thioflavin
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Figure 4.18: Mass spectrum of Thioflavin
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Synthesis of Thioflavin-6-Br linker

ThT-NH2 (452.6 mg, 2.00 mmol) was dissolved in 20 ml of anhydrous CH2Cl2. To this mixture 6Bromohexonoyl chloride (305.0 µl, 2.00 mmol) was added drop wisely. The reaction was
performed inside the glove box with a Nitrogen atmosphere. The reaction mixture was stirred
overnight at room temperature. The reaction was monitored by TLC. After overnight stirring the
mixture was poured into several centrifuge tubes and centrifuged for 15 minutes at 6000 rpm. Once
centrifugation was completed, the supernatant was discarded. CH2Cl2 was added into the remaining
precipitate and centrifuged again. Once again, the supernatant was discarded, and this was done for
two more times with a total of three washes with CH2Cl2. Finally, the remaining precipitate was
dissolved in deuterated CDCl3 and centrifuged, and the precipitate was collected with the removal
of CDCl3. (CDCl3 was used to remove the CH2Cl2 peak from the spectra.) This was subjected to
overnight vacuum. The product was further purified using automated flash chromatography. The
reaction yielded 59%. 1H-NMR and 13C-NMR were performed using DMSO-d6. 1H NMR (400
MHz, DMSO-d6) δ 10.25 (s, 1H), 8.12 (dd, J = 8.0, 1.2 Hz, 1H), 8.03 (td, J = 8.7, 7.8, 2.5 Hz, 3H),
7.80 (dd, J = 8.8, 2.6 Hz, 2H), 7.53 (ddd, J = 8.3, 7.2, 1.3 Hz, 1H), 7.43 (ddd, J = 8.3, 7.2, 1.2 Hz,
1H), 3.64 (q, J = 6.6 Hz, 1H), 3.55 (t, J = 6.7 Hz, 1H), 2.38 (t, J = 7.4 Hz, 2H), 1.80 (dm, J = 34.0,
7.5, 7.0, 6.8 Hz, 2H), 1.68 – 1.58 (m, J = 7.5 Hz, 2H), 1.44 (t, J = 8.2, 7.1 Hz, 2H).LRMS ESI
(m/z): [M+H] calculated for C19H19BrN2OS 403.05, observed 403.05
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Figure 4.19: 1H NMR of Thioflavin-6-Br linker
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Figure 4.20: 13C NMR of Thioflavin-6-Br linker
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Synthesis of Thioflavin-6-azide

ThT-6-Br (1 equiv.) was dissolved in anhydrous DMF 30 ml and to this solution Sodium
azide (4 equiv.) was added. This reaction mixture was stirred at 80 °C for 12 hours. The
resulted reaction mixture was quenched by adding 150 ml of DI water and the extraction
with ethyl acetate (3 x 100ml). The collected organic layer was dried over anhydrous
sodium sulfate and subjected to dry loaded automated flash chromatography. 1H NMR was
performed using DMSO-d6. 1H NMR (300 MHz, DMSO-d6) δ 10.23 (s, 1H), 8.16 – 8.11
(m, 1H), 8.08 – 8.01 (m, 3H), 7.84 – 7.78 (m, 2H), 7.54 (ddd, J = 8.3, 7.2, 1.4 Hz, 1H),
7.44 (ddd, J = 8.3, 7.2, 1.3 Hz, 1H), 3.37 (t, J = 6.8 Hz, 2H), 2.38 (t, J = 7.3 Hz, 2H), 1.60
(dq, J = 18.5, 7.2 Hz, 4H), 1.46 – 1.32 (m, 2H). 13C NMR (101 MHz, DMSO-d6) δ 172.1,
167.5, 154.1, 142.6, 134.7, 128.5, 127.8, 127.0, 125.7, 123.0, 122.7, 119.6, 50.9, 36.8, 28.5,
26.3, 25.0.
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Figure 4.21: 1H NMR of Thioflavin-6-azide linker
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Figure 4.22: Mass spectrum of Thioflavin-6-azide linker
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Synthesis of ThT-CoP5A

Co-P5A (46.3 mg) , ThT-6N3 (23.8 mg), CuSO4.5H2O (25.0 mg) and L-ascorbic acid
(20.1 mg) was added in to a 10 ml microwave vial, to this vial 2 ml of 1,2-DCE was added
in, which was followed up with 2 ml of ultra-pure water. Next this reaction mixture was
subjected to 300 W microwave power at 70 °C for 1 hour in a microwave with stirring. The
resulting mixture was the transferred in to a separatory funnel. DI water 10 ml was added
in to the same funnel and extraction was performed with 3 x 10 ml DCM. The collected
DCM layer was dried over anhydrous sodium sulfate and subjected to dry loaded
automated flash chromatography for purification. 1H NMR and 13C NMR was performed
using DMSO-d6 and CDCl3. 1H NMR (400 MHz, DMSO-d6) δ 10.21 (s, 2H), 8.27 (s, 2H),
8.11 (dd, J = 8.0, 1.1 Hz, 2H), 8.06 – 7.95 (m, 6H), 7.84 – 7.75 (m, 4H), 7.53 (ddd, J = 8.2,
7.2, 1.3 Hz, 2H), 7.47 – 7.39 (m, 2H), 7.09 (s, 2H), 7.01 – 6.90 (m, 6H), 6.83 (s, 2H), 5.18
(d, J = 11.3 Hz, 2H), 4.95 (d, J = 11.1 Hz, 2H), 4.44 (q, J = 8.0, 7.5 Hz, 9H), 4.30 – 4.19
(m, 3H), 4.09 (dq, J = 11.5, 5.7 Hz, 10H), 3.88 – 3.74 (m, 21H), 2.38 (t, J = 7.3 Hz, 4H),
1.92 (p, J = 7.1 Hz, 4H), 1.69 (p, J = 7.4 Hz, 4H), 1.36 (p, J = 7.8 Hz, 4H).

13

C NMR (101

MHz, DMSO-d6) δ 171.9, 167.5, 154.1, 149.4, 149.3, 149.3, 143.6, 142.6, 134.7, 129.0,
128.9, 128.7, 128.7, 128.4, 127.8, 127.0, 125.6, 124.4, 123.0, 122.7, 119.6, 115.6, 115.1,
79.8, 79.5, 79.1, 69.2, 69.1, 68.7, 62.3, 49.7, 36.7, 32.9, 32.7, 30.2, 29.5, 28.8, 26.0, 24.8.
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Table 4-2: Various click reaction conditions that were used during the screening process of
identifying the correct reaction conditions for the ThT-based CoP5A synthesis
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Figure 4.23: 1H-NMR of ThT-CoP5A in CDCl3
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Figure 4.24: 1H-NMR of ThT-CoP5A in DMSO-d6
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Figure 4.25: 13C-NMR of ThT-CoP5A in DMSO-d6
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Figure 4.26: ROESY spectra of ThT-CoP5A in CDCl3
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Figure 4.27: Zoomed image of ROESY spectra of ThT-CoP5A in CDCl3
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Figure 4.28: TOCSY spectra of ThT-CoP5A in CDCl3
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Figure 4.29: Zoomed image of TOCSY spectra of ThT-CoP5A in CDCl3
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Figure 4.30: HMBC spectra of ThT-CoP5A in DMSO-d6
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Figure 4.31: TOCSY spectra of ThT-CoP5A in CDCl3
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Figure 4.32: Mass spectra of ThT-CoP5A in methanol
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Synthesis of water soluble ThT Co-P5A

ThT-CoP5A (143. 2 mg) was mixed with tri methylamine (250 ul) to this 1 ml CHCl3 and
2 ml ethanol was added. All these was added into a pressure tube. This reaction mixture
was then heated at 100 °C for 48 hours with stirring. After the 48 hours, the reaction
mixture was cooled to room temperature, and the solvent was evaporated. To the dried
mixture, 5 ml of ultra-pure water was added, and any resulting precipitate was filtered using
Whatman 40 filter paper. The final filtered solution was cooled in a -20 °C refrigerator and
then freeze-dried to obtain the final dried product. 1H NMR and 13C NMR were performed
using DMSO-d6. 1H NMR (400 MHz, DMSO-d6) δ 10.61 (s, 2H), 8.42 (s, 2H), 8.15 – 8.09
(m, 2H), 8.05 – 7.98 (m, 6H), 7.91 – 7.84 (m, 4H), 7.53 (ddd, J = 8.3, 7.2, 1.3 Hz, 2H),
7.44 (ddd, J = 8.3, 7.2, 1.2 Hz, 2H), 7.14 – 6.89 (m, 10H), 5.20 – 5.04 (m, 4H), 4.75 – 4.35
(m, 20H), 4.08 (d, J = 47.9 Hz, 19H), 3.72 (d, J = 38.1 Hz, 11H), 3.23 (s, 87H), 2.42 (t, J =
7.3 Hz, 4H), 1.89 (p, J = 7.2 Hz, 4H), 1.67 (p, J = 7.6 Hz, 4H), 1.32 (p, 4H). 13C NMR (101
MHz, DMSO-d6) δ 172.2, 167.5, 154.1, 149.5, 149.3, 142.7, 134.7, 128.7, 128.4, 127.7,
127.1, 125.7, 123.0, 122.7, 119.6, 57.8, 54.9, 54.8, 54.8, 53.6, 53.5, 49.8, 44.4, 36.6, 34.6,
30.0, 25.9, 24.8.
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Figure 4.33: 1H-NMR of water-soluble ThT-CoP5A in DMSO-d6
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Figure 4.34: COSY spectrum of water soluble ThT-CoP5A in DMSO-d6
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Figure 4.35: ROESY spectrum of water soluble ThT-CoP5A in DMSO-d6
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Figure 4.36: 13C NMR spectrum of water soluble ThT-CoP5A in DMSO-d6
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Figure 4.37: Absorbance curve for ThT-CoP5A in chloroform
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Figure 4.38: SEM images, as indicated from the arrows each one represents the increase of the
level of magnification and decrease of the particle size ranging from 100 µm to 200 nm. The yellow
boxes indicate the area that was zoomed in. The sample was loaded on to a platform and then it
was gold spluttered. This gold spluttered surface was used to observe the surface in its dried form
under vacuum.
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Figure 4.39: SEM image of ThT-CoP5A at 100 µm level
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Figure 4.40: SEM image of ThT-CoP5A at 20 µm level
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Figure 4.41: SEM image of ThT-CoP5A at 10 µm level
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Figure 4.42: SEM image of ThT-CoP5A at 2 µm level
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Figure 4.43: SEM image of ThT-CoP5A at 1 µm level
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Figure 4.44: SEM image of ThT-CoP5A at 1 µm level
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Figure 4.45: SEM image of ThT-CoP5A at 1 µm level
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Figure 4.46: SEM image of ThT-CoP5A at 1 µm level
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Figure 4.47: SEM image of ThT-CoP5A at 1 µm level
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Figure 4.48: Titration of ThT-6-azide to a solution of CoP5A in CDCl3 solvent
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Figure 4.49: Titration of ThT-6azide to a solution of CoP5A in CDCl3
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Figure 4.50: Computational model after molecular dynamics in CHCl3 solvent system.
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Figure 4.51: Zoomed image of the Computational model after molecular dynamics in CHCl3
solvent system.
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Figure 4.52: Computational model after molecular dynamics in DMSO solvent system

Figure 4.53: Computational model after molecular dynamics in DMSO solvent system. (Space
filling model)
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Abstract
The ability to detect biologically relevant small molecules with high levels of selectivity, sensitivity
and broad applicability for a variety of analytes in a variety of complex environments is an essential
goal in bioanalytical chemistry. Methods to achieve such detection vary widely and include the use
of electrochemical, spectroscopic, and visible read-out signals. The purpose of supramolecular
chemistry to accomplish such detection has many notable advantages, including straightforward
tunability, high general applicability, and ease of modification of every component. Reported
herein is the use of supramolecular chemistry of pillar[5]arenes to accomplish precisely such
detection. A variety of pillar[5]arenes has been synthesized and analyzed for their applicability
toward small molecule detection schemes. Water-soluble pillar[5]arenes functionalized with
cationic linker arms have been found to bind small molecule toxicants in their hydrophobic cavities
with association constants on the orders of 105 and 106 M-1. With the use of exchange resins,
cationic pillar[5]arenes could be removed from solution along with their encapsulated guests,
allowing for potential application to water purification systems.
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Introduction
The development of methods for the selective removal of highly toxic organic pollutants from
aqueous environments is a pressing research need with significant implications in public health,1
environmental legislation,2 and biological sciences.3,4 Many existing methods for such removal
suffer from significant drawbacks, including lack of selectivity in toxicant removal, 5 introduction
of toxic removal agents in order to remove the targeted pollutants,6 inefficient toxicant removal
performance,7 and lack of recyclability of the removal agents.8 These drawbacks are particularly
significant for compounds that are highly environmentally persistent, which means that such
compounds will remain in the environment for several years after an initial contamination event
unless actively removed, as well as for compounds that lack clear detectable signatures,9 including
visible colour and/or high luminescence, which means that their continued presence in the
environment is challenging to detect.
Previous work from our research groups has reported extensive results using cyclodextrin-based
systems for highly effective toxicant detection and medical imaging applications.10,11,12 Some work
in synthetically-modified cyclodextrins,13-15modified curcubiturils,16 and fully synthetic all-organic
macrocycles17,18 has also been reported, but the utility of such materials in small molecule binding
and sequestration has not been fully explored. The highly efficient removal of micropollutants
using insoluble cyclodextrin polymers cross-linked with rigid aromatic groups has been reported
by Dichtel and co-workers.19,20 While this material was highly effective at pollutant capture in both
air and water,21 it required anhydrous conditions and a multi-day reaction time to synthesize the
porous polymer in 45% isolated yield. Moreover, the use of an insoluble material for pollutant
removal rather than the soluble macrocycle reported herein comes with additional trade-offs in
terms of detailed material characterization, as well as rationally-guided opportunities for further
tunability and structural optimization.
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Compared to cyclodextrin-based systems, pillararenes are relatively new, with the first reported
pillararene synthesized by Ogoshi and co-workers in 2008.22 These macrocycles, which are formed
from the condensation reaction of a 1,4-dialkoxybenzene with paraformaldehyde, and generally
form the thermodynamically favored 5-membered cyclic oligomer, termed a pillar[5]arene,23
having symmetrical, rigid, pillar-like cavities,24 The electronic and steric properties of pillararenes
can be tuned via judicious choice of dialkylhydroquinone starting material, although overall highly
electron-rich structures are obtained.25 As a result, pillar[5]arenes are well-suited to bind electron
deficient small molecule guests in their interior cavities,26 with binding constants between 103 and
105 M-1 generally obtained.27 Examples of small molecule guests include biologically relevant
analytes such as methionine,28 tryptophan,29 and adenosine triphosphate (ATP),30 with the
pillararenes in those cases bearing cationic groups that facilitate aqueous solubility.
Despite the significant advances in pillararene syntheses and applications that have been
reported in recent years, the use of pillararenes for environmental remediation applications such as
purification of contaminated water has been only rarely reported. This is true despite the fact that
pillararene-induced binding of environmentally relevant analytes has strong potential to facilitate
such environmental remediation, provided that there is a mechanism to remove the analytes of
interest after binding in the pillararene is achieved. Such analytes include polycyclic aromatic
hydrocarbons (PAHs),31 polyfluorooctanoic acid (PFOA),32 aromatic pesticides,33 pharmaceutical
drugs such as Tylenol and Advil,34 and plasticizers such as phthalate esters,35 all of which have
been found in aqueous environments and have the potential to induce deleterious health effects.36
Reported herein is the use of a newly synthesized cationic pillar[5]arene to bind a broad
variety of small molecule organic analytes, including several of the analytes listed above, with
strong binding constants up to 109 M-1 observed. This macrocyclic host demonstrates good
generality for a range of analytes as well as high aqueous solubility due to its cationic pendant
groups, which facilitates its usage in water purification efforts. Moreover, the ability to use cationic
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exchange resins to remove the cationic pillar[5]arene after binding the analyte, which facilitates
practical water purification efforts, is also demonstrated, as are comparisons to a neutral
pillar[5]arene host. Computational efforts are invoked to explain the observed experimental data
and overall trends.
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Results and Discussion
The water-soluble pillar[5]arene host was synthesized with an 80% overall yield over three
steps. The first step of the synthesis consisted of bromination of para-hydroquinone to form the
dialkoxyether monomer 1, followed by cyclization using boron trifluoride etherate as a Lewis acid
to promote the desired cyclization in a solution of 1,2-dichloroethane, which serves as both the bulk
solvent and as the molecular template for the macrocyclization to form pillar[5]arene 2. A
subsequent substitution using N-methylimidazole provided the decacationic pillar[5]arene 3 in an
81% yield over two steps.37,38

Figure 5.1: Illustration of the synthesis of pillar[5]arene 3 via cyclization of monomer 1 in the
presence of dichloroethane solvent, followed by nucleophilic substitution of the terminal bromine
moieties on compound 2.Three-dimensional structures underneath the reaction scheme show
energy-minimized molecular conformations.
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Molecular mechanics calculations predicted that compound 3 has a unique structure with
a central cavity (Figure 1), which is readily accessible due to the repulsion created by the ten
positive charges on the ethylene arms. Pillararene 3’s hydrophobic core, flexible aperture, and

high water solubility make it a great candidate for binding a wide variety of small organic
molecules in aqeous media. Furthermore, the imidazolium cations that are present at the
termini have the potential to participate in π-π39 or cation-π40 interactions. Consequently,
we predicted that 3 could accommodate different types of toxicants with a broad variety of
sizes, electronics, and other structural components.
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Figure 5.2: Array of toxicants and small molecules that were used in the binding study with
supramolecular host 3, with calculated stabilization energies of the toxicants upon binding in host
3 (obtained via Spartan 16) shown.The values given represents the stabilization energy for the final
complex formation between the toxicant and 3. The equation used is ΔΔH (stabilation energy) =
ΔH (𝟑 + guest) − ΔH(𝟑) − ΔH(guest). Top - Cartoon image represents the binding phenomena
taking place between 3 and the toxicants.
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Computational Investigations
Pillararene 3 has a calculated internal diameter of 9 Å and an outer diameter of 11 Å. The diameters
of toxicants 4-15 in this study ranged from 7 Å to 11.5 Å, which means that most of them should
be able to fit in the cavity of the supramolecular host. Furthermore, docking studies performed
using supramolecular host 3 and toxicants 4-15 resulted in calculated stabilization energies and
docking scores (Table 1) that highlight the favourability of supramolecular complexation.
As shown in Table 1, the most favourable stabilization energy (largest negative value)
corresponds to the binding of naproxen (analyte 10), a pharmaceutical drug with some associated
toxicity, likely as a result of the good complementary fit between the analyte and the
supramolecular cavity (Figure 3A). This is also true for other molecules such as PFOA (Figure 3B),
cyclophosphamide (Figure 3C), and 1,10-phenanthroline (Figure 3D), all of which appear to be
using the majority of the interior space and all of which have key favourable interactions. More
generally, the uniformly negative stabilization energies obtained for all toxicants in the
supramolecular host 3 indicate that all complexes should spontaneously form in aqueous media. Of
note, toxicants such as 1,10-phenanthroline were bound more towards the outer portal of the host
(Figure 3D), which generally displayed weaker binding compared to binding that was deeper in the
interior cavity.
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Figure 5.3: Computed images of analytes docked in macrocycle 3. (A) Naproxen; (B) PFOA; (C)
Cyclophosphamide; and (D) 1,10-Phenanthroline
NMR Spectroscopy
Additionally, 1H NMR spectroscopy investigations provided structural insight into the
host: guest complex, with shifts observed in the peaks that correspond to the interior protons of
host 3 and the methylene protons on the imidazolium-terminated side chains (Figure 4). Similarly,
19

F NMR spectroscopy (Figure 5) demonstrated broadening of the fluorine signal that corresponds

to the PFOA analyte 4 in the presence of the pillararene host, indicating restricted conformational
freedom as a result of host-guest inclusion.
299

Figure 5.4: 1H NMR spectra of: (A) macrocycle 3; and (B) macrocycle 3 and naproxen 10 in a 1:1
molar ratio. The concentrations of the guest and host were 10 mM each

Figure 5.5: Fluorine NMR spectra of: (A) Perfluorooctanoic acid (PFOA); and (B) complex
between PFOA and supramolecular host 3
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Fluorescence Spectroscopy of Inclusion Complexes
Fluorescence studies were undertaken to elucidate the binding modes and affinities of the
small molecule toxicants shown in Figure 2. The results of analyte binding inside cationic
pillararene 3 are summarized in Table 2, with selected results highlighted in Figures 6 and 7. These
studies showed that most of the analytes formed 1:1 association complexes both in phosphate
buffered saline (PBS) as well as in DMSO. The compounds that formed 1:2 complexes in PBS
included clofibric acid, myclobutanil, and 1,10-phenanthroline, with only 1,10-phenanthroline
maintaining the 1:2 complex in DMSO as well. Of note, both clofibric acid and myclobutanil
contain a chlorine-substituted benzene ring with the chlorine in the para-position relative to the rest
of the structure. Para-chlorobenzene structures have been shown in the literature to bind strongly
in pillararene structures,41 and the relatively small size of this structure allows for the inclusion of
two small molecule guests simultaneously. Simazine formed an unusual 2:1 complex, likely due
to the ability of the amine substituents to associate with two different pillararene hosts
simultaneously. The fact that phenanthroline formed a 1:2 complex is likely due to the ability of
the heterocyclic aromatic architecture to form strong π-stacked association complexes, in
accordance with literature precedent.42,43
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Compound number

Host:Guest
Association Constant in
Stoichiometry water (M-1)

Anthracene

1:1

7.18 (0.0001) x 10

Carbamazepine

1:1

1.06 (0.12) x 10

Clofibric acid

1:2

Ka1 = 6.34 (1.27) x 10

5

N/A

5

N/A

Ka2 = 4.77 (0.32) x 10

6

N/A

5

6

Cyclophosphamide

1:1

1.33 (0.19) x 10

Dibutylphtalate

1:1

5.67 (0.97) x 10

Myclobutanil

1:2

Ka1 = 5.10 (0.92)

2.17 (0.35) x 10

5

3.32 (0.45) x 10

1.62 (0.12) x 10

Naproxen

1:1

6.51 (0.911) x 10

PFOA

1:1

1.13 (0.13) x 10

Phenanthrene

1:1

2.32 (0.02) x 10

1,10-Phenothroline

1:2

N/A

5

10

6

1:1

5

N/A

Ka2 = 2.62 (0.0044) x 10
N,N,N,N tetramethylbenzidine

Association
constant in
DMSO (M-1)

N/A
3

N/A

6

2.44 (0.17) x 10

4

8.10 (1.80) x 10

4

3

Ka1 = 4.40 (0.027)
x 10

5

Ka2 = 2.67 (0.24) x
10
Simazine

2:1

Ka1 = 1.37 (0.22) x 10
Ka2 = 6.47 (1.42) x 10

10

9

Ka1 = 7.52 (0.001)
x 10
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11

Ka2 = 6.47 (0.42) x
10

Table 5-1: Association constants obtained from fluorescence titrations

4

4

Figure 5.6: Sample fluorescence titrations of analytes with cationic host 3 used to determine
binding constants: (A) with simazine guest; and (B) with phenanthrene guest. The black line
represents the calculated values and the red line represents the experimentally determined values

Figure 5.7: Job’s plot analysis of binding of cationic host 3 with: (A) anthracene and (B)
phenanthrene small molecule guests
Interestingly, we synthesized a neutral pillar[5]arene that contains ten propargyl groups as
a control to compare with the cationic structure of supramolecular host 3. In the control case, most
of the toxicants formed 1:2 complexes with the propargyl-substituted host, likely as a result of the
fact that the alkynes extend the size of the hydrophobic cavity and facilitate the binding of multiple
guest molecules.44 Moreover, cationic host 3 is likely to suffer from charge repulsion, either via
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self-repulsion or via repulsion with cationic small molecule guests.1 This charge repulsion, in turn,
leads to more 1:1 complexation than any other binding stoichiometry.
Moreover, pillararene 3 showed the strongest binding to simazine in aqueous solution, with
a 1010 M-1 binding constant observed (for binding the first equivalent of toxicant), and
myclobutanil, with a 1010 M-1 binding constant observed (for binding a second equivalent of
toxicant). These binding constants are four orders of magnitude higher than the next highest
strength constants, seen for clofibric acid, cyclophosphamide, N,N,N’,N’-tetramethylbenzidine,
perfluorooctanoic acid, and 1,10-phenanthroline, all of which displayed association constants on
the order of 106 M-1. A structural comparison between the two strongest binding guests indicates
high levels of electron deficiency for both simazine and myclobutanil. Although other analytes also
show moderate to significant electron deficiencies, the highly aminated structures of myclobutanil
and simazine provide additional benefits for association with a cationic supramolecular host, with
the nitrogen atoms able to associate with the cationic charge. The weakest binding guests,
phenanthrene (104 M-1) and naproxen (103 M-1), have much higher electron density, which
disfavours binding inside the pillararene host.
Switching the solvent to DMSO resulted in decreases in host: guest association complexes,
with a reduction in binding affinity of up to three orders of magnitude observed (simazine in PBS
= 1010 M-1; in DMSO = 107 M-1). The decreased binding affinity in non-aqueous environments
means that the likely mechanism of binding is via hydrophobic association and that switching to
non-aqueous solvents results in decreasing the energetic favorability of such association. Literature
precedent strongly supports the notion of hydrophobically-driven binding in pillararene
architectures, as well as the fact that switching to non-aqueous solvents reduces the favorability of
hydrophobically-driven inclusion.
Finally, linear discriminant analysis of the experimentally obtained binding constants
revealed 100% differentiation between the different toxicants (Figure 8), with clustering between
structurally similar analytes observed. For example, anthracene, 1,10-phenanthroline and
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phenanthrene all grouped near each other due to similarities in their planar, polycyclic aromatic
core. The only fluorinated analyte, PFOA, was found to be separate on the graph from the other
analytes investigated. Such separation among different analytes, even those with high degrees of
structural similarity, highlight the potential of this method to enable selective toxicant detection
capabilities.

Figure 5.8: Linear discriminant analysis of analyte-induced responses upon binding in cationic
host 3
Finally, we have shown that pillararene host 3 can be removed by a cation exchange resin
after it binds the toxicant small molecule guests (Figure 9).
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C

D

Figure 5.9: (A) Schematic illustration of removal of toxicant-bound pillararene with cationic
exchange resin; (B) Quantitative assessment of the amount of 3 that was removed by different
cation resin types.The black line represents Dowex Marathon resin, the red line represents Dowex
50WX2 resin, and the blue line represents Amberlite IRN150 resin. (C) Quantitative assessment of
the amount of naproxen removed after treatment of 3 with resin and (D) Quantitative assessment
of the amount of phenanthrene removed after treatment of 3 with resin
As seen on figure 9 we were able to successfully remove naproxen and phenanthrene from an
aqueous solution using WSP5A as the capture agent and exchange resin as a removal agent, to
remove the whole guest encapsulated 3 from the aqueous solution with ease.
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Conclusion
The ability to use rationally designed supramolecular hosts such as pillararene 3 for the
removal of toxic compounds from contaminated aqueous environments has significant potential
advantages, provided that the removal can occur with high efficacy for toxic compounds and broad
relevance for a variety of potential contaminants, and that the contaminants can be removed from
the aqueous solution following binding. The results reported herein constitute significant progress
towards achieving this goal, through the development of polycationic pillararene host 3, using
computational and experimental results to understand its binding to a variety of small molecule
toxicants, and then demonstrating the practical relevance of such systems via the use of cationic
exchange resins to remove the complex after toxicant binding. Current efforts in our laboratory are
focused on the development of practical environmental remediation systems based on such
technology, and on developing other effective supramolecular systems based on the progress
reported herein. The results of these and other investigations will be reported in due course.
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5.2

SUPPORTING INFORMATION

Cationic Pillararenes: Porous Single Molecules for Binding Toxicants in Aqueous Media
Reagents
Substrates, including CBr4, dry acetonitrile, dry 1,2-dichloroethane, boron trifluoride etherate,
triphenylphosphine, methylimidazole were purchased from Sigma-Aldrich, Fisher Scientific,
and TCI chemicals. All reagents were stored under an inert atmosphere before use. Unless
otherwise noted, all reactions were performed under N2.

Instrumentation
NMR spectra were obtained using Bruker Avance 300 MHz and 400 MHz spectrometers. Lowresolution mass spectrometry was performed using a Shimadzu LRMS-2020. High-resolution
mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap XL™ instrument.
UV-Vis spectra was obtained via Shimadzu UV-Vis spectrophotometer, and Fluorescence
spectra was obtained via Shimadzu Fluorimeter.
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The synthetic route for the synthesis of Water-soluble pillar[5]arene

The above molecule was synthesized according to the literature procedures1, with further
optimizations and better yields.
[In the UV-Vis, fluorescence spectra and jobs plot WSP5A is mentioned as PA1 and the neutral
proapargylated is mentioned as PA2]
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Synthesis of guest molecules
Synthesis of brominated monomer, 1

A solution of 1,4-bis(2-hydroxyethyl)benzene (10.0 g, 50.4 mmol) and triphenylphosphine
(31.5 g, 120mmol) in dry acetonitrile (250 mL) was cooled in an ice bath. Under vigorous
stirring, carbon tetrabromide (39.8 g, 120 mmol) was slowly added in four portions. In every
addition, the solution immediately turns bright yellow and with stirring returns to its colorless
form. On the final addition, the solution stays cloudy. The mixture was stirred at room
temperature for 4 hours and 20 minutes. Then cold water (200 mL) was added to the reaction
mixture to give a white precipitate. The precipitate was collected, washed with another 200 ml
of cold water followed with methanol/water (3:2, 3 × 100 mL). The collected white solids were
dried under vacuum for 24 hours and used without further purification. (14.5 g, 97%). 1H NMR
and 13C NMR was performed using CDCl3. 1H NMR (400 MHz, Chloroform-d) δ 6.89 (s, 4H),
4.27 (t, J = 6.3 Hz, 4H), 3.64 (t, J = 6.3 Hz, 4H).
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Figure 5.10: 1H NMR of brominated monomer
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Figure 5.11: 13C NMR of 1
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Synthesis of deca-brominated pillar[5]arene, 2

A solution of brominated monomer (3.37 g, 11.5 mmol) and paraformaldehyde (0.349 g, 11.5
mmol) in 1,2-dichloroethane (50 mL) was cooled with an ice bath. Boron trifluoride etherate
(3.26 g, 23.0 mmol) was added to the solution, and the mixture was stirred at room temperature
for 1 hour. During the 1 hour, the reaction undergoes various color changes. This reaction
mixture was washed with DI water (2 × 50 mL), saturated sodium bicarbonate (2 x 50 ml) and
brine solution (2 x 50ml). The organic layer was dried with anhydrous Na2SO4. The solvent
was evaporated to provide a crude product. The crude product was pure; hence no further
purification was required. (yield 85%). 1H NMR and 13C NMR were performed using CDCl3.
H NMR (400 MHz, Chloroform-d) δ 6.91 (s, 10H), 4.23 (t, J = 6.3, 5.1 Hz, 20H), 3.84 (s,

1

10H), 3.63 (t, J = 5.6 Hz, 20H).
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Figure 5.12: 1H NMR of Brominated pillar[5]arene 2
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Figure 5.13: 13C NMR of Brominated pillar[5]arene 2
320

Synthesis of deca methyl imidazolium pillar[5]arene, 3

A mixture of brominated pillar[5]arene (1.68 g, 1.00 mmol) and N-methylimidazole (1.64 g, 20.0
mmol) in toluene (25 mL) was stirred in a 40 mL pressure tube at 120 ºC for 24 hours. The reaction
was performed multiple times using a round bottom flask, but the reaction never worked. After
cooling, the solvent was subjected to rotaroy evaporation of the solvent and the residue was then
dissolved in ethanol and diethylether was added to crash the solid material out of the ethanol
solution. This white precipitate consisting solution was further cooled for 24 hours and then filtered
and collected as a off white product. (2.1 g, 87%). 1H NMR and 13C NMR were performed using
DMSO-d6. 1H NMR (300 MHz, DMSO-d6) δ 9.17 (br, 10H), 8.11 (s, 10H), 7.44 (br, 11H), 6.72
(br, 10H), 4.72 (br, 21H), 4.45 (br, 20H), 3.74 (br, 31H), 3.51 (br, 10H).
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Figure 5.14: 1H-NMR of 3
322

Figure 5.15: 13C-NMR of 3
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Mass spectrometry of the water soluble P5A

Figure 5.16: [M − 3Br]3+ Calculated C95H121O10N20Br7 754.1270

Figure 5.17: [M − 5Br]5+ Calculated C95H121O10N20Br5 420.1090

324

Figure 5.18: [M − 6Br]6+ Calculated C95H121O10N20Br4 336.9378

Figure 5.19: [M − 7Br]7+ Calculated C95H121O10N20Br3 277.2442
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Synthesis of proapargylated monomer

Hydroquinone and anhydrous potassium carbonate were added into a solution of
acetonitrile in RBF. Then the reaction mixture was placed in an ice bath. Next, the
propargyl bromide was added in dropwise. Then, the reaction solution was stirred 20 hours
at 60 °C. Once the reaction was completed, the solvent was removed via rotary evaporation.
Dichloromethane (100 ml) was added into the RBF, and this was transferred into a
separatory funnel for further washes. Washing steps were conducted using 2.5 M NaOH (3
x 100 ml) followed with DI water ( 3 x 100 ml) and finally with brine (2 x 100 ml). Then
the DCM layer was collected and dried over anhydrous sodium sulfate. The final mixture
was subjected to dry loaded automated flash chromatography. 1H NMR and 13C NMR were
performed using CDCl3. 1H NMR (400 MHz, DMSO-d6) δ 6.95 (s, 4H), 4.74 (d, J = 2.5
Hz, 4H), 3.53 (t, J = 2.4 Hz, 2H). 13C NMR (101 MHz, DMSO-d6) δ 147.6, 111.3, 74.1,
70.6, 51.7.
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Figure 5.20: 1H spectrum of proapargylated monomer
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Synthesis of proapargylated P5A

Proapargylated monomer (3.0 g) and paraformaldehyde (1.45 g) were added into an anhydrous
solution of DCM. Then FeCl3 was added. The complete reaction mixture was stirred for 3 hours at
room temperature. Once the 3 hours was over, the reaction was quenched by adding in 200 ml of
DI water. The organic layer was extracted and washed with 200 ml of brine solution. The collected
organic layer was dried over anhydrous sodium sulfate and subjected to rotatory evaporation. Next,
this was packed with silica and dry loaded into automated flash chromatography instrument. The
final product was light brown.1H NMR and 13C NMR were performed using CDCl3. 1H NMR (400
MHz, Chloroform-d) δ 6.76 (s, 10H), 4.47 (d, J = 2.4 Hz, 21H), 3.74 (s, 10H), 2.21 (t, J = 2.4 Hz,
10H).
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Figure 5.21: Flash chromatogram for the purification of Proapargylated P5A, Product was
separated at 23 – 35 CV. First peak corresponds to the unreacted proapargylated monomer
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Figure 5.22: 1H NMR of proapargylated P5A
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Figure 5.23: Mass spectrum of proapargylated P5A
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Methods for Job’s Plot Experiments

Figure S15 - Job’s plot of anthracene and PA1 in PBS obtained by fluorescence spectroscopy indicating a 1:1
anthracene – PA2 binding mode (γmax = 0.5). γ is mole fraction of guest and ΔF is the change in fluorescence
integration.

γ(PA1)
1

γ(PA1)*ΔF
0

0.875
0.78
0.68
0.59
0.50
0.41
0.31

106699
159832
170877
193647
203499
200956
147395

0.22
0.125
0

117708
81313
0

Table 1 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with anthracene in PBS. γ is mole
fraction of guest and ΔF is the change in fluorescence integration.
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Figure S16 - Fluorescence titration of anthracene with PA1 in PBS fit to a 1:1 anthracene - PA2 stoichiometry. Ka =
7.18 (0.000076) x 105 M-1; Sum(χ2) = 0.0014.

Figure S17 – Job’s plot of anthracene and PA2 in PBS obtained by fluorescence spectroscopy indicating a 1:2
anthracene – PA2 binding mode (γmax = 0.37). γ is mole fraction of guest and ΔF is the change in fluorescence
integration. Moderately sharp peak indicates a relatively high association constant.
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γ(PA2)

γ(PA2)*ΔF

1

0

0.90

53301

0.74

111496

0.57

173350

0.47

186621

0.37

189407

0.27

152836

0.16

112304

0

0

Table 2 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with anthracene in PBS. γ is mole
fraction of guest and ΔF is the change in fluorescence integration.

Figure S18– Fluorescence titration of anthracene with PA2 in PBS fit to a 1:2 anthracene - PA2 stoichiometry. Ka1 =
7.34 (0.39) M-1; Ka2 = 1.13 (0.0097) x 109 M-1; Sum(χ2) = 0.0012.
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Figure S19 - Job’s plot analysis of carbamazepine and PA1 in PBS obtained by fluorescence spectroscopy. Indicates a
likely 1:1 PA1 – carbamazepine binding mode (γmax = 0.55). γ is mole fraction of guest and ΔF is the change in
fluorescence integration. Sharp profile indicated high association constant.

γ(carbamazepine)

γ(carbamazepine)*ΔF

1
0.85
0.75
0.64
0.55
0.45
0.36
0.27
0.19
0.11
0

0
37710
46092
51796
59415
51421
53709
45267
34796
23555
0

Table 3 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with carbamazepine in PBS. γ is
mole fraction of guest and ΔF is the change in fluorescence integration.
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Figure S20 - Fluorescence titration of PA1 with carbamazepine in PBS fit to a 1:1 stoichiometry. Ka = 1.06(0.12) x 105
M-1; Sum(χ2) = 0.0017.

Figure S21 – Job’s plot analysis of carbamazepine and PA2 in PBS obtained by fluorescence spectroscopy. Indicates a
likely 1:2 PA2 – carbamazepine binding mode (γmax = 0.68). γ is mole fraction of guest and ΔF is the change in
fluorescence integration. Sharp profile indicated high association constant.
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γ(carbamazepine)
1
0.875
0.78

γ(carbamazepine)*ΔF
0
3961737
5517031

0.68
0.59
0.5
0.41
0.31
0.22

7427062
5385965
3994950
3293915
726593
75621

0.125
0

461212
0

Table 4 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with carbamazepine in PBS. γ is
mole fraction of guest and ΔF is the change in fluorescence integration.

Figure S22 – Fluorescence titration of PA2 with carbamazepine in PBS fit to a 1:2 stoichiometry. Ka1 = 2.43
(0.000000036) x 1012 M-1; Ka2 = 1.06 (0.12) x 105 M-1; Sum(χ2) = 0.00066.
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Figure S23 - Job’s plot analysis of clofibric acid and PA1 in PBS obtained by fluorescence spectroscopy. Indicates a
likely 1:2 PA1 – clofibric acid binding mode (γmax = 0.41). γ is mole fraction of guest and ΔF is the change in
fluorescence integration. Sharp profile indicated high association constant.

γ(PA1)
1
0.875
0.78
0.68

γ(PA1)*ΔF
0
33832
53374
59387

0.59
0.5
0.41
0.31
0.22
0.125

70250
74500
74550
50702
34148
21776

0

0

Table 5 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with clofibric acid in PBS. γ is
mole fraction of guest and ΔF is the change in fluorescence integration.
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Figure S24 - Fluorescence titration of PA1 with clofibric acid in PBS fit to a 1:2 stoichiometry. Ka1 = 6.34 (1.27) x 106
M-1; Ka2 = 4.77 (0.32) x 105 M-1; Sum(χ2) = 0.016.

Figure S25 - Job’s plot analysis of cyclophosphamide and PA1 in PBS obtained by fluorescence spectroscopy.
Indicates a likely 1:1 stoichiometry (γmax = 0.55). γ is mole fraction of guest and ΔF is the change in fluorescence
integration.
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γ(cyclophosphamide)

γ(cyclophosphamide)*ΔF

1
0.85
0.75
0.64
0.55
0.45
0.36
0.27
0.19
0

0
38243
49068
64809
67065
57459
59221
45382
35006
0

Table 6 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with cyclophosphamide PBS. γ is
mole fraction of guest and ΔF is the change in fluorescence integration.

Figure S26 – Fluorescence titration of PA1 with cyclophosphamide in PBS fit to a 1:1 host-guest stoichiometry. Ka =
1.33 (0.19) x 106 M-1; Sum(χ2) = 0.000040.
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Figure S27 - Job’s plot analysis of cyclophosphamide and PA1 in DMSO obtained by fluorescence spectroscopy.
Indicates a likely 1:1 stoichiometry (γmax = 0.5). γ is mole fraction of guest and ΔF is the change in fluorescence
integration.

γ(cyclophosphamide)
1
0.875
0.78
0.68
0.59
0.5
0.41
0.31
0.22
0.125
0

γ(cyclophosphamide)*ΔF

0
62124
102147
153694
147182
170639
168673
144670
105210
75556
0

Table 7 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with cyclophosphamide PBS. γ is
mole fraction of guest and ΔF is the change in fluorescence integration.
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Figure S28 – Fluorescence titration of PA1 with cyclophosphamide monohydrate in DMSO fit to a 1:1 host-guest
stoichiometry. Ka = 2.17 (0.35) x 105 M-1; Sum(χ2) = 0.00113.

Figure S29 - Job’s plot analysis of cyclophosphamide and PA2 in DMSO obtained by fluorescence spectroscopy.
Indicates 1:1 host – guest stoichiometry (γmax = 0.50). γ is mole fraction of guest and ΔF is the change in fluorescence
integration.
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γ(cyclophosphamide)

γ(cyclophosphamide)*ΔF

1
0.875
0.78
0.69
0.59
0.5
0.41
0.31
0.22
0.125
0

0
48486
35875
41085
76436
86439
71293
73743
51353
35179
0

Table 8 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with cyclophosphamide in DMSO.
γ is mole fraction of guest and ΔF is the change in fluorescence integration.

Figure S30 – Fluorescence titration of PA2 with cyclophosphamide in DMSO fit to a 1:1 host-guest stoichiometry. Ka
= 9.44 (0.59) x 104 M-1; Sum(χ2) = 0.0080.
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Figure S31 – Job’s plot analysis of dibutylphthalate and PA1 in PBS obtained by fluorescence spectroscopy. Indicates
a 1:1 host-guest stoichiometry (γmax = 0.55). γ is mole fraction of guest and ΔF is the change in fluorescence
integration.

γ(dibutylphthalate)

γ(dibutylphthalate)*ΔF

1
0.85
0.745
0.64
0.545
0.45
0.36
0.27
0.19
0.105
0

0
30345
49700
59034
67596
65952
56825
48619
27800
18541
0

Table 9 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with dibutylphthalate in PBS. γ is
mole fraction of guest and ΔF is the change in fluorescence integration.
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Figure S32 - Fluorescence titration of PA1 with dibutylphthalate in PBS fit to a 1:1 host-guest stoichiometry. Ka = 5.67
(0.95) x 105 M-1; Sum(χ2) = 0.00028.

Figure S33 – Job’s plot analysis of dibutylphthalate and PA1 in DMSO obtained by fluorescence spectroscopy.
Indicates 1:1 host – guest stoichiometry (γmax = 0.50). γ is mole fraction of guest and ΔF is the change in fluorescence
integration. Sharp peak indicates a high association constant.
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γ(dibutylphthalate)

γ(dibutylphthalate)*ΔF

1
0.875
0.78
0.69
0.59
0.5
0.41
0.31
0.22
0.125
0

0
45565
105280
153838
160319
197152
176401
143167
102695
71629
0

Table 10 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with dibutylphthalate in DMSO.
γ is mole fraction of guest and ΔF is the change in fluorescence integration.

Figure S34 – Fluorescence titration of PA1 with dibutylphthalate in DMSO fit to a 1:1 host-guest stoichiometry. Ka =
3.32 (0.45) x 105 M-1; Sum(χ2) = 0.00144..
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Figure S35 - Job’s plot analysis of dibutylphalate and PA2 in PBS obtained by fluorescence spectroscopy. Indicates a
likely 1:2 PA2 - dibutylphthalate binding (γmax = 0.74). γ is mole fraction of guest and ΔF is the change in fluorescence
integration.

γ(dibutylpthalate)

γ(dibutylphthalate)*ΔF

1
0.90
0.82
0.74
0.66
0.57
0.47
0.37
0.27
0.16
0

0
26135622
32020706
35383754
34671733
30192845
26285783
17952058
13621627
8121965
0

Table 11 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with dibutylphthalate in PBS. γ is
mole fraction of guest and ΔF is the change in fluorescence integration.
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Figure S36 – Fluorescence titration of PA2 with dibutylphthalate in PBS fit to a 1:2 host-guest stoichiometry. Ka1 =
6.05 (0.0011) x 1010 M-1; Ka2 = 7.14 (2.52) x 104 M-1; Sum(χ2) = 0.0016.

Figure S37 – Job’s plot analysis of dibutylphalate and PA2 in DMSO obtained by fluorescence spectroscopy. Indicates
a likely 1:2 PA2 - dibutylphthalate binding (γmax = 0.59). γ is mole fraction of guest and ΔF is the change in
fluorescence integration.
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γ(dibutylpthalate)

γ(dibutylphthalate)*ΔF

1
0.875
0.78
0.69
0.59
0.5
0.41
0.31
0.22
0.125
0

0
81301
124959
153719
167295
123351
136497
110655
93099
68344
0

Table 12 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with dibutylphthalate in DMSO.
γ is mole fraction of guest and ΔF is the change in fluorescence integration.

Figure S38 – Fluorescence titration of PA2 with dibutyl phthalate in DMSO fit to a 1:2 host-guest stoichiometry. Ka1 =
6.73 (0.72) M-1; Ka2 = 9.10 (0.78) x 109 M-1; Sum(χ2) = 0.066.

349

Figure S39 – Job’s plot analysis of PA1 and myclobutanil in PBS obtained by fluorescence spectroscopy. Indicates a
1:2 PA1 – myclobutanil stoichiometry (γmax = 0.64). γ is a mole fraction of guest and ΔF is the change in fluorescence
integration.

γ(myclobutanil)

γ(myclobutanil)*ΔF

1
0.85
0.745
0.64
0.545
0.45
0.36
0.27
0.19
0.105
0

0
28700
47267
67438
51800
55205
50117
33720
31537
17782
0

Table 13 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with dibutyl phthalate in DMSO.
γ is a mole fraction of guest and ΔF is the change in fluorescence integration.
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Figure S40 – Fluorescence titration of PA1 with myclobutanil in PBS fit to a 1:2 host-guest stoichiometry. Ka1 = 5.10
(0.92) M-1; Ka2 = 2.62 (0.0044) x 1010 M-1; Sum(χ2) = 0.00045.

Figure S41 – Job’s plot fluorescence analysis of myclobutanil and PA2 in PBS. Indicates no host-guest binding. γ is
mole fraction of guest and ΔF is the change in fluorescence integration.
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γ(myclobutanil)

γ(myclobutanil)*ΔF

1
0.90
0.82
0.74
0.66
0.57
0.47
0.37
0.27
0.16
0

0
10417838
13358125
14847663
13068972
11874350
8733928
6798844
4689125
3188900
0

Table 14 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with GUEST in PBS. γ is mole
fraction of guest and ΔF is the change in fluorescence integration.

Figure S42 – Fluorescence titration of PA2 with myclobutanil in PBS. Indicates no host-guest binding.
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Figure S43– Job’s plot titration analysis of N,N,N,N-tetremethylbenzidine and PA1 in PBS obtained by fluorescence
spectroscopy. Indicates a 1:1 host-guest binding. γ is mole fraction of guest and ΔF is the change in fluorescence
integration.

γ (TMB)
1
0.875
0.78
0.68
0.59
0.5
0.41
0.31
0.22
0.125
0

γ(TMB)*ΔF

0
13122.45
36299.1
52250.05
47104.49
73686.17
66586.39
62295.91
50968.7
34709.95
0

Table 15 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with N,N,N,Ntetramethylbenzidine in PBS. γ is mole fraction of guest and ΔF is the change in fluorescence integration.
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Figure S44 – Fluorescence titration of N,N,N,N-tetramethylbenzidine with PA1 in PBS fit to a 1:1 host-guest
stoichiometry. Ka = 1.62 (0.12) x 106 M-1; Sum(χ2) = 0.00023.

Figure S45 - Job’s plot analysis of N,N,N,N-tetramethylbenzidine and PA2 in PBS obtained by fluorescence
spectroscopy indicating a 1:1 host-guest stoichiometry. γ is mole fraction of guest and ΔF is the change in fluorescence
integration.
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γ (TMB)
1
0.875
0.78
0.68
0.59
0.5
0.41
0.31
0.22
0.125
0

γ(TMB)*ΔF

0
111850.2
147019.3
173735.7
181535.2
181265.3
164089.6
141234.2
120231.6
74424.13
0

Table 16 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with N,N,N,Ntetramethylbenzidine in PBS. γ is mole fraction of guest and ΔF is the change in fluorescence integration.

Figure S46 – Fluorescence titration of N,N,N,N-tetramethylbenzidine with PA2 in PBS fit to a 1:1 host-guest
stoichiometry. Ka = 1.11 (0.19) x 105 M=1; Sum(χ2) = 0.0034.
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Figure S47 – Job’s plot analysis of naproxen and PA1 in PBS obtained by fluorescence spectroscopy indicating a 1:1
host-guest stoichiometry. γ is mole fraction of guest and ΔF is the change in fluorescence integration.

γ (PA1)

γ(PA1)*ΔF

1
0.875
0.78
0.69
0.59
0.5
0.41
0.31
0.22
0.125
0

0
229185
360646
382989
479015
505076
486672
420425
330083
210426
0

Table 17– Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with naproxen in PBS. γ is mole
fraction of guest and ΔF is the change in fluorescence integration.

356

Figure S48 – Fluorescence titration of naproxen with PA1 in PBS fit to a 1:1 host-guest stoichiometry. Ka = 6.51
(0.011) x 103 M-1; Sum(χ2) = 0.00051.

Figure S49 - Job’s plot analysis of naproxen and PA2 in PBS obtained by fluorescence spectroscopy indicating a 1:1
host-guest stoichiometry (γmax = 0.47). γ is mole fraction of guest and ΔF is the change in fluorescence integration.
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γ (PA2)

γ(PA2)*ΔF

1
0.90
0.82
0.74
0.66
0.57
0.47
0.37
0.27
0.16
0

0
225597
457604
472464
795249
705349
839436
792306
679991
439301
0

Table 18 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with naproxen in PBS. γ is mole
fraction of guest and ΔF is the change in fluorescence integration.

Figure S50 – Job’s plot analysis of perfluorooctanoic acid and PA1 in PBS obtained by fluorescence spectroscopy
indicating a 1:1 host-guest stoichiometry. γ is mole fraction of guest and ΔF is the change in fluorescence integration.
Sharp peak indicates a high association constant.
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γ (PA1)

γ(PA1)*ΔF

1
0.875
0.78
0.69
0.59
0.5
0.41
0.31
0.22
0.125
0

0

34780.01
67396.37
61746.16
66159.53
82911.04
64180.84
50905.04
41277.98
24741.22
0

Table 19 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with naproxen in PBS. γ is mole
fraction of guest and ΔF is the change in fluorescence integration.

Figure S51 – Fluorescence titration of PA1 with PFOA in PBS fit to a 1:1 host-guest stoichiometry. Ka = 1.13 (0.13) x
106 M-1; Sum(χ2) = 0.0039.
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Figure S52 – Job’s plot fluorescence analysis of PFOA and PA1 in DMSO. Indicates a 1:1 host-guest stoichiometry
(γmax = 0.5). γ is mole fraction of guest and ΔF is the change in fluorescence integration.

γ(PFOA)

γ(PFOA)*ΔF

1
0.875
0.78
0.69
0.59
0.5
0.41
0.31
0.22
0.125
0

0
83616.51
154572.9
177051.2
207423.2
225409
200726
178311.5
130961.6
81500.66
0

Table 20 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with PFOA in DMSO. γ is mole
fraction of guest and ΔF is the change in fluorescence integration.
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Figure S53 – Fluorescence titration of PA1 with PFOA in DMSO fit to a 1:1 host-guest stoichiometry. Ka = 2.44 (0.17)
x 104 M-1; Sum(χ2) = 0.0018.
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Figure S54 – NMR titration of PA1 with PFOA in DMSO fit to a 1:1 stoichiometry. Ka = 2.06 (0.0000060) x 102 M-1;
Sum(χ2) = 0.00000079.

Figure S55 – Job’s plot fluorescence analysis of PFOA and PA2 in DMSO. Indicates a 1:1 host-guest binding
stoichiometry (γmax = 0.5). γ is mole fraction of guest and ΔF is the change in fluorescence integration.
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γ(PFOA)

γ(PFOA)*ΔF

1
0.78
0.68
0.59
0.5
0.41
0.31
0.22
0.125
0

0
64300
83733
92254
93618
92091
83826
61046
34855
0

Table 21 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with PFOA in DMSO. γ is mole
fraction of guest and ΔF is the change in fluorescence integration.

Figure S56- Fluorescence titration of PA2 with PFOA in DMSO fit to a 1:1 host-guest stoichiometry. Ka = 2.45 (0.21)
x 105 M-1; Sum(χ2) = 0.0477.
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Figure S57 – Job’s plot analysis of phenanthrene and PA1 in PBS, obtained by fluorescence spectroscopy, indicating
1:1 stoichiometry (γmax = 0.54). γ is mole fraction of guest and ΔF is the change in fluorescence integration.

γ(PA1)

γ(PA1)*ΔF

1
0.85
0.75
0.64
0.54
0.45
0.36
0.27
0.19
0.11
0

0
173913
296923
337636
389594
385205
356463
319288
240142
147871
0

Table 22– Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with phenanthrene in PBS. γ is
mole fraction of guest and ΔF is the change in fluorescence integration.
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Figure S58 – Fluorescence titration of phenanthrene with PA1 in PBS fit to a 1:1 stoichiometry. Ka = 2.32 (0.020) x
104 M-1; Sum(χ2) = 0.0016.

Figure S59 – Job’s plot fluorescence analysis of phenanthrene and PA1 in DMSO. Indicates a 1:1 host-guest
stoichiometry (γmax = 0.5). γ is mole fraction of guest and ΔF is the change in fluorescence integration.
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γ(PA1)

γ(PA1)*ΔF

1
0.875
0.78
0.69
0.59
0.5
0.41
0.31
0.22
0.125
0

0
295283
439788
487040
555976
578021
548629
490763
381913
243145
0

Table 23– Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with phenanthrene in DMSO. γ is
mole fraction of guest and ΔF is the change in fluorescence integration.

Figure S60 – Fluorescence titration of phenanthrene with PA1 in DMSO fit to a 1:1 stoichiometry. Ka = 8.1 (1.8) x 103
M-1; Sum(χ2) = 0.0029.

366

Figure S61 – Job’s plot fluorescence analysis of phenanthrene and PA2 in PBS. Indicates a 1:1 stoichiometry (γ max =
0.47). γ is mole fraction of guest and ΔF is the change in fluorescence integration.

γ(PA2)

γ(PA2)*ΔF

1
0.90
0.82
0.74
0.66
0.57
0.47
0.37
0.27
0.16
0

0
201867
404914
494296
696248
659321
738205
672004
581949
412505
0

Table 24 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with phenanthrene in PBS. γ is
mole fraction of guest and ΔF is the change in fluorescence integration.

367

Figure S62 – Fluorescence titration of phenanthrene and PA2 in PBS fit to a 1:1 stoichiometry. Ka = 1.10 (0.011) x 105
M-1; Sum(χ2) = 0.0032.

Figure S63 – Job’s plot analysis of phenanthrene and PA2 in DMSO obtained by fluorescence spectroscopy. Indicates
a 1:1 stoichiometry (γmax = 0.5). γ is mole fraction of guest and ΔF is the change in fluorescence integration.
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γ(PA2)

γ(PA2)*ΔF

1
0.875
0.69
0.59
0.5
0.41
0.31
0.22
0.125
0

0
588262
1130353
1162188
1225575
1125203
1017866
796796
491291
0

Table 25 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with phenanthrene in DMSO. γ is
mole fraction of guest and ΔF is the change in fluorescence integration.

Figure S64 – Fluorescence titration of phenanthrene with PA2 in DMSO fit to a 1:1 stoichiometry. K a = 5.04 (0.81) x
104 M-1; Sum(χ2) = 0.00060.
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Figure S65 - Job’s plot analysis of 1,10-phenanthroline and PA1 in PBS obtained by fluorescence spectroscopy.
Indicates a 2:1 PA1 – 1,10-phenanthroline stoichiometry (γmax = 0.64). γ is mole fraction of guest and ΔF is the change
in fluorescence integration.

γ(PA1)

γ(PA1)*ΔF

1
0.85
0.75
0.64
0.55
0.45
0.36
0.27
0.19
0.11
0

0
34488.69
41389.97
45144.56
27294.92
29286.59
17361.3
20136.69
16426.48
13523.37
0

Table 26 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with 1,10-phenanthroline in PBS.
γ is mole fraction of guest and ΔF is the change in fluorescence integration.
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Figure S66 - Job’s plot analysis of 1,10-phenanthroline and PA1 in DMSO obtained by fluorescence spectroscopy.
Indicates a 1:2 1,10-phenanthroline - PA1 stoichiometry (γmax = 0.41). γ is mole fraction of guest and ΔF is the change
in fluorescence integration.

γ(1,10phenanthroline)

γ(1,10-phenanthroline)*ΔF

1
0.875
0.78
0.59
0.5
0.41
0.31
0.22
0.125
0

0
33515.75
37238.53
91632.53
91982.69
103467.7
101743.1
85906.53
54374.94
0

Table S27 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with 1,10-phenanthroline in
DMSO. γ is mole fraction of guest and ΔF is the change in fluorescence integration.
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Figure S67 - Fluorescence titration of 1,10-phenanthroline with PA1 in DMSO fit to a 1:2 1,10-phenanthroline-PA1
stoichiometry. Ka1 = 4.40 (0.027) x 105 M-1; Ka2 = 2.67 (0.24) x 104 M-1; Sum(χ2) = 0.17.

Figure S68- Job’s plot analysis of 1,10-phenanthroline and PA2 in PBS obtained by fluorescence spectroscopy.
Indicates a 1:2 1,10-phenanthroline - PA1 stoichiometry (γmax = 0.66). γ is mole fraction of guest and ΔF is the change
in fluorescence integration.
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γ(1,10phenanthroline)

γ(1,10-phenanthroline)*ΔF

1
0.90
0.82
0.74
0.66
0.47
0.37
0.27
0.16
0

0
12111
44767
71112
95513
80894
73608
64035
41137
0

Table 28 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with 1,10-phenanthroline in PBS.
γ is mole fraction of guest and ΔF is the change in fluorescence integration.

Figure S69 - Fluorescence titration of 1,10-phenanthroline with PA2 in PBS; fit to a 1:2 1,10-phenanthroline-PA2
stoichiometry. Ka1 = 4.19 (0.46) M-1; Ka2 = 1.18 (0.052) x 109 M-1; Sum(χ2) = 0.029.
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Figure S70 - Job’s plot analysis of 1,10-phenanthroline and PA2 in DMSO obtained by fluorescence spectroscopy.
Indicates a 1:2 1,10-phenanthroline - PA1 stoichiometry (γmax = 0.59). γ is mole fraction of guest and ΔF is the change
in fluorescence integration.

γ(PA2)

γ(PA2)*ΔF

1
0.6875
0.59375
0.5
0.40625
0.3125
0.21875
0.125
0

0
260452
278432
270227
218522
188525
123410
79874
0

Table S29 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with 1,10-phenanthroline in
DMSO. γ is mole fraction of guest and ΔF is the change in fluorescence integration.
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Figure S71 – Fluorescence titration of 1,10-phenanthroline with PA2 in DMSO fit to a 1:2 phenanthroline:PA2
stoichiometry. Ka1 = 3.08 (0.041) x 102 M-1; Ka2 = 2.89 (0.12) x 107 M-1; Sum(χ2) = 0.066.

Figure S72– Job’s plot fluorescence analysis of simazine and PA1 in PBS. Indicates a 2:1 PA1-simzaine stoichiometry
(γmax = 0.36). γ is mole fraction of guest and ΔF is the change in fluorescence integration.
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γ

γ*ΔF

1
0.85
0.75
0.64
0.55
0.45
0.36
0.27
0.19
0.11
0

0
41046.37
57558.8
60336.2
50067.1
55206.53
78167.7
50534.78
39151.16
18074.73
0

Table S30 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with simazine in PBS. γ is mole
fraction of guest and ΔF is the change in fluorescence integration.

Figure S73 – Fluorescence titration of PA1 with dilute simazine in PBS fit to a 2:1 host-guest stoichiometry. Ka1 =
1.37 (0.22) x 1010 M-1; Ka2 = 6.47 (1.42) x 109 M-1; Sum(χ2) = 0.00073.
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Figure S74– Job’s plot analysis of simazine and PA1 in DMSO obtained by fluorescence spectroscopy indicating a 1:1
host-guest stoichiometry (γmax = 0.5). γ is mole fraction of guest and ΔF is the change in fluorescence integration.

γ

γ*ΔF

1
0.875
0.78
0.69
0.59
0.5
0.41
0.31
0.22
0.125
0

0
37444
91458
119288
148709
157071
155605
137561
114808
73085
0

Table S31– Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with simazine in DMSO. γ is
mole fraction of guest and ΔF is the change in fluorescence integration.
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Figure S75 – Fluorescence titration of PA2 with simazine in PBS fit to a 1:2 host-guest stoichiometry. Ka1 = 7.52
(0.000065) x 1011 M-1; Ka2 = 5.80 (0.42) x 104 M-1; Sum(χ2) = 0.00073.

Figure S76 – Job’s plot fluorescence analysis of simazine and PA2 in DMSO indicating a 1:1 host-guest stoichiometry
(γmax = 0.5). γ is mole fraction of guest and ΔF is the change in fluorescence integration.
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γ

γ*ΔF

1
0
0.875
126139
0.78
145421
0.69
142554
0.59
155742
0.5
156445
0.41
136213
0.31
113450
0.22
91863
0.125
56677
0
0
Table S32 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with
simazine in DMSO. γ is mole fraction of guest and ΔF is the change in fluorescence integration
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Molecular modeling and stabilization energies
Two major software packages were used to energy minimize structures, and for docking purposes,
first one is Spartan16 and the second software is MOE 2018. Spartan was used to perform semiempirical level calculations on the complexes, guests and host. These energies obtained after PM3
calculations were further used for obtaining stabilization energy for complex formation. MOE
software was used to visualize these structures and to dock specific guests into the cavity of the
WSP5A using docking tools. For docking receptor was chosen to be the WSp5a, and the ligand
was chosen to be as the any of the toxicants. Docking parameters were as follows; no wall
constraints were used to enhance free movement of both ligand and receptor. The docking
placement method used was “Triangle Matcher,” and the docking score was done using “London
dG” and “GBVI/WSA dG.” Docking refinement was performed using the “induced fit” method.
Out of 100 possible confirmations the best 5 were chosen and, and out of the best 5 highest docking
score placement was used for obtaining ligand interaction diagrams.
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Toxicants

Anthracene
Phenanthrene
1,10-Phenanthroline
mono hydrate
Cyclophosphamide
mono hydrate
Myclobutanil
N,N,N,NTetramethylbenzidine
Naproxen
PFOA
Dibutylpthalate
Carbamazepine
Clofibric acid
Simazine

Toxicant
/ kJ mol-

WS P5A /
kJ mol-1

WSP5A
Stabilization Docking
and
energy / kJ
score /
1
-1
Toxicant /
mol
kcal mol-1
1
kJ mol
242.6439 11053.948 11210.6926
-85.8993
-8.8798
213.8413 11053.948 11235.4887

-32.3006

-8.6756

770.1826 11053.948

11276.176

-547.9546

-5.4557

329.438

11053.948 10563.1687

-820.2173

-10.5119

344.917

11053.948

11295.111

-103.754

-8.5231

144.785

11053.948 11131.1368

-67.5962

-9.8271

476.927

11053.948 10577.8805

-952.9945

-11.4858

7699.1544

-931.8556

-11.8114

10247.378

-47.9354

-9.7201

11098.568

-61.515

-8.2642

11053.948 10487.153
486.3014
300.1766 11053.948 11037.9903

-80.4936

-9.9923

-316.1343

-10.7143

11053.948
2422.938
11053.948
758.6346
106.135 11053.948
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Figure S77. Docking of 1,10-phenonthraline in WSP5A

Figure S78. Ligand interaction of 1,10-phenanthroline in WSP5A
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Figure S79. Docking of Carbamazepine in WSP5A

Figure 80. Ligand interaction of Carbamazepine in WSP5A
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Figure S81. Docking of Clofibric acid in WSP5A

Figure S82. Ligand interaction of Clofibric acid in WSP5A
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Figure S83. Docking of Cyclophosphamide acid in WSP5A

Figure S84. Ligand interaction of Cyclophosphamide acid in WSP5A
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Figure 85. Docking of Dibutyl phthalate acid in WSP5A

Figure S86. Ligand interaction of Dibutyl phthalate acid in WSP5A
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Figure S87. Docking of Naproxen in WSP5A

Figure S88. Ligand interaction of Naproxen in WSP5A
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Figure S89. Docking of PFOA in WSP5A

Figure S90. Ligand interaction of PFOA in WSP5A
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Figure S91. Docking of Simazine in WSP5A

Figure S92. Ligand interaction of Simazine in WSP5A
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Figure S93. Docking of Phenancene in WSP5A

Figure S94. Ligand interaction of Phenancene in WSP5A
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Figure S95. Docking of Anthracene in WSP5A

Figure S96. Ligand interaction of Anthracene in WSP5A
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Figure S97. Docking of Myclobutanil in WSP5A

Figure S98. Ligand interaction of Myclobutanil in WSP5A
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Figure S99. Docking of tetramethylbenzidine in WSP5A

Figure S100. Ligand interaction of tetramethylbenzidine in WSP5A
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NMR experiments
Equimolar concentrations (10mM) of WSP5A and Toxicants were prepared in DMSO-d6; the
reason for using DMSO was used because some of the toxicants are not soluble in water. Then
these solutions were mixed in a 1:1 ratio in an NMR tube. These were then ultrasonicated for 5
minutes to enhance complexation. They were allowed out to equilibrate for another 10 minutes.
Once equilibration was completed all NMR was performed in 400 MHz Bruker NMR spectrometer
with 16 scans.
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Figure S101. 1H- NMR stacked spectra of Carbamazepine, WSP5A and complex
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Figure S102. 1H- NMR stacked spectra of Clofibric acid, WSP5A and complex
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Figure S103. 1H- NMR stacked spectra of 1,10-phenonthraline, WSP5A and complex
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Figure S103. 1H- NMR stacked spectra of Simazine, WSP5A and complex
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Figure S104. 1H- NMR stacked spectra of Phenanthrene, WSP5A and complex
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Figure S105. 1H- NMR stacked spectra of Anthracene, WSP5A and complex
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Figure S106. 1H- NMR stacked spectra of dibutyl phthalate, WSP5A and complex
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Figure S106. 1H- NMR stacked spectra of myclobutanil, WSP5A and complex
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Figure S107. 1H- NMR stacked spectra of PFOA, WSP5A and complex
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Figure S107. 1H- NMR stacked spectra of Naproxen, WSP5A and complex
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Figure S108. Stacked 1H NMR of all toxicants in WSp5A with respect to reference WSp5A at
4.60 ppm

Figure S109. Stacked 1H NMR of all toxicants in WSp5A with respect to reference WSp5A at
6.72 ppm
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Abstract
We prepared water-insoluble self-assembled composite materials by stoichiometric mixing of
water-soluble decamethylimidazolium pillar[5]arene (WSP5A) with dsDNA obtained from salmon
milt. The WSP5A has the ability to encapsulate organic molecules into its intramolecular cavity;
subsequent addition of dsDNA then forms the insoluble network material. By employing this
strategy, the WSP5A-dsDNA composite material was used for the sequestration and removal of the
environmental pollutant, perfluorooctanoic acid (PFOA), from aqueous media.
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Introduction
Double-stranded DNS (dsDNA) is a very stable structure and has unique structural
properties.1 The dsDNA contains a backbone that is consists of phosphate groups which can act as
a negative charge barrier. In this study, we used dsDNA that is cheap and readily available from
salmon testes. It was reported in the Hokkaido Bureau of Economy Journal that more than 10,000
tons/year of milt from salmon trout and others have been removed as industrialized wastes from
fishery industries in Hokkaido, Japan2 The cost of using milt is low, which enables us to use milt
as a cost-effective material in this study and to be expanded into practical applications. Also, milt
is an environmentally friendly biomaterial that has no hazardous effects on the environment after
use.
The high anionic charge present salmon milt, due to the phosphate backbone in the DNA
has been previously used for capturing rare earth elements.2 This dsDNA is stable and can be used
for several months when its stored at 4 °C. In general applications, salmon testes DNA is used as a
substrate for deoxyribonuclease assays and other molecular biological techniques.
Pillar[5]arenes (P5A) were first discovered by Ogoshi and his group;3 these five-membered
supramolecular structures are formed via a Lewis acid-mediated Friedls-Crafts reaction between
formaldehyde and hydroquinone derivatives. In the recent past, this structure has been widely used
in multiple applications, such as rotaxane synthesis, drug delivery, imaging applications, etc. P5As
are highly versatile and can be functionalized in various ways. P5A is also used for host-guest
studies because the hydrophobic cavity can bind small molecules tightly.
Perfluoroalkylated substances (PFAS) are both environmentally persistent 4 and lack
straightforward detectable methods, which means that the development of methods for their
removal from contaminated environments is particularly urgent.5 Currently utilized methods for
PFAS removal include the use of covalent organic frameworks to remove PFAS,6 cyclodextrin
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polymers for micropollutant (including PFAS) removal,7 chemical oxidation procedures to generate
highly polar, water-soluble PFAS byproducts,8 and the use of carbon adsorbents to remove PFAS
from contaminated water,9 Practical drawbacks to these methods include the fact that oxidation
procedures that generate water-soluble waste products still result in contamination of the water
supply, and the use of carbon-based absorbents is often non-selective.
The use of a soluble supramolecular based material for PFAS sequestration and removal
has not been reported to date, even though such macrocycles could provide maximum flexibility
by binding PFAS while in solution and could be designed to be removed from solution with ease.

Figure 6.1: Synthesis of dmWSP5A (left), cartoon representation of the dmWSP5A (right)
This project focused on using the dsDNA as an anchor to hold a host structure. The host structure
of choice was water soluble methyl imidazolium pillar-5-arene. The methyl dmWSP5A has been
used for toxicant removal in our previous studies. The concept we wanted to show in this study is
the use of simple electrostatic interactions in aqueous media to form a self-assembled structure that
will capture small molecules from water and clump together. This complexed material with the
harmful toxicant can then be removed from solution by physical means.
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Scheme 6-1: Schematic representation of the self-assembled dsDNA-dmWSP5A composite
material for encapsulation of PFOA
Experimental section
Materials. Double-stranded DNA (sodium salt from salmon milt, molecular weight approx. 5 ×
106). Carbon tetrabromide, PFOA, boron trifluoride etherate, and N-methylimidazole were
purchased from Fisher Scientific. Paraformaldehyde was purchased from Baker Chemicals. All
solvents

and

chemicals

were

purchased

from

Sigma-Aldrich

or

Fisher

Scientific.

Decabromopillararene, 1, was synthesized according to literature procedure.16
Synthesis of decamethylimidazolium pillar[5]arene, A mixture of 1 (1.68 g, 1.00 mmol) and Nmethylimidazole (1.64 g, 20.0 mmol) in toluene (25 mL) was stirred in a 40 mL pressure tube at
120 ºC for 24 hours.16 (The use of a pressure tube was essential for the success of the reaction in
our hands.) After cooling, the solvent was removed by rotatory evaporation. The collected residue
was recrystallized from ethanol/diethyl ether (1:2) to give a white solid (2.1 g, 87%). NMR and
mass spectra are shown in the attached supplementary information.
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Preparation of dsDNA-dmWSP5A Composite Material, When an aqueous solution of doublestranded DNA sodium salt (dsDNA) combined with an aqueous solution of WSP5A, a white,
gelatanous precipitate formed. The composite material can be formed using a stoichiometric 1:1
ratio of dmWSP5A: dsDNA. This fact is interesting in that similar composite materials require a
much greater ratio of dsDNA to the host.

Figure 6.2: Stochiometric assay of dsDNA with dmWSP5A. From R to L decreasing WSP5A
concentration while the dsDNA concentration was held constant
Accumulation of harmful PFOA This is done by first adding 40 mM WSP5A solution to a
solution of 20 mM PFOA. The WSP5A rapidly encapsulated the PFOA as it reached equilibrium.
Next, dsDNA was added to the PFOA/WSP5A mixture, the complex was formed instantly, and it
could subsequently be removed from the vial. The resulting supernatant solution was tested for
PFOA using 19F NMR. The precipitate was allowed to sit in fresh water to test whether PFOA
would leach from the sold. After 6 months, no leaching was observed.
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Figure 6.3: Zoomed image of self-assembled composite material in aqueous media (gelatinous)
Results and Discussion
The formation of the dsDNA-WSP5A material was obtained by simple mixing of the aqueous
dsDNA (100 μL, 20 mg/mL) and WSP5A (10-100 μL, 200 mg/mL) solutions. We conducted a
concentration variation assay, to find the most optimum concentrations for the formation of the
composite material. Hence, we discovered that at very low concentrations (below 0.1 mM) of
WSP5A such formation is weak, but after 1:1 or slightly higher concentrations/stoichiometries
more composite material were observed as seen in Figure 6-2 and 6-3. At very high concentrations
of WSP5A (500 mM), we did not see any composite material formation; we assume that this is due
to the lack of enough dsDNA to accommodate the excess WSP5A. The visual observation cue for
this experiment is the formation of white gel-like material from solution. This gel looks like a “Lava
lamp” and is a very distinct way of identifying product formation. This gelatinous material is
insoluble in water and common organic solvents such as dichloromethane, ether, methanol, DMSO
or NMP. This gel can be then be stored in ultra-pure water for more than six months without any
degradation of the structure (Figure 4). All the composite material was made at pH 7, and the
material was stable at pH 7. The figure shows the changes in composite material formation going
from lower stoichiometric ratios to higher ratios (0 to 1.8 equivalents of WSP5A).
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Figure 6.4: L to R, Stable self-assembled composite material in ultra-pure water after six months,
Composite material after drying under vacuum and crushed dried composite material
Another interesting phenomenon was the dependence of the rate of addition of dsDNA solution
into the WSP5A solution; the cloudy white material takes on different forms. If dsDNA is added
slowly or dropwise, individual strands or drops of the composite material can be formed in the
solution. If dsDNA is added quickly, the composite material forms a long string. Our general
hypothesis is that electrostatic interactions between the negatively charged phosphate backbone11
of the dsDNA and the ten positive charges from the methylimidazolium groups on the P5A form
the composite material.
Furthermore, the composite material can be removed from the aqueous solution after being formed
using only tweezers, making it very easy to manipulate and use. This material can also be dried to
produce a long rigid string of material that is still brittle enough to be broken. Its brittleness allows
one to obtain a powder of the composite material.
Characterization of dsDNA-dmWSP5A composite material. Though the composite material’s
ability to precipitate from solution and its insolubility are significant assets to our work, it also
provides drawbacks in terms of structure determination. The pseudorandom nature of the dsDNA
sequence makes crystallography unsuitable. However, we were able to obtain IR spectroscopy
measurements and thermogravimetric analysis (TGA). As shown in Figure 6-5, WSP5A (green)
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has a broad IR signal at 3000 cm-1 which indicates C-H stretching vibrations for WSP5A and the
broadening significantly shows the vibration of these flexible imidazole containing arms. When
these imidazoles form a strong interaction with the negatively charged backbone of the doublestranded DNA the flexibility is converted into a more rigid structure; hence the 3000 cm-1 broad
signal is no longer seen. Another significant change is shown in the phosphate vibrations; The 1238
cm-1 peak has moved from left to right going from free DNA to self-assembled complex, which
represents the interaction of DNA with WSP5A. This data aligns with a similar study performed
by Hasimato.12

Figure 6.5: IR analysis of the starting materials and the dried composite material
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Figure 6.6: Thermogravimetric analysis (TGA) of dsDNA, dmWSP5A and dried composite
As observed in the TGA study, WSP5A and dsDNA show a sharp decrease in weight, showing that
the starting materials are pure and un-complexed with other material. The curve for the dried
composite clearly shows that the decomposition rate has been significantly lowered. This data
indicates that dsDNA and WSP5A have formed a composite material, presumably via strong
electrostatic interactions because it requires more time and heat to break these interactions, as
compared to the starting materials.
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Figure 6.7: L to R, Protein patch map, the blue is positively charged WSP5A, and red regions are
for negatively charged phosphate backbone, Ligand interaction diagram of WSP5A to dsDNA
Figure 6-7 shows that electrostatic interactions play a significant role in bringing the
dsDNA and the WSP5A together to form a complex. Electrostatic potential maps support our
prediction by highlighting the positive and negative areas coming together. Also, the ligand
interaction diagram shows the critical role the positively charged imidazolium ions are playing in
order to form the complex. Therefore, this rationale can be used to explain the self-aggregated
structures.
Accumulation and efficient removal of PFOA from solution and leaching investigations.
Potential Applications of the Material; DNA is a well-known intercalator for planar molecules13,
and pillar[n]arenes are known for their ability to encapsulate a guest molecule within their central
hydrophobic cavity14. Therefore, combining these two materials into one composite material
allows for the combination of their properties to encapsulate small molecules. A natural conclusion
from these observations is to experiment with encapsulating a socially-relevant small molecule.
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Figure 6.8: 19F NMR of PFOA capture through the self-assembled composite material
Perfluorinated compounds have recently been newsworthy because they are harmful byproducts of
industry suspected to be carcinogens15. Perfluorooctanoic acid (PFOA) is the guest we chose to
encapsulate within the complex. We first investigated the PFOA binding towards the dmWSP5A
by conducting UV-Vis absorbance studies, which revealed that PFOA binds to the cavity of the
dmWSP5A with an association constant of 1.13 ± 0.1 x 106 M-1. Also, the binding was a 1:1
complexation. This was further proven by conducting docking studies followed by molecular
dynamics computations (Figure 6-8). The experiment was started by first adding 40 mM P5A
solution to a solution of 20 mM PFOA, and the P5A is allowed to encapsulate the PFOA as it
reaches equilibrium. Next, dsDNA is added to the PFOA/P5A mixture, the complex is formed, and
it can be removed from the vial. The resulting supernatant solution was tested for PFOA using 19F
NMR, and no PFOA fluorine peaks were observed in the spectra even after 15,000 scans. We
presume the composite material is capturing all the PFOA within its structure. This Experiment
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worked even with a stoichiometrically small amount of composite material as compared to PFOA.
Our experiments ranged from 0.2 equivalents complex to 1.8 equivalents and showed (according
to 19F NMR) that there was no fluorine within the supernatant solution. We also tested the idea that
this composite material could be useful as an environmentally sustainable encapsulation device.
By using a 1:1 ratio of PFOA to the composite material, we tested the supernatant solution of
complexes in fresh water over time in order to determine whether PFOA leached out of the
composite material. These tests also gave positive results, signaling that no PFOA was found to
leach from the material throughout over 6 months. In addition, Figure 6-9 clearly shows that there
is binding of PFOA inside the cavity of the WSP5A, due to when it binds the 19F NMR is showing
broadening of peaks compared to non-complexed.

Figure 6.9: L to R, hydrophobic pocket present in dmWSP5A, Docked PFOA inside the
dmWSP5A
We performed a sub-stoichiometric NMR titration of WSP5A (20 mM) and dsDNA (20 mM) in a
1:1 ratio to a PFOA (20 mM) solution, with an external standard (1-Fluoro-2,4,6-trimethylpyridinium tetrafluoroborate) in order to quantify the efficiency of the removal. The result of the
titration clearly shows the encapsulation of the PFOA in WSP5A, and once the dsDNA was added,
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the broad peak shrunk in size, signaling that the encapsulated PFOA was complexed inside the selfaggregated dsDNA complex. Also, we can observe that a sharp PFOA peak is seen. This peak
corresponds to the un-complexed PFOA that is present in the solution. Due to the presence of the
internal standard, we were able to integrate the area for the PFOA bound, and with that, we can
conclude that 90% complexed PFOA was removed via the self-aggregation process with the use of
dsDNA. Furthermore, the final concentration of PFOA in the supernatant solution was found out
to be 2 mM. Hence, we can assume that with two more cycles of purification that can be taken out
of the water.

PFOA in DI water with
a few drops of D2O

After titration of
dmWSP5A

After titration of
dsDNA

Figure 6.10: 19F NMR of PFOA capture through the self-assembled composite material

419

Conclusion
The dmWSP5A-dsDNA composite system was used as a successful method to encapsulate and
removal of PFOA with 90% removal from an aqueous environment.
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6.2

SUPPORTING INFORMATION

Double-stranded DNA-Water soluble P5A based self-aggregate composite material for removal of
PFOA from an aqueous environment

Reagents
Substrates, including CBr4, dry acetonitrile, dry 1,2-dichloroethane, boron trifluoride ethane,
triphenyl phosphine, methylimidazole were purchased from Sigma-Aldrich, Fisher Scientific,
and TCI chemicals. All reagents were stored under an inert atmosphere before use. Unless
otherwise noted, all reactions were performed under N2.

Instrumentation
NMR spectra were obtained using Bruker Avance 300 MHz and 400 MHz spectrometers. Lowresolution mass spectrometry was performed using a Shimadzu LRMS-2020. High-resolution
mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap XL™ instrument.
UV-Vis spectroscopy, Fluorescence spectroscopy

The synthesis of the dmWSP5A is the same as mentioned in chapter 3 and chapter 5 supporting
information.
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Stoichiometry Experiment

40 mM stock solutions of Pillar[5]arene and DNA from salmon milt were first prepared. The
P5A stock solution consisted of dissolving 1.000 g P5A into 10 mL of ultrapure water. The
DNA stock solution was determined using the molecular weight per base pair, so 208 mg of
DNA was dissolved in 10 mL ultrapure water to obtain a 40 mM/b.p. stock solution. The
experiment consisted of forming ten complexes separately and then allowing them to rest in
fresh water for a set period of time. 1 mL of DNA solution was added into each of the 10 vials.
The ratio of P5A to DNA was varied from 0 to 1.8 eq. See the chart below for equivalents and
volumes of solutions added.
Equivalents
dmWSP5A to
dsDNA
0
0.2
0.4
0.6
0.8
1.0
1.2

Mol. DNA

Mol. P5A

4 x 10-5

1.4
1.6
1.8

Volume (mL) of
dmWSP5A

0
8 x 10-6
1.6 x 10-5
2.4 x 10-5
3.2 x 10-5
4.0 x 10-5
4.8 x 10-5

0
0.2
0.4
0.6
0.8
1.0
1.2

5.6 x 10-5
6.4 x 10-5
7.2 x 10-5

1.4
1.6
1.8

First, the DNA solution was added to the vials. Then, the corresponding amount of DNA was
added in order to aggregate the complex spontaneously. These solutions were allowed to rest
overnight. The amount of complex formed was studied and examined in order to determine
the optimal ratio of DNA to P5A needed for complexation.
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Leaching Experiment

40 mM stock solutions of Pillar[5]arene and DNA from salmon milt were first prepared. The
P5A stock solution consisted of dissolving 1.000 g P5A into 10 mL of ultrapure water. The
DNA stock solution was determined using the molecular weight per base pair, so 208 mg of
DNA was dissolved in 10 mL ultrapure water to obtain a 40 mM/b.p. stock solution. PFOA
solutions were prepared at the maximum solubility of PFOA (20 mM) by dissolving 165.6 mg
PFOA in 20 mL ultrapure water. The leaching experiment consisted of forming ten complexes
separately and then allowing them to rest in fresh water for a set period. 2.0 mL PFOA was
placed into each of the 10 vials. Then, the ratio of complex to PFOA was varied from 0 to 1.8
eq. See the chart below for equivalents and volumes of solutions added.
Equivalents
Complex to
PFOA
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8

Mol. PFOA

4 x 10-5

Mol. Complex
(equivalent amounts
of dmWSP5A and
dsDNA)
0
8 x 10-6
1.6 x 10-5
2.4 x 10-5
3.2 x 10-5
4.0 x 10-5
4.8 x 10-5
5.6 x 10-5
6.4 x 10-5
7.2 x 10-5

Volume (mL) of
dmWSP5A and dsDNA
solutions added to PFOA
0/0
0.2/0.2
0.4/0.4
0.6/0.6
0.8/0.8
1.0/1.0
1.2/1.2
1.4/1.4
1.6/1.6
1.8/1.8

First, the P5A solution was added to the PFOA solutions in order for the PFOA to be encapsulated
by the P5A. This mixture was allowed to rest for 10 min. Then, the corresponding amount of DNA
was added in order to spontaneously aggregate the complex. These solutions were allowed to rest
overnight, and then the excess liquid was analyzed using NMR spectroscopy. The 1:1 equivalent
PFOA to the complex was placed in 3 mL fresh D2O and was analyzed using NMR spectroscopy
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to determine PFOA leaching at 0 h, 1 h, 1 d, 4 d, 7d, and 14 d. No PFOA leaching was found to
occur.

Figure 6.11: PFOA bound inside the cavity of the dmWSP5A after multiple iterations using
molecular dynamics with AMBER 19 force field
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Figure 6.12: Protein patches representation of the dsDNA and WSP5A
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Figure 6.13: Electrostatic potential map representation of dsDNA and WSP5A
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Figure 6.14: H-bonding interactions between the WSP5A and dsDNA
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ABSTRACT
Chloramphenicol is an inhibitor of peptide bond formation by the ribosome and acts by binding to
the peptidyl transferase active site of the 50S ribosomal subunit. Resistance to chloramphenicol can
arise from mutations in the 23S rRNA of the ribosome or, more commonly, by inactivation of the
antibiotic by chloramphenicol acetyltransferase (CAT). Using crystal structures of ribosomechloramphenicol and CAT-chloramphenicol complexes as guides, we have synthesized derivatives
of chloramphenicol rationally modified to impair binding to CAT while still allowing binding to
ribosomes. While less potent than native chloramphenicol, several derivatives inhibit the growth
of Bacillus subtilis expressing type III CAT expressed from the resistance determinant pC194. We
predict that crystal structures of ribosomes bound to modified chloramphenicol will allow more
precise predictions for the second generation of semi-synthetic derivatives.
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INTRODUCTION
Chloramphenicol (CAM) is a bacteriostatic protein synthesis inhibitor effective against both Grampositive and Gram-negative bacteria1. It acts as a competitive inhibitor of peptide bond formation
by binding to the peptidyltransferase active site of the 50S ribosomal subunit, and base substitutions
in 23S rRNA residues that comprise the drug binding site confer resistance. Early crystal structures
of chloramphenicol bound to the 50S subunits2 of the bacterium Deinococcus radiodurans and the
archaeon Haloarcula marismortui3 led to conflicting interpretations of the correct binding mode of
chloramphenicol. While the H. marismortui structure was at a higher resolution, the D. radiodurans
structure was more consistent with known chloramphenicol-resistant mutations4. Further, the fact
that chloramphenicol does not normally inhibit Archaeal protein synthesis added to the confusion.
This issue was ultimately resolved by crystal structures of chloramphenicol bound to 70S ribosomes
from the bacteria Escherichia coli5 and Thermus thermophilus.
Current literature cites various ways CAM has been functionalized, ranging from the attachment
of amino acids, sugar moieties and bulky groups such as adamantly groups, heterocycles, spermine,
palmitate, and etc6. Chloramphenicol Acetyltransferase (CAT, EC 2.3.1.28) mono- and diacetylates chloramphenicol using acetyl-coenzyme A (Ac-CoA) as the acyl donor, producing
coenzyme A (CoA-SH) and acetyl-chloramphenicol (Ac-CHL) and di-acetylated chloramphenicol
(Ac2-CHL) as reaction products. Acetylation presumably sterically hinders interaction with the
binding site on the ribosome. The crystal structure of type III CAT in complex with
chloramphenicol has been solved to 1.75 Å resolution. (Leslie, 1990).
The primary goal of this project was to functionalize CAM in a simple synthetic manner, binding
studies through in-silico methods and obtain ribosomal based results to continue on further studies.
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MATERIALS AND METHODS
Synthesis of chloramphenicol derivatives. Chloramphenicol (56-75-7) was purchased from Sigma
Chemical. Assay for antibiotic sensitivity, Bacillus subtilis 168 and B. subtilis 168 carrying
plasmid pC194 were obtained from the Bacillus Genetic Stock Center (The Ohio State University)
and grown in LB medium and plated on Tryptose Blood Agar Base (TBAB). Approximately 108
cells from a saturated overnight culture were plated onto TBAB. A disc (Whatmann)
Assay for chloramphenicol acetyltransferase activity, CAT enzyme activity was measured using
a spectrophotometric assay according to the manufacturer’s instructions (Sigma). This assay is
based on the transfer of the acetyl group of acetyl-CoA to chloramphenicol, and the subsequent
reaction of CoA-SH with 5,5'-dithio-bis (2-nitrobenzoic acid; DTNB). Acetyl-CoA, (cat no.),
DTNB (cat no. D8130) and CAT (cat no. C8413) were purchased from Sigma.
RESULTS & DISCUSSION
Rational design of chloramphenicol derivatives. We took advantage of high-resolution cocrystal structures of ribosome-chloramphenicol (Dunkle et al. 2010; Bulkley et al., 2010) and CATchloramphenicol (Leslie et al. 1988; Leslie 1990) complexes in order to determine the direct contact
sites between chloramphenicol and these two enzymes. Fortuitously, the interaction of
chloramphenicol and the two enzymes involve distinct sets of contacts (Figure 1), allowing the
prediction of sites of modification that would impair recognition by CAT while allowing binding
to the ribosome.
As mentioned earlier literature has reported multiple ways to synthesize derivatives of CAM. Our
group also investigated multiple synthetic procedures. Out of all the procedures, we discovered that
obtaining CAM base which is the free amine form of the CAM can be obtained with sufficiently
high yields. The method suggested the use of a 0.1 M NaOH solution in the dark overnight at room
temperature. We were able to optimize the yields significantly by using 1.46 M NaOH solution.
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Previous synthesis of CAM base required the use of recrystallization from water. The use of 1.46
M NaOH instead of the lower concentration helped us to achieve higher yield with approximately
100% conversion of CAM to CAM-base without the need for recrystallization. The CAM base was
then subjected to multiple reactions such as peptide coupling, reaction with an acid chloride, etc.
The most promising derivatives were obtained using isothiocyanates. The reaction between amine
and iso-thiocyanates or iso-cyanates is known to proceed with high yields and with ease of
synthesis. This was confirmed by in-silico methods. MOE, molecular operating environment
computational package was used for this screening process. Out of multiple derivatives, we selected
a couple of the isothiocyanate derivatives that shows high binding to the 70s ribosome pocket.
Furthermore, we docked these same derivatives to the pocket of chloramphenicol acetyltransferase
(CAT), to see if the binding is decreased towards the enzyme. This rationale was used in
computations, due to the commercially available CAM is known to be inactivated due to the
binding of CAM to acetyltransferase enzyme, once bound it acetylates the CAM and its anti-biotic
properties no longer exists. The thiourea derivatives that we synthesize are too large for the pocket
of the CAM enzyme; hence it does not bind into the enzyme pocket. Binding to the ribosome was
much higher and we concluded that the thiourea derivatives will still have anti-biotic properties
even with the presence of CAT.
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Figure 7.1: Topmost, Complete structure of Thermus thermophilus 70S ribosome in its native
form, (Bottom left) Active pocket inside the ribosome docked with CAM, (Bottom right) Distances
from CAM towards surrounding amino acids present inside the pocket
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Figure 7.2: Topmost, Complete structure of Chloramphenicol acetyltransferase. (Bottom left)
Active pocket inside the CAT enzyme docked with CAM (A more open pocket compared to the
ribosome pocket), (Bottom right) Distances from CAM towards surrounding amino acids
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Figure 7.3: Synthetic scheme and substrate scope for the synthesis of derivatives of CAM using
isothiocyanates
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Figure 7.4: Ligand interaction diagrams for CAM, CAM base and CAM derivative compared with
ribosome pocket binding (Left side images) and CAM acetyltransferase binding (right side images)
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As seen in figure 4, compared to CAM and CAM base, the novel thiourea derivative shows more
interactions with surrounding amino acids present inside the cavity of the ribosome pocket. This is
due to the introduction of multiple interaction points in the novel derivative such as the thiourea
moiety along with aromatics and other functional groups these help to form new interactions, which
in return results in stronger binding to the ribosome pocket. We postulate that due to the tight
ribosome binding with a high number of interactions, this results in lower or no binding towards
the incoming CAM acetyltransferase enzyme. This is further clarified with ligand interaction
diagrams that are related to the enzyme binding. Comparatively the CAM is bound in the tight
pocket as seen from the pocket dimensions represented in dashed lines. Hence, in CAM derivative
the binding is seen in a more open pocket, also there more blue spots which shows the ligand
exposure to the outside of the cavity, which clearly shows that the derivative binding interactions
are less.

Figure 7.5: Flow chart diagram representation of the procedure implemented for the growth
inhibition zone study in growth media described in methods
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Growth inhibition of B. subtilis and B. subtilis/pC194 expressing chloramphenicol
acetyltransferase. We initially tested the inhibitory activity of chloramphenicol derivatives using
the Gram-positive species B. subtilis 168 due to its sensitivity to this drug, and because of the
availability of this strain containing the Staphylococcus aureus chloramphenicol-resistance plasmid
pC194 (Löfdahl et al. 1978). This plasmid expresses a type III CAT enzyme.

DMS

CAM

CAM derivative

Figure 7.6: Representation of a disk assay and the control disk, the dark area is an indication of no
growth zone of the bacteria or knows as an inhibition zone
Chloramphenicol derivatives are poor substrates for acetylation by CAT. CAT enzyme assays
typically use thin-layer chromatography to detect mono- and di-acetylation of [14C]chloramphenicol (Gorman et al. 1982). This assay is not practical for working with semi-synthetic
chloramphenicol derivatives. Instead, we employed a colorimetric assay (see Materials and
Methods) based on the detection of deacetylated coenzyme A reaction product by its subsequent
reaction with DTNB via its free thiol group.
Effects of derivatives on the growth of Thermus thermophilus chloramphenicol-resistant
mutants. While less common, resistance to chloramphenicol can be conferred by base substitutions
in 23S rRNA in the peptidyltransferase active site. We have previously reported a number of such
mutants of the thermophilic bacterium T. thermophilus (Gregory et al. 2005). These include the
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base substitutions A2032G, G2061A, A2062G, G2447A, C2452U, A2453G, U2500C, A2503G,
U2504G, U2504C, U2504A, and G2505A.
Protein synthesis inhibition of an E. coli extract. One possible explanation for growth inhibition
by derivatives is the fortuitous generation of an alternative mode of action. The above experiment
was to determine the inhibitory action of chloramphenicol derivatives against ribosomes
specifically.

Figure 7.7: Left: B. subtilis 168 (Cam-sensitive); Right: B. subtilis with pC194 (Cam-resistant).
All new derivatives inhibit Cam-resistant strain
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The figure 7 shows the inhibition zones with and without the pC194 strain which results in the
production of CAM acetyltransferase enzyme. This suggests that even with the presence of the
enzyme all the derivatives show anti-bacterial activity. This data aligns with the data predicted from
computational docking studies.

Table 7-1: Inhibition zones chart, all the above distances are measured from the end of the disk
In vitro protein synthesis was carried out using a kit supplied by NEB Labs (PURExpress® In
Vitro Protein Synthesis Kit) which is a coupled transcription-translation system using E. coli
ribosomes. The template DNA used was a plasmid containing a T7 polymerase promoter and a
super folded GFP gene so raw fluorescence could be measured about protein synthesis. Using the
BioSpectrometer from Eppendorf with the capability to measure fluorescence, an RFU520 value
was taken every 15 minutes throughout 2 hours. CAM, CAM2, and CAM4 all show inhibition of
protein synthesis in comparison to the “No Drug” control.
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Figure 7.8: In vitro protein synthesis obtained via raw fluorescence units vs. time, excitation at 470
nm and emission is monitored at 520 nm
Conclusions
This study was able to show that eight novel derivatives of CAM has potential anti-bacterial effects
and does not undergo acylation via the CAT enzyme while retaining their anti-biotic properties.
Further studies will be conducted to investigate the toxicity of the CAM derivatives and possible
drug formulations.
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Experimental section
Reagents
CAM, NaOH, Methanol, diethylether, all the isothiocyantes, dichloromethane
were purchased from Sigma-Aldrich, Fisher Scientific, and TCI chemicals. All reagents
were stored under an inert atmosphere before use. Unless otherwise noted, all reactions
were performed under N2.
Instrumentation
NMR spectra were obtained using Bruker Avance 300 MHz and 400 MHz spectrometers.
Low resolution mass spectrometry was performed using a Shimadzu LRMS-2020. High
resolution mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap
XL™ instrument.
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Synthesis of CAM base

Chloramphenicol (3g) was charged with 1.46 N NaOH (200 ml) solution, then the RBF was left in
dark, covered in aluminum foil at room temperature. The reaction time was 18 hours. Then
extraction was performed as follows, 5 times with diethyl ether (200 ml each), and further
extractions were performed using ethyl acetate (3 times 200 ml each). Both layers were dried over
anhydrous sodium sulfate then followed with rotary evaporation. CAM base was obtained as an
off-white product. This product was used without further purification for the next steps. 1H NMR
and 13C NMR was performed using DMSO-d6. 1H NMR (400 MHz, DMSO-d6) δ 8.21 – 8.14 (m,
2H), 7.63 – 7.56 (m, 2H), 5.58 – 5.40 (m, 1H), 4.68 (d, J = 4.3 Hz, 1H), 4.60 (t, J = 5.4 Hz, 1H),
3.18 (ddd, J = 10.3, 6.0, 4.1 Hz, 1H), 2.71 (td, J = 5.9, 4.3 Hz, 1H), 1.35 (s, 2H).
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Figure 7.9: Chloramphenicol reference 1H NMR before the hydrolysis
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Figure 7.10: 1H NMR of CAM base (Hydrolysis of CAM
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Figure 7.11: 13C NMR of CAM base
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Figure 7.12: Stacked 1H NMR of CAM and CAM base
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Figure 7.13: Mass spectrum of CAM base
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Synthesis of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3(4nitrophenyl)thiourea

CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using
DMSO-d6. 1H NMR (400 MHz, DMSO-d6) δ 10.36 (s, 1H), 8.32 – 8.28 (m, 2H), 8.22 –
8.19 (m, 2H), 8.16 – 8.13 (m, 2H), 8.02 (d, J = 8.6 Hz, 1H), 7.92 – 7.87 (m, 2H), 7.68 (d,
J = 2.3 Hz, 2H), 6.25 (d, J = 4.4 Hz, 1H), 5.25 – 5.16 (m, 1H), 5.11 (br, 1H), 4.60 (qt, J =
5.9, 2.1 Hz, 1H), 3.62 – 3.51 (m, 2H).
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Figure 7.14: 1H NMR of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3(4nitrophenyl)thiourea
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Figure 7.15: 13C NMR of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3(4nitrophenyl)thiourea
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Figure 7.16: Mass spectrum of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3(4nitrophenyl)thiourea
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Synthesis of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)thiourea

CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using
DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 10.01 (s, 5H), 8.25 – 8.18 (m,
11H), 7.83 (d, J = 8.6 Hz, 5H), 7.68 – 7.61 (m, 22H), 7.24 (t, J = 1.9 Hz, 5H), 6.22 (d, J =
4.4 Hz, 5H), 5.23 – 5.16 (m, 5H), 5.05 (dd, J = 6.1, 4.8 Hz, 6H), 4.57 (d, J = 7.6 Hz, 6H),
3.60 – 3.48 (m, 11H), 2.09 (s, 4H), 1.70 (s, 1H).
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Figure 7.17: 1H NMR of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan2-yl)thiourea
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Figure 7.18: 13C NMR of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan2-yl)thiourea

459

Figure

7.19:

Mass

spectrum

of

1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea
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Synthesis of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan2-yl)thiourea

CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using
DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 9.94 (s, 1H), 8.24 – 8.19 (m,
2H), 8.07 (t, J = 1.9 Hz, 1H), 7.74 – 7.70 (m, 1H), 7.69 – 7.60 (m, 4H), 7.42 (t, J = 7.9 Hz,
1H), 6.22 – 6.11 (m, 1H), 5.20 (d, J = 3.5 Hz, 1H), 5.04 (s, 1H), 4.58 (t, J = 7.5 Hz, 1H),
3.63 – 3.26 (m, 4H).
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Figure 7.20: 1H NMR of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan2-yl)thiourea
462

Figure 7.21: 13C NMR of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan2-yl)thiourea
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Figure

7.22:

Mass

spectrum

of

1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea
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Synthesis of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea

CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at
room temperature. Next, the reaction solution was subjected to rotatory evaporation.
Then it was subjected to flash chromatography. 1H NMR and 13C NMR was performed
using DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 10.34 (s, 1H), 8.30 – 8.17
(m, 4H), 7.95 (d, J = 8.6 Hz, 1H), 7.72 – 7.63 (m, 3H), 6.25 (d, J = 4.4 Hz, 1H), 5.22 (t, J
= 2.9 Hz, 1H), 5.07 (s, 1H), 4.58 (dtd, J = 8.8, 6.4, 5.9, 2.8 Hz, 1H), 3.61 – 3.50 (m, 2H).
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Figure 7.23: 1H NMR of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea
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Figure 7.24:

13

C NMR of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea

467

Figure 7.25: Mass spectrum of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea

468

Synthesis of 1-(2-chloro-4-nitrophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea

CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using
DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 9.74 (s, 1H), 8.74 (d, J = 8.7 Hz,
1H), 8.35 – 8.30 (m, 2H), 8.23 – 8.18 (m, 2H), 8.10 (dd, J = 9.2, 2.7 Hz, 1H), 7.69 – 7.64
(m, 2H), 6.21 (d, J = 4.3 Hz, 1H), 5.22 (dd, J = 4.5, 2.1 Hz, 1H), 5.08 (dd, J = 6.2, 4.6 Hz,
1H), 4.62 (q, J = 7.3 Hz, 1H), 3.58 (dtd, J = 19.4, 10.0, 6.0 Hz, 2H).
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Figure

7.26:

1

H

NMR

of

1-(2-chloro-4-nitrophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea
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Figure

7.27:

13

C

of

1-(2-chloro-4-nitrophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea
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Synthesis of 1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea

CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using
DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 10.02 (s, 1H), 8.26 – 8.16 (m,
2H), 7.83 (d, J = 8.6 Hz, 1H), 7.69 – 7.60 (m, 4H), 7.24 (t, J = 1.9 Hz, 1H), 6.22 (d, J = 4.4
Hz, 1H), 5.20 (dd, J = 4.5, 2.0 Hz, 1H), 5.05 (t, J = 5.4 Hz, 1H), 4.63 – 4.51 (m, 1H), 3.54
(dt, J = 8.6, 4.1 Hz, 2H).
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Figure

7.28:

1

H

NMR

of

1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea
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Figure

7.29:

13

C

NMR

of

1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea
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Figure

7.30:

Mass

spectrum

of

1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea
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Synthesis of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(4methoxyphenyl)thiourea

CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using
DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 9.52 (s, 1H), 8.26 – 8.19 (m,
2H), 7.65 – 7.55 (m, 2H), 7.44 – 7.35 (m, 3H), 7.24 – 7.15 (m, 2H), 7.04 – 6.95 (m, 3H),
6.93 – 6.86 (m, 2H), 6.10 (d, J = 4.5 Hz, 1H), 5.16 (s, 1H), 5.00 (dd, J = 6.4, 4.4 Hz, 1H),
4.55 (s, 1H), 3.78 (s, 4H), 3.74 (s, 3H), 3.57 (dt, J = 9.5, 4.6 Hz, 1H), 3.48 (td, J = 9.4, 6.4
Hz, 1H).
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Figure

7.31:

1

H

NMR

of

1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(4-

methoxyphenyl)thiourea
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Figure 7.32:

13

C NMR of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(4-

methoxyphenyl)thiourea
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Figure 7.33: Mass spectrum of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(4methoxyphenyl)thiourea
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Synthesis of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(3,5dimethylphenyl)thiourea

CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using
DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 9.60 (s, 1H), 8.25 – 8.20 (m,
2H), 7.66 – 7.58 (m, 2H), 7.31 (d, J = 8.6 Hz, 1H), 7.04 (ddt, J = 10.5, 1.6, 0.8 Hz, 4H),
6.96 (s, 2H), 6.74 (dq, J = 1.7, 0.8 Hz, 1H), 6.14 (d, J = 4.5 Hz, 1H), 5.21 – 5.14 (m, 1H),
5.01 (dd, J = 6.4, 4.4 Hz, 1H), 4.58 (d, J = 6.9 Hz, 1H), 3.57 (dt, J = 9.6, 4.7 Hz, 1H), 3.49
(td, J = 9.5, 6.4 Hz, 1H), 2.25 – 2.20 (m, 6H).
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Figure 7.34:

1

H NMR of

1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(3,5-

dimethylphenyl)thiourea
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Figure 7.35:

13

CNMR of

1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(3,5-

dimethylphenyl)thiourea
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Figure 7.36: Mass spectrum for 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(3,5dimethylphenyl)thiourea
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Figure 7.37: Disk assay for CAM base without any functionalization using Thermus thermophilus
HB27
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Molecular modelling and docking studies
The PDB structures that was used are 4V7W and 1PD5. Both structures had CAM docked in to
them in their crystal form. Hence this was a starting point for our calculations. We kept the CAM
at the same bound site and we changed the functional groups accordingly, then molecular dynamics
was performed to investigate the most optimum flexible assignment. Once this was obtained the
CAM derivative was then docked. The docking method used was triangle matcher, with London
dG scoring system. 100 poses were allowed. Refinement was performed using rigid receptor
method with a scoring function of GBVI/WSA dG. Next the best 5 poses were refined, and the top
one with the highest docking score was used to find ligand interactions and surfaces.
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Figure 7.38: Binding of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea to the ribosome pocket, with the generated surface for the
receptor
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Figure 7.39: Van der Waals interactions of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3dihydroxy-1-(4-nitrophenyl)propan-2-yl)thiourea with the ribosome amino acids

Figure 7.40: Ligand interaction diagram of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3dihydroxy-1-(4-nitrophenyl)propan-2-yl)thiourea to the ribosome
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Figure 7.41: Binding of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea to the CAM acetyl transferase pocket, with the generated surface
for the receptor
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Figure 7.42: Van der Waals interactions of of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3dihydroxy-1-(4-nitrophenyl)propan-2-yl)thiourea with the CAM acetyl transferase amino acids

Figure 7.43: Ligand interaction diagram of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3dihydroxy-1-(4-nitrophenyl)propan-2-yl)thiourea for the CAM acetyl transferase enzyme
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Figure

7.44:

Binding

of

1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-

(4nitrophenyl)thiourea to the ribosome pocket, with the generated surface for the receptor
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Figure 7.45: Van der Waals interactions of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)-3-(4nitrophenyl)thiourea with the CAM acetyl transferase amino acids

Figure 7.46: Ligand interaction diagram of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)-3-(4nitrophenyl)thiourea for the CAM acetyl transferase enzyme
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Figure

7.47:

Binding

of

1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-

(4nitrophenyl)thiourea to the CAM acetyl transferase pocket, with the generated surface for the
receptor

492

Figure 7.48: Van der Waals interactions of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)-3-(4nitrophenyl)thiourea with the CAM acetyl transferase amino acids

Figure 7.49: Ligand interaction diagram of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)-3-(4nitrophenyl)thiourea for the CAM acetyl transferase enzyme
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Figure 7.50: Binding of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)thiourea to the ribosome pocket, with the generated surface for the receptor
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Figure 7.51: Van der Waals interactions of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea with the ribosome amino acids

Figure 7.52: Ligand interaction diagram of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea to the ribosome
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Figure

7.53:

Binding

of

of

1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea to the CAM acetyl transferase pocket, with the generated surface
for the receptor
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Figure 7.54: Van der Waals interactions of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea with the CAM acetyl transferase amino acids

Figure 7.55: Ligand interaction diagram of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea for the CAM acetyl transferase enzyme
497

Figure

7.56:

Binding

of

1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(4-

methoxyphenyl)thiourea to the ribosome pocket, with the generated surface for the receptor
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Figure 7.57: Van der Waals interactions of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)-3-(4-methoxyphenyl)thiourea with the ribosome amino acids

Figure 7.58: Ligand interaction diagram of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)-3-(4-methoxyphenyl)thiourea to the ribosome
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Figure

7.59:

Binding

of

1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(4-

methoxyphenyl)thiourea to the CAM acetyl transferase pocket, with the generated surface for the
receptor
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Figure 7.60: Van der Waals interactions of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)-3-(4-methoxyphenyl)thiourea with the CAM acetyl transferase amino acids

Figure 7.61: Ligand interaction diagram of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)-3-(4-methoxyphenyl)thiourea for the CAM acetyl transferase enzyme
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Figure

7.62:

Binding

of

1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(3,5-

dimethylphenyl)thiourea to the ribosome pocket, with the generated surface for the receptor
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Figure 7.63: Van der Waals interactions of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)-3-(3,5-dimethylphenyl)thiourea with the ribosome amino acids

Figure 7.64: Ligand interaction diagram of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)-3-(3,5-dimethylphenyl)thiourea to the ribosome
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Figure

7.65:

Binding

of

1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(3,5-

dimethylphenyl)thiourea to the CAM acetyl transferase pocket, with the generated surface for the
receptor
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Figure 7.66: Van der Waals interactions of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)-3-(3,5-dimethylphenyl)thiourea with the CAM acetyl transferase amino acids

Figure 7.67: Ligand interaction diagram of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)-3-(3,5-dimethylphenyl)thiourea for the CAM acetyl transferase enzyme
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Figure

7.68:

Binding

of

1-(2,5-dihydrofuran-2-yl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea to the ribosome pocket, with the generated surface for the
receptor
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Figure 7.69: Van der Waals interactions of 1-(2,5-dihydrofuran-2-yl)-3-((1R,2R)-1,3-dihydroxy1-(4-nitrophenyl)propan-2-yl)thiourea with the ribosome amino acids

Figure 7.70: Ligand interaction diagram of 1-(2,5-dihydrofuran-2-yl)-3-((1R,2R)-1,3-dihydroxy1-(4-nitrophenyl)propan-2-yl)thiourea to the ribosome
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Figure

7.71:

Binding

of

1-(2,5-dihydrofuran-2-yl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea to the CAM acetyl transferase pocket, with the generated surface
for the receptor
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Figure 7.72: Van der Waals interactions of 1-(2,5-dihydrofuran-2-yl)-3-((1R,2R)-1,3-dihydroxy1-(4-nitrophenyl)propan-2-yl)thiourea with the CAM acetyl transferase amino acids

Figure 7.73: Ligand interaction diagram of 1-(2,5-dihydrofuran-2-yl)-3-((1R,2R)-1,3-dihydroxy1-(4-nitrophenyl)propan-2-yl)thiourea for the CAM acetyl transferase enzyme
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Figure

7.74:

Binding

of

1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea to the ribosome pocket, with the generated surface for the
receptor
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Figure 7.75: Van der Waals interactions of 1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1(4-nitrophenyl)propan-2-yl)thiourea with the ribosome amino acids

Figure 7.76: Ligand interaction diagram of 1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1(4-nitrophenyl)propan-2-yl)thiourea to the ribosome
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Figure

7.77:

Binding

of

1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea to the CAM acetyl transferase pocket, with the generated surface
for the receptor
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Figure 7.78: Van der Waals interactions of 1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1(4-nitrophenyl)propan-2-yl)thiourea with the CAM acetyl transferase amino acids

Figure 7.79: Ligand interaction diagram of 1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1(4-nitrophenyl)propan-2-yl)thiourea for the CAM acetyl transferase enzyme
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Figure 7.80: Binding of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)thiourea to the ribosome pocket, with the generated surface for the receptor
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Figure 7.81: Van der Waals interactions of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea with the ribosome amino acids

Figure 7.82: Van der Waals interactions of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea with the ribosome amino acids
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Figure 7.83: Binding of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)thiourea to the CAM acetyl transferase pocket, with the generated surface for the receptor
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Figure 7.84: Binding of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2yl)thiourea to the CAM acetyl transferase pocket, with the generated surface for the receptor

Figure 7.85: Ligand interaction diagram of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4nitrophenyl)propan-2-yl)thiourea for the CAM acetyl transferase enzyme
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Figure

7.86:

Binding

of

1-(2-chloro-4-nitrophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea to the ribosome pocket, with the generated surface for the
receptor
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Figure 7.87: Ligand interaction diagram of 1-(2-chloro-4-nitrophenyl)-3-((1R,2R)-1,3-dihydroxy1-(4-nitrophenyl)propan-2-yl)thiourea to the ribosome
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Figure

7.88:

Binding

of

1-(2-chloro-4-nitrophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-

nitrophenyl)propan-2-yl)thiourea to the CAM acetyl transferase pocket, with the generated surface
for the receptor
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Figure 7.89: Ligand interaction diagram of 1-(2-chloro-4-nitrophenyl)-3-((1R,2R)-1,3-dihydroxy1-(4-nitrophenyl)propan-2-yl)thiourea for the CAM acetyl transferase enzyme

521

